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Genetic sequencing has been recognized as an effective approach to accurately address
biological problems, such as clinical detection of disease, mutation discovery, and targeting
specific biomarkers associated with complex diseases. Compared with conventional Sanger
sequencing, next-generation sequencing costs much less due to massively parallel highthroughput sequencing. However, due to large numbers of short read sequences, the accuracy of
high-throughput sequencing data remains a challenge in that the data obtained from nextgeneration sequencing often has higher error rates, which may impact downstream genomic
analysis. Even if the downstream genomic analysis performs well, the quality of the result will
still be impacted by the quality of the data. Before proceeding to downstream analysis, data
quality assessment is necessary. Error rate estimation studies have been able to describe the
quality of sequencing reads obtained from a sample. However, these studies may have
limitations when sequencing a new genome or under a linearity assumption that the number of
sequences containing errors increases linearly with the number of error-free read counts, which
may not be available for all types of sequencing data. Therefore, it is necessary to estimate
sequencing error rates in a more reliable way. In this dissertation, we proposed an empirical error
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rate estimation approach that employs nonlinear statistical models of cubic smoothing splines
and robust smoothing splines to analyze the association between the number of shadow counts
and the number of error-free read counts. Traditional approaches to simulation when analyzing
sequencing data may not reflect the real structure of the sequencing data. We also proposed a
frequency-based simulation approach that mimics the real sequencing count framework and has
more computational efficiency. Based on all the simulation scenarios tested, our proposed
empirical error rate estimation approach provided more accurate estimations than the shadow
regression approach. We also redefined the per-read error rate so that it is more flexible and
provides more information according to the sequencing reads. The proposed empirical error rate
estimation approach was applied to assess the sequencing error rates of bacteriophage PhiX
DNA samples, a MicroArray Quality Control project, a mutation screening study, the
Encyclopedia of DNA Elements project. The proposed empirical error rate estimation approach
is free from the limitation of a linearity assumption between the number of shadow counts and
the number of error-free read counts and demonstrates more accurate error rate estimations for
next-generation short read sequencing data.
The errors of next-generation sequencing data discussed in the literature concern sequences with
up to two bases that are different from error-free reads by substitution. In this thesis, we also
extended the study of error rate estimations to different shadow scenarios, including varying the
substitution shadows to be sequences in which only one base is different, only two bases are
different, and up to two bases are different form error-free sequencing reads, and extending the
investigation to deletion and insertion error rates. The deletion and insertion error rates are
calculated differently from multiple approaches. For the extended investigation, both simulation
studies and real data analyses were performed using empirical error rate estimation approaches
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and shadow regression approaches. Under the simulation scenarios tested, the empirical error
rate proved to be more accurate and resulted in less biased estimation for the deletion and
insertion analysis.

In this dissertation, we also studied the human microbiome, which has been associated with
complex diseases, for example, cardiovascular disease, diabetes, obesity, and specific cancers.
To our knowledge, the existing literature has rarely discussed how to process raw human
microbiome data and convert it into the format of downstream operational taxonomic units. We
reviewed multiple statistical methods for processing, summarizing and analyzing microbiome
data, and also provided detailed programming scripts about how to process human microbiome
data into a downstream analysis format and assess alpha diversities, beta diversities, and the
association between sample diversities and the outcome of interest. For illustration, the statistical
approaches were also applied to analyze the foregut microbiome in esophageal adenocarcinoma.
For future directions of research, we provided a potentially effective strategy for analyzing
longitudinal human microbiome data associated with complex diseases by using a Bayesian
network approach. The Bayesian graphical model approach accounts for interaction with the
microbiome and captures the common structure of change within the microbiome, which
provides insights to predict the change in the composition of the microbiome over time and find
specific microbiome taxa that may be associated with complex diseases.
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Chapter 1
Introduction

Biomedical research has identified associations between genetic variants and complex human
diseases. Studies on genetic sequences have provided invaluable insights into complex diseases,
suggested novel therapeutic strategies, and contributed to effective personalized treatment
regimens and disease prevention strategies (1, 2). Downstream genomic sequencing analyses
have been conducted to identify sequences associated with complex diseases using multiple
sequencing methods. However, it remains a challenge to accurately assess the quality of the
sequencing data each time a sample is obtained.
The percentage of reads mapped has been widely used as a quality indicator; however, that does
not directly address the fundamental question of how much error is present in the samples to be
studied in downstream genomic analyses (3, 4). Estimating the error rate typically requires using
a reference genome, which may not be appropriate when sequencing a new genome when such a
reference genome has not been established.
In this thesis, we developed statistical models to estimate sequencing error rates, including those
of substitution, deletion, and insertion in next-generation sequencing data. We also studied and
reviewed the statistical approaches used to analyze human microbiome data, and provided a
future direction for analyzing longitudinal human microbiome data. The study on the human
microbiome may provide novel strategies about effective treatment and prevention of complex
diseases.
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In Chapter 1, we introduce multiple sequencing approaches, including Sanger sequencing, nextgeneration sequencing, DNA sequencing, RNA sequencing, and 16S rRNA sequencing of the
human microbiome.

1.1 Sanger Sequencing

Automated Sanger sequencing represents the first generation of DNA sequencing (5), and has
been widely used in a diverse range of areas to solve various biological problems and identify
clinically significant DNA variants associated with disease (6). For example, Sanger sequencing
has been used to identify an appropriate treatment strategy that inhibits epidermal growth factor
receptor tyrosine kinase for specific patients with non–small-cell lung cancer (6, 7). Sanger
sequencing has been used so widely to evaluate non-syndromic hearing loss that most genetic
testing strategies for this disorder depend on the gene-specific Sanger sequencing technique (8).

Developed by Sanger and colleagues (9), the original sequencing technology used a chaintermination sequencing approach to determine nucleotide sequences in DNA. Novel technologic
developments have been applied to improve Sanger sequencing, resulting in the modern form of
Sanger sequencing, which detects fluorescently labeled nucleotide sequences by applying
automated sequencing instruments (6). In Sanger sequencing, a DNA sample is sheared into
fragments, subcloned into different vectors, and then amplified in bacterial or yeast hosts (10).
The amplified DNA is then isolated and sequenced with the Sanger chain termination approach.

Sanger sequencing has a low error rate and was long considered to be the “gold standard” for
sequencing genetic mutations (11, 12). Sanger sequencing can achieve up to about 1,000 bp, with
2

per-base “raw” accuracies as high as 99.999%, which makes it the most accurate sequencing
approach currently available (5). Sanger sequencing can read DNA fragments that are
approximately 500 bp to 1kb in length. Performing traditional Sanger sequencing requires
moderate expertise; whereas sequencing approaches such as next-generation sequencing require
a high level of expertise (6).

Despite the advantage of accuracy and strong availability in Sanger sequencing, there are
technical limitations in this first-generation sequencing technique. One major limitation involves
the limited throughput of the DNA sequence that can be read with each sequencing reaction (13).
Traditional Sanger sequencing is generally restricted to one gene at a time; hence it does not
easily sequence hundreds of genes in a sample. In addition, traditional Sanger sequencing cannot
detect deletions, translocations, or gene copy number alterations. (6) Sanger sequencing requires
electrophoretic separation of DNA fragments for DNA sequence reading, which leads to the
primary bottleneck for throughput data in this traditional sequencing approach (13). The process
of Sanger sequencing is lengthy and requires labor-intensive cloning-based amplification that
also limits its application for high-throughput genome sequencing (10). Another limitation is the
high cost of traditional Sanger sequencing. With a throughput of Sanger sequencing of
approximately 115 kb per day (1,000 bp), the current cost to sequence the entire human genome
using Sanger sequencing is estimated to be up to 30 million U.S. dollars. In addition, using one
single machine, this task will take approximately 60 years. (13)

These limitations of Sanger sequencing restrict its use to mainly the generation of reference
genome sequences of many species, including those of humans. (10)
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1.2 Next-Generation Sequencing

New sequencing approaches have been emerging that overcome the limitations of Sanger
sequencing. Next-generation sequencing technology has played an essential role in biological
research. Next-generation sequencing offers radically fast sequencing capability and produces
large amounts of DNA, which has significantly driven down the cost of genetic sequencing (13).
For example, one typical next-generation sequencing procedure can sequence millions of short
reads at the same time and provide high-throughput of parallel DNA sequences in a single
reaction.

In general, next-generation sequencing uses double-stranded DNA as the initial input material,
although the technology can accommodate multiple types of starting materials. Even though the
source of starting material may vary, the data are then converted into a sequencing library in a
process that uses common fragmentation steps, size selection, and adapter ligation (13). As the
sequencing material comes into the fragmentation and size selection stage, DNA templates are
broken into smaller fragments for further DNA-pair synthesizing, and adapter ligations are then
added with synthetic DNA to the ends of the library fragments that serve as primers for
downstream amplification and sequencing reactions (13). In the next-generation technique, the
sequencing library is either sequenced directly or is amplified and then is sequenced (13). DNA
sequencing represents a single format, but projects a wide variety of biological phenomena
through the analysis of high-throughput sequencing data (5, 13).

Compared to other sequencing techniques, next-generation sequencing has significantly
decreased the per-base sequencing cost and increased the sequencing volumes, which always
4

leads to high-throughput genome-wide sequencing data. The next-generation sequencing
approach has a number of appealing features, including the high-throughput capacity of parallel
sequencing and the ability to simultaneously detect multiple genetic events, including deletions,
insertions, copy number alterations, translocations, and exome-wide base substitutions
(especially known “hot-spot mutations”) in genes associated with disease susceptibility (6).
Moreover, compared with traditional Sanger sequencing, next-generation sequencing is not
restricted to sequencing a single gene at a time and can generate millions of sequencing reads
simultaneously using a surface area of a reasonable size (5, 6). With the advent of highthroughput next-generation sequencing, genomic investigations have expanded to include a more
diverse range of genomic alteration phenomena, which has opened entirely new areas of
biological inquiry, such as single-nucleotide polymorphisms (14), epigenetic events (15), copy
number variants (16), differential expression (17), alternative splicing, the characterization of
ecological diversity, and the identification of unknown etiologic agents (6, 18-20). In addition,
next-generation sequencing platforms have enabled researchers to directly sample the nuclear
genomes obtained from ancient remains, including those of a cave bear (21), mammoth (22), and
Neanderthal(18, 23, 24). Next-generation sequencing has widened the scope of metagenomic
analysis to environmentally derived samples (18).

Despite the advantages of next-generation sequencing, the increased capacity of high-throughput
parallel sequencing comes at the cost of read length and sequencing accuracy (13). The most
prominent shortcomings in next-generation sequencing are the short sequencing read lengths and
raw accuracy, which has affected how the reads are utilized in bioinformatic analyses and
downstream analyses (5, 18). In addition, researchers face the computational challenge of
mapping the sequenced reads against a reference genome to independently verify the alignment
5

of the reads of interest. Moreover, for comprehensive resequencing of short reads, a much higher
read coverage or sampling depth is required to cover the reference sequence at adequate depth
and ensure a low gap size in a valid phenotype-genotype association study using the nextgeneration technique (18). There is a great need for new statistical approaches to use in the
generation and analysis of next-generation sequencing since traditional methods have
shortcomings when measuring the quality of sequencing data. The commonly used per-base
quality score, which counts the probability of a called base in the read being the true sequence
base, is quite raw and inaccurate. These misaligned reads and inaccurate quality scores, which
propagate into genotyping and single-nucleotide polymorphism (SNP) discovery, have become
general and acute problems in many centers that use rapidly evolving experimental processing
pipelines, including the 1000 Genomes Project. Even if well-mapped and calibrated reads are
given, caution should be taken when statistical modeling is used to resolve the case of simple
SNPs, not to mention the more complicated variations such as multi-nucleotide substitutions,
insertions, deletions, inversions, and copy number variation. (25)

Next-generation platforms are affecting a complete paradigm shift, including in the organization
of large-scale data production, downstream bioinformatics, information technology,
computational data storage, and support of laboratory information management infrastructure
(18). Existing data analysis pipelines that use next-generation data and the accompanying
algorithms must be adjusted to accommodate short read sequencing data. For example, new
algorithms and data visualization interfaces are being devised and modified to satisfy the
demands in next-generation sequencing (18).
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1.3 RNA Sequencing

Another application of next-generation sequencing is RNA sequencing, which uses the nextgeneration sequencing approach to sequence, map, and quantify a population of transcripts (10,
20, 26). RNA sequencing transcriptomes can be profiled with deep sequencing technologies (27).
Deep sequencing technologies for RNA sequencing are invaluable for detecting RNA expression
levels and identifying changes in RNA structure (28). At the time of sequencing, a general
procedure is to convert a region of RNA to cDNA fragments with adaptors attached to either one
or both ends of the read (29). After the initial sequencing, short sequences, ranging from 30 to
400 bases, can be generated in a high-throughput manner (29).

RNA sequencing technology provides a precise measurement of the levels of transcripts and
isoforms (27). The transcriptome refers to the complete transcript set in a cell, and the
corresponding quantity can be synthesized and then measured in a specific developmental stage
or condition via RNA sequencing (27). With RNA sequencing, it is feasible to distinguish
specific genomic locations of transcription boundaries in the fairly high resolution of a single
base pair as well as the rare variations in transcription regions (29-31). In addition, mRNA
expression studies that use RNA sequencing have been utilized in microarrays or quantitative
polymerase chain reactions (18). The identification of epigenetic events by investigating changes
of RNA expression in RNA sequencing can be used to reveal historical environmental exposures
and identify associated impacts in disease (28). Another big contribution of RNA sequencing is
to address the heritability component of both common and rare variants, and measure the
interactions between the genome and the environment in biological studies (28). RNA
sequencing technology has provided unprecedented insights into the transcriptional complexities
7

of a variety of organisms, including yeast (32), mice (26), Arabidopsis (33), and humans (19,
20). RNA sequencing has revolutionized the analysis of eukaryotic transcriptomes and has been
applied to the study of Saccharomyces cerevisiae, Schizosaccharomyces pombe, Arabidopsis
thaliana, and mouse and human cells (27, 29, 30, 34-37). Benefits of implementing RNA
sequencing include a potentially unlimited dynamic range of expression, better sensitivity in
genetic sequencing, greater capacity to discriminate regions of high sequence identity, and the
ability to profile transcription without prior assumptions on which genomic regions are expressed
(38). The analysis of RNA sequencing has generated an unprecedented global view of the
transcriptome and the corresponding organization and grouping for species and cell types (27).
Compared to DNA sequencing, RNA sequencing provides a lower background signal and does
not require an upper limit of quantification that correlates with the number of sequencing reads
that would be obtained in the sequencing procedure (27). RNA sequencing also facilitates
learning the dynamics of the transcriptome across different tissues or conditions without data
normalization (27, 30, 36). For example, researchers have utilized RNA sequencing to accurately
monitor gene expression in yeast vegetative growth (34), yeast meiosis (35), mouse embryonic
stem cell differentiation (30), and to track and measure the differences in gene expression
between various tissues (27, 36).

After obtaining sequencing data, the most urgent challenge arises from mapping the RNA
sequencing data to the reference genome, which is regarded as much harder than mapping the
data derived from DNA due to the high-throughput sequencing (38). RNA sequencing brings
additional challenges of how to efficiently store, retrieve, and process large volumes of
sequencing data and how to reduce sequencing errors and remove low-quality sequencing reads
(27). Typically, the larger the set of sequencing genomic data, the more complicated the
8

statistical modeling of the transcriptome. This occurs because sufficient sequencing depth must
be controlled to achieve adequate coverage of such a large volume of data (27). Improper control
will result in complicated, error-prone estimations of the transcriptome coverage since it is hard
to know the usual number and level of different transcript isoforms, and the activity of
transcription can vary across the genome (27). For example, when dealing with rare RNA
isoforms, it becomes even harder to use RNA sequencing to target these complicated
transcriptomes to monitor the changes in gene expression levels across the whole genome (27).

1.4 Human Microbiome

Another application of next-generation sequencing technology is the sequencing of the human
microbiome (18). The advantages offered by next-generation sequencing techniques have
initiated a revolution in our understanding of how the human microbiome affects a human health
and diseases (18). Recent technologic advances have enabled the deep sequencing and analysis
of the composition of the microbiome (39). The microbiome refers to the entire set of
microorganisms living within a given habitat and the corresponding genomes and surrounding
environmental conditions (40). The metagenome consists of the complex set of genetic
sequences of the microbiome plus human DNA sequences (41).

The human microbiome interacts dynamically with our daily environment and is essential to
human health (42). Studies have suggested that the human microbiome plays a central role in an
individual’s nutrition, immunity, and protection from various pathogens within the body (41, 43,
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44). The microbiome functions within a complicated microbial community and processes energy
and materials for the human body (45, 46). According to the Human Microbiome Project, the
majority of microbial species in humans have never been isolated or cultured due to our inability
to reproduce the necessary growth conditions in the lab (47).

The human body is inhabited by a complicated collection of microbes that includes bacteria,
fungi, viruses and eukaryotes that live symbiotically within several highly specific environments
that may vary according to the individual’s health status (18, 39, 42). On average, each human
hosts a microbiome that consists of 10-100 trillion symbiotic microbial cells, which are almost
10 times the total number of human somatic and germ cells in the body (42, 45, 46). The
composition of the microbiome varies according to the individual’s genotype, health, diet,
lifestyle, social interactions, early use of antibiotic therapy, and exposure to environmental
chemicals (45, 48). The variation of bacterial species within the microbiome is significantly
different between individuals, and the corresponding composition in the microbiome impacts its
habitat (41, 44). The composition and diversity of the microbiome may be further impacted by
the mode of birth delivery, and hospitalizations (41). For example, dietary habits may impact the
phylogenetic diversity and function of the human microbiome in disease risk and penetrance
(41).

In addition, the composition of the microbiome undergoes dynamic change in the human body
over time. For example, the intestinal microbiome changes dramatically in composition
throughout infancy and childhood (41). A study showed that the composition of the gut
microbiome is significantly different between adolescents, children, and adults, which implies
that the composition of the human microbiome evolves during the periods of childhood and
10

adolescence (41). Therefore, the study on longitudinal data in humans may provide essential
insights and further understanding of the fundamental interactive structure of the human
microbiome and its association with complex diseases.

The understanding and recognition of the importance of the human microbiome has not been
fully accomplished due to the complicated and dynamic nature of the microbiome and the limited
sequencing analysis related to the microbiome (39). Studies of the human microbiome may
provide diagnostic solutions for certain diseases and play a role in standard clinical practice in
the future (39).

1.4.1 16S ribosomal RNA Sequencing
One major application in the analysis of the human microbiome using next-generation
sequencing methods refers to 16S ribosomal RNA (rRNA) sequencing, which identifies and
compares bacteria within a given sample (49)[49]. The 16S rRNAs are the genes encoding from
a ribosomal RNA molecule, which are conserved in both bacteria and archaea (40). The 16S
rRNA sequencing procedure allows for the identification of species from a complicated mixture
of the microbiomic community (40). The terms “16S rRNA gene” and “16S rDNA gene” have
been used interchangeably. The current Application Security Manager (ASM) policy uses the
term “16S rRNA” (50). The 16S rRNA sequences are often between 500 bp and 1550 bp in
length(50). Universal primers are utilized that are complementary to conserved regions. The
sequences in the variable region are utilized as comparative taxonomy (50).
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With the rapid development of sequencing technology, 16S rRNAs have been widely used as the
primary tool to investigate taxonomic assignment and phylogenetic trees (51). For instance, 16S
rRNA has been commonly used for phylogenic study, taxonomic classification, and to infer
microbiome diversity of clinical or environmental samples (51).

One prominent advantage that makes 16S rRNA the primary tool in microbiome sequencing is
that 16S rRNA is universal in bacterial. 16S rRNA is present in at least one copy over all the
bacterial genome, which makes the comparison and measurement in the same window for all the
bacteria. Another advantage is the stability in 16S rRNA that the corresponding function in 16S
rRNA does not vary over time. In addition, the 16S rRNA genes are adequately large for
informatics purposes, and the conserved regions are available for simple sample identification.
16S rRNA sequencing provides reliable information on the bacterial family or species (50-52) .

16S rRNA sequencing provides rapid, robust, reproducible, and accurate identification measures
for various bacteria, which may lead to clinical improvements, such as the discovery of novel
pathogens and identifying noncultured bacteria (50). Studies that analyze 16S rRNA gene
sequencing contribute to further understanding of clinical microbiology and associated infectious
diseases, enables accurate identification on the level of the microbiome species, and clarifies the
associated clinical importance (50).

Despite the advantages associated with using 16S rRNA sequencing, a downside of the 16S
rRNA technique may refer to the difficulty in specifying the one-to-one correspondence. As
there are more distinct taxonomy than the well-known ones that have names or phenotypic
descriptions, it is challenging to assign names to each taxon in a meaningful way (50). Another
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downside may refer to the high expertise requirement for technical skills and the high cost of 16S
rRNA sequencing (50).

Currently, there are two established approaches for utilizing 16S rRNA to measure and quantify
the microbiome and assign sequences to different microbiome groups at different taxonomic
levels. These two established approaches are the phylotypes approach and the operational
taxonomic units approach (40). The phylotypes approach depends on the comparison with
reference sequences and assignment into taxonomic bins. The phylotypes approach searches
public databases, such as the Ribosomal Database Project (53), the SILVA database (54), or the
Greengenes database (40, 55). The major benefit of using the phylotypes approach is that it
enables sequencing classification based on the previously characterized and often clinically
related microbiome (40). A limitation is that this approach lacks a coherent definition of the
reference sequences for the bacterial species for the whole taxonomic lineage, which makes it
impossible to consistently define bacterial taxa (40). There are also conflicts in several widely
used taxonomies regarding taxonomic lineages (40). The second approach to measuring
microbiome communities refers to operational taxonomic units (OTUs), where 16S rRNA gene
sequences are clustered into OTUs at a pre-specified similarity threshold (usually the threshold is
defined to be 97%), which are equivalent to species-level clusters (40). The approach of
measuring the OTUs overcomes the limitations in the phylotypes approach, which lacks a
coherent definition for all taxonomic lineages. Initially, the OTUs measuring approach calculates
the taxonomic unit independently from a reference database. Sequences that can be mapped to
known bacteria are assigned to the known taxonomy, while sequences that do not match the
known taxonomy are clustered based on similarity (40). A table about abundance within the
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microbiome can be generated and used for downstream statistical analysis with species counts or
compositional structure.

In the use of 16S rRNA for microbiome studies, a harmonious set of guidelines and measures for
the interpretation of sequencing data is necessary in order to accurately compare the results
between different studies (52). Standard 16S rRNA gene sequencing downstream analysis
includes microbiome alpha diversity, beta diversity, and an association study. The diversity is an
estimate to characterize and quantify the structure of a microbiome community based on
measuring information, including the number of species (richness) and relative abundance
(evenness) (40). The alpha diversity estimates the diversity within a sample, such as the Shannon
index (56), Simpson index (57), and Chao1 (58) estimators. Furthermore, the beta diversity
estimates the between-sample habitat diversity, which describes the distance or similarity
between samples (40). Some widely used beta diversity measures include Bray-Curtis (59), Cao
dissimilarity index (60), and UniFrac (61).

As adapting 16S rRNA gene sequencing as a tool in species identification is still a relatively new
undertaking in most clinical laboratories, the standard measuring approaches will continue to
evolve over time (52). Despite the accuracy in 16S rRNA, this type of analysis has not been
widely implemented in large clinical and research laboratories due to technical and cost
considerations. Thus, further studies in 16S rRNA sequencing may depend on translating 16S
rRNA sequencing information into convenient biochemical testing schemes and making it
available in a routine analysis format (50).

14

1.4.2 16s rRNA versus Whole-Genome Shotgun Sequencing
16S rRNA has been widely used to study species composition in bacterial communities (62).
However, 16S rRNA sequencing might be biased when unequal amplification occurs in the
sequencing process and a direct genetic identification is lacking (62, 63).

An alternative method for studying bacterial composition and diversity is whole-genome shotgun
sequencing, which utilizes a sequencing technique with random primers to sequence overlapping
regions in a genome (62, 63). In whole-genome shotgun sequencing, DNA sequences are
extracted from all cells in a community and subsequently sheared into small fragments that are
independently sequenced. The small fragments are then aligned to various genomic locations
(64). Whole-genome shotgun sequencing can be used to sequence the genome over all
microorganisms in a sample, whereas the domain of 16S rRNA is restricted to bacteria and
archaea (65).

The major advantage to whole-genome shotgun sequencing is the capacity to identify taxa more
accurately at the species level (63). Studies have shown that whole-genome shotgun sequencing
can detect a more specific taxonomic and functional classification of sequencing reads (65, 66).
Whole-genome shotgun sequencing also allows for the simultaneous study of archaea, viruses,
virophages, and eukaryotes (66, 67).

Despite its benefits, whole-genome sequencing presents several challenges. The shotgun
metagenomic sequencing is more expensive and usually not deep enough to detect rare species
within the microbiome (62, 63). In addition, shotgun sequencing requires more extensive data
analysis and sequencing a genome with high coverage in order to identify and understand the
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taxa in bacteria (63). Moreover, the relative abundances obtained from shotgun sequencing vary
significantly depending on the DNA extraction and sequencing protocol (62). When the genome
database is limited, it may miss taxa due to unassigned sequences in the whole-genome shotgun
sequencing approach (68). As the metagenomic dataset is relatively complicated and large, it
may also be difficult to determine from which read the genome was derived (64).

16S rRNA sequencing has been the most commonly employed approach to study bacterial
microbiomes (63). Previous studies revealed that 16S rRNA sequencing can profile bacterial
communities in greater detail than shotgun sequencing. In addition, 16S rRNA sequencing can
better identify species with low abundance compared with shotgun sequencing (62). Moreover,
16S rRNA sequencing is cost-effective, and allows data analysis to be performed on established
pipelines (63). There is a large number of archived datasets available for reference in 16S rRNA
sequencing (63). Studies have also shown that it may be more appropriate to use 16S rRNA
sequencing for the analysis of a large number of samples, such as multiple patients and
longitudinal studies (65).

1.5 Motivation and Rationale of the Thesis

Next-generation sequencing has been used to address a wide variety of biological investigations,
for example, quantification of gene expression, microRNA profiling study, genome-wide
association study of protein–DNA interactions, and polymorphism and mutation discovery (4, 5,
69-75). Next-generation sequencing applied to the clinical practice of medicine has laid the
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foundation of personalized genome-based medicine, which is enhancing the accuracy and
efficiency of disease diagnosis and treatment (13).

Due to the high capacity of parallel sequencing and much smaller reaction volume in nextgeneration sequencing, large-scale research projects have quickly come to depend entirely on
next-generation sequencing because of the accompanying advantages in cost and sequencing
capacity, and the practical aspects of implementation (4, 5, 69, 74).

However, the quantity of large number of short reads and quality of the data in next-generation
sequencing has posed challenges for biostatistics and bioinformatics in terms of sequencing
quality scoring (5). The quality and quantity of next-generation sequencing ultimately
determines the comprehensiveness and accuracy of the downstream statistical analysis (13).
Qualitatively, the platforms of next-generation sequencing provide confidence scores for each
individual base call, and the individual base calling error rates vary based on different
sequencing platforms (13). According to a study on the chemistry of next-generation reactions,
the initial portion of each sequencing read is generally more accurate than the latter portion (13).
Quantitatively, the amount of sequencing data is assessed by the sequencing coverage, which
refers to the average sequencing time for a base pair in the experiment (13).

Producing a large number of short reads at the same time leads to difficulty correctly and fully
assembling the sequencing reads in next-generation sequencing (69). The quality of the
sequencing data directly impacts the downstream genomic analysis (69, 74, 76). Before
performing downstream genomic analysis, it is necessary to have quality assessment to ensure
the sequencing data do not negatively impact the downstream genomic analysis (69, 77). The
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traditional method that uses a reference to estimate the sequencing error rate depends on a wellestablished reference, which has limitations when sequencing new data, such as the microbiome
or the genome of a new species (69, 78). A shadow regression approach that uses a referencefree method and is applicable to multiple datasets, including mRNA sequencing data and DNA
sequencing data, has been proposed. (4, 69) However, the shadow regression approach depends
on the underlying assumption that the number of sequencing reads with shadows increases
linearly with the number of error-free sequences, which may not be appropriate for all types of
sequencing data (69).

In Chapter 2, an empirical error rate estimation approach is proposed to model the nonlinear
relationship between the number of sequences with shadows and the number of error-free read
counts by cubic smoothing spline and robust smoothing spline approaches (69). The per-read
sequence error rate is redefined, and provides more information according to the sequencing
reads (69). In addition, a frequency-based simulation approach is developed based on the
sequencing read counts, which can mimic the real sequencing data structure and reflect the
nonlinear structure more realistically than Wang et al.’s simulation method (69). The study
described in Chapter 2 has been published in BMC Bioinformatics (69).

Chapter 2 focuses on developing an empirical error rate estimation approach for substitution
error rates, which are the sequencing error rates discussed in the majority of the literature. The
shadows defined are sequences with up to two bases different from the error-free reads in the
sample. In Chapter 3, the sequencing error rate estimation is extended to more general scenarios.
The sequencing error rates are tested by extending the definition of shadows to be different
numbers of bases in substitution, as well as error rates for deletion and insertion.
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Chapter 4 describes statistical approaches to study the association between human microbiome
and outcome of interest. The human microbiome has been associated with complex disorders.
Advances in sequencing technology have allowed us to generate large amounts of microbiome
data and enabled the quantification of the composition of the microbiome as high-dimensional
data. Such a study on the human microbiome will potentially inform the discovery of species in
the microbiome that are related to human health and disease. This chapter discusses approaches
for analyzing microbiome data, from the initial steps of processing raw sequencing data to the
downstream analysis, including assessing community-level diversities and their association with
outcomes of interest.

Chapter 5 discusses the extension for the study of human microbiome cross-sectional data to
longitudinal data, and provides a future direction regarding the analysis of the microbiome
through a time series of longitudinal data, which can sufficiently reflect the overall performance
of the composition of the human microbiome over time. A traditional longitudinal analysis of
microbiome data using a general linear model with a fixed effect or a single summary about
which indexes change for each sample has limitations, even in well-designed studies. Such
limitations involve taking the correlation of repeated measures into account and detecting
important effects on bacterial connections (79, 80). The analytical Bayesian network model for
longitudinal data not only accounts for the correlation on repeated observations, but also
performs more accurate estimation than conventional approaches. Chapter 5 provides a future
direction regarding processing sparse compositional microbiome data and using a Bayesian
network in a study of longitudinal time-series microbiome data.
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Chapter 2
Empirical estimation of substitution sequencing error rates using
smoothing splines

(Most of the studies in this chapter have been published online in BMC Bioinformatics,
April 2016: Xuan Zhu, Jian Wang, Bo Peng, Sanjay Shete, “Empirical estimation of
sequencing error rates using smoothing splines”. According to the journal policy, the
author retains the right to include the published article in full or in part in a dissertation.)
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2.1 Background

Complex diseases have been recognized associated with miscellaneous genetic variants. The
advent of next generation sequencing technology has enabled the studies to investigate a diverse
range of biological areas and provided unprecedented opportunities and insights to further
understand multiple disease functions. Next generation sequencing has been used in biological
investigations, such as identifying disease associated biomarkers, quantification of gene
expression, microRNA profiling, discovery of transcription factor binding sites, and wholegenome sequencing (5, 69, 70, 73, 81-83). Next generation sequencing refers to be the massively
paralleling high-throughput sequencing, which is capable of sequencing millions of short reads at
the same time (69, 84, 85). Due to large numbers of parallel sequencing and much smaller
reaction volumes, Next generation sequencing has a number of advantages over conventional
Sanger sequencing, such as significantly driving down the per base sequencing cost and
producing high-throughput sequencing (6, 19, 20, 69, 74, 83). Despite the advantages of next
generation sequencing, large numbers of short-read sequences of this technique makes it difficult
to correctly and fully assemble the sequences (69, 86-88). In addition, high throughput
sequencing in next generation sequencing is at a cost of raw accuracy that the error rates in next
generation sequencing are often higher than those in traditional Sanger sequencing, which has
become a general and acute problem using next generation sequencing data that negatively
impacts downstream genomic analysis (4, 25, 74, 83, 89, 90). Therefore, it is essential to assess
the quality of next generation sequencing data before performing downstream genomic analysis
(69, 77). Generally, the quality assessment methods include investigating sequence coverage,
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paired-end and fragment-size distributions, measuring sequence error rates, and quality matrices
(FastQC) (69, 77, 91, 92).
Currently, the percentage of reads mapped has been as a quality indicator assessing next
generation sequencing data; nonetheless, it does not address the fundamental question about how
much error is present from the sequencing reads in a sample (4). Alternative error rate estimation
approaches have been developed either using or not using a reference genome. Bullard et al. (93)
proposed a mismatch sequence counting approach under the assumption that the sequencing
reads with 0 mismatch had no error and the sequencing reads with 1 or 2 mismatches were errors
instead of polymorphisms. This mismatch sequence counting approach aligns the reads to a
reference genome in order to acquire the number of uniquely mapped reads with 0, 1, or 2
mismatches, and then calculates the per-read error rate as the proportion of sequence reads
containing errors (83). However, this approach requires a well-established reference, which may
not be applicable to sequence a new genome (69, 91).
Another approach using error correction tools according to k-mer (77, 94-100) is capable to
perform error rate estimation without requiring a reference genome and is less sensitive to errors
due to polymorphisms (101). Nonetheless, these error correction tools based on k-mer approach
calculates the frequencies of all distinct sub-strings in the sequence with length k, resulting in
much computational cost and requiring a large amount of computer memory, which may be
difficult to apply for large sequencing genomes (69, 102-104).
Wang et al. (83) developed a shadow regression approach to estimate the error rates for next
generation sequencing data with the added advantage of not using a reference genome. Based on
observations, the shadow regression approach estimates the error rates depending on the
assumption that the number of shadows increases linearly with the number of error-free sequence
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reads. In shadow regression approach, the per-read error rate referred to the rate of the number of
sequences containing errors over the total number of sequence reads in a sample. The shadow
regression approach employs a linear regression model to evaluate the sequencing error rates.
Nonetheless, in practice, the linearity assumption may not be appropriate for all types of
sequence data, which might lead to estimation bias when studying sequencing error rates and
performing downstream genomic analysis (4, 69).
Consequently, in this study, we proposed the empirical error rate estimation approach to model
the non-linear relationship between the number of sequence reads containing errors and the
number of error-free sequences by employing cubic smoothing spline and robust smoothing
spline approaches. We also redefined the sample per-read error rate which is capable to capture
the sequence error rate according to the sequence reads and provide more information based on
read counts. In addition, we developed a frequency-based simulation approach that is capable to
mimic the real sequence data structure more realistically than the Wang et al.’s simulation
approach, especially the non-linear relationship between the number of sequences containing
errors and the number of error-free reads (4, 69). The simulation studies were investigated using
next generation sequence data from the MicroArray Quality Control (MAQC) project (105), a
mutation screening study (106), the Encyclopedia of DNA Elements (ENCODE) project (107),
and bacteriophage PhiX 174RF1 DNA samples (83) and compared the performances between
shadow regression approach and empirical error rate estimation approach. Under all simulation
scenarios tested, the proposed empirical error rate approach provided a more accurate error rate
estimation when the linearity assumption was not valid compared with shadow regression
approach, and yielded similar error rate estimation when the linearity assumption hold. The real
data analysis was also performed by applying the proposed empirical error rate estimation and
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shadow regression approach for MAQC, mutation screening, ENCODE, and PhiX DNA samples
(69).

2.2 Methods

2.2.1 Shadow Regression Overview
Wang et al. (83) made the important observation that the number of shadows due to sequencing
errors increases linearly with the number of reads sequenced, whereas the number of true
shadows is independent of the number of reads sequenced. In the current study, we employed
and modified the definitions and notations from the Wang et al. (83) study.

Specifically, given a sequence t in a sample, the total number of reads can be given as 𝑟𝑡 = 𝑛𝑡 +
𝑒𝑡 , where, rt is the total number of reads with sequence t, nt is the number of reads that are error
free with sequence t, and et is the number of reads that contain sequencing errors with sequence t.
In practice, one would not know the true error-free sequence reads. Wang et al. first converted a
sequence file (i.e., fastq format with equal length for all reads) from a sample into a read counts
file. The number of reads for each sequence was counted over the sample, and then the authors
ranked all the sequences according to the read counts (see an example of read counts in
Additional file 2). The top 1,000 reads with the highest frequencies in a sample were selected as
the error-free sequences and used to calculate nt and et in a different sequence t. The shadows of
a given sequence t were defined as the reads differing from the error-free reads by up to two
bases, which was deemed by Wang et al. (83) to be sufficiently similar to the given error-free
24

sequence t to estimate substitution errors. Finally, the top 1,000 reads with the highest
frequencies in a sample were excluded from the assessment of the shadow counts.

The per-read error rate was defined as the proportion of reads containing sequencing errors over
all the reads in a given sample (83), or 𝐸𝑅 =

∑𝑡 𝑒𝑡
∑𝑡 𝑟𝑡

=

Δ𝑒𝑡
Δ𝑟𝑡

. Based on the observation that the

number of shadows due to the sequencing errors increases linearly with the number of reads,
Wang et al. proposed a linear model as 𝑠𝑡 = 𝛼 + 𝛽𝑛𝑡 + 𝜖, where st is the number of shadows of
sequence t and ϵ is the independent error that follows approximately Gaussian distribution.
Robust linear regression was used to estimate the coefficients α and β because shadows can come
from legitimate error-free reads. In this situation, the per-read error rate can be estimated by the
slope of the linear model as 𝐸𝑅 =

Δ𝑒𝑡
Δ𝑟𝑡

Δ𝑒

𝛽

𝑡
= Δ𝑛 +Δ𝑒
= 1+𝛽, which was denoted as the shadow
𝑡

𝑡

regression error rate (SRER) in the current study.

2.2.2 Empirical Per-Read Error Rate with Smoothing Splines

The error rates assessed by shadow linear regression were based on the assumption of a linear
relationship between the error-free read counts and shadow counts. However, the real data
examples in Wang et al.’s paper (e.g., Figure 3) show that for many types of sequencing data the
relationship between error-free read counts and shadow counts does not follow a linear trend. In
these situations, shadow regression based on a linear assumption might lead to a biased
estimation of the sequence error rate. Therefore, in this study, we employed the cubic smoothing
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spline and robust smoothing spline methods to model the relationship between the error-free read
counts and the shadow counts; the piecewise curve resulting from these spline methods is
capable of capturing relationships of widely varying form and tends to avoid erratic behavior
near the extremes of the data (108). Based on the empirical read-shadow relationship, we
proposed the error rate estimation as a function of error-free read counts, which we hypothesized
would be more useful in practice than the shadow regression approach for estimating error rates.

We first used the cubic smoothing spline method (109, 110) to model the shadow counts (st) as a
function of the error-free read counts (nt). The cubic smoothing spline method fits a smooth
curve to a set of observations using a cubic function (110, 111). Specifically, given a set of
observations of error-free read counts and shadow counts, (n1, s1), (n2, s2), …, (nm, sm), n1 <
n2 <…< nm, we modeled the relationship between ni and si as a function 𝑠𝑖 = 𝒰(𝑛𝑖 ), with two
continuous derivatives, where ni is the number of error-free read counts with sequence i, si is the
number of shadow counts with sequence i, i = 1, …, m, and m is the total number of sequences.
Among all such functions with two continuous derivatives, the purpose of the smoothing spline
is to find the estimated function minimizing the penalized residual sum of squares
𝑛𝑚 ′′
2
̂
̂
∑𝑚
(𝑛)2 𝑑𝑛, where λ is a smoothing parameter (110). We used the
1 (𝑠𝑖 − 𝒰 (𝑛𝑖 )) + 𝜆 ∫𝑛 𝒰
1

cubic smoothing spline implemented in the R function “smooth.spline” in the “stats” package
(93). To improve the robustness of the spline, we used a robust smoothing spline approach to
model the relationship between shadow counts (st) and error-free read counts (nt). This approach
uses an iterative re-weighted smoothing spline algorithm with the inverse of the absolute value of
the residuals as the weights. We used the robust smoothing spline implemented in the R function
“robustSmoothspline” in the package “aroma.light” (112, 113).
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Based on the fitted model of shadow counts as a spline function of error-free read counts, we
used the definition of the per-read error rate used by Wang et al. (83). Let n1, n2, …, nm be the
read counts of m sequences, where n1 < n2, …, nm-1 < nm, and let 𝑆̂1, 𝑆̂2, …, 𝑆̂m be the
corresponding fitted values of shadow counts using the smoothing spline approaches described
above. Given a sequence t with read count nt and fitted shadow count 𝑆̂t, we defined the per-read
error rate as

𝐸𝑅(𝑛𝑡 ) = ∑𝑡

∑𝑡𝑗=1 𝑆̂𝑗

𝑡
̂
𝑗=1 𝑆𝑗 +∑𝑗=1 𝑛𝑗

.

Estimation of error rates using this definition also assumes the increasing number of shadows
with the increasing number of read counts in the presence of sequencing errors, but this
definition allows error rates to vary by read counts, whereas the Wang et al. (83) approach
assumes the error rate to be a constant irrespective of the number of reads. For the purpose of
comparison with the Wang et al. (83) approach, we also defined a sample per-read empirical
error rate. Given a sample with m sequences, we randomly sampled 1,000 numbers of read
counts from n1 to nm and calculated the per-read error rates for each of these read counts using
the fitted spline. The median of these per-read error rates was reported as a sample per-read
empirical error rate (henceforth denoted as EER).

27

2.2.3 Next-Generation Sequencing Data

We used next-generation sequencing data from four projects--the MicroArray Quality Control
(MAQC) project (mRNA-seq) (105), a mutation screening study (re-sequencing) (106), the
Encyclopedia of DNA Elements (ENCODE) project (mRNA-seq) (107), and bacteriophage PhiX
174RF1 (PhiX) DNA samples (83)--to perform the simulations and demonstrate the accuracy of
the proposed empirical error rate estimation approach. PhiX DNA data in FASTQ format were
generated by the Center for Cancer Computational Biology at Dana-Farber Cancer Institute and
provided by Wang et al. (83). The other three data sets are publicly available from the National
Center for Biotechnology Information Sequence Read Archive (114) in FASTQ format with
equal read lengths in each sample. All the data were converted to read counts using the shadow
regression program provided by Wang et al. (83).

2.2.3.1 MAQC Brain Experiment 2 Data
The MAQC project was initiated to address concerns about the reliability of microarray
technology (105). This project provided gene expression levels measured from two RNA
samples, including a Universal Human Reference RNA from Stratagene and a Human Brain
Reference RNA from Ambion, in four titration pools on seven microarray platforms with three
expression methodologies. In this study, we used the sequence data from the MAQC brain
experiment 2 (Sequence Read Archive [SRA]010153), including 14 samples on two flowcells
(SRX016366 and SRX016368) run on the Illumina 1G Genome Analyzer with each sample
containing ~12 million reads.
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2.2.3.2 Mutation Screening Resequencing Data

The mutation screening study provided re-sequencing data (SRA010105) from 24 patients with
X-linked mental retardation (XLMR) for mutations in 86 previously identified XLMR genes,
using a method that combined a novel droplet-based multiplex PCR method and next-generation
sequencing (106). An Illumina/Solexa Genome Analzer II platform was used to perform the
sequencing, and each sample contained ~12 million reads.

2.2.3.3 ENCODE Transcriptome Data

The ENCODE project used high-throughput approaches to provide a biologically more
informative representation of the human genome (107). The ENCODE pilot phase included more
than 200 experimental and computational data sets from 35 groups (107). In this study, we used
the ENCODE human mRNA sequence data (SRA001150), including 5 samples of human cell
line K562 (SRX000570) run on the Illumina 1G Genome Analyzer; each sample contained ~12
million reads.
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2.2.3.4 PhiX DNA Data
The bacteriophage PhiX 174 is an icosahedral virus. It contains a closed circular single-stranded
DNA molecule with 5,386 nucleotide bases (115). PhiX 174 was the first DNA-based genome
for which the complete nucleotide sequence was successfully determined (115-117). In this
study, we used two PhiX DNA samples provided by Wang et al., which were generated from the
Center for Cancer Computational Biology at Dana-Farber (83). The PhiX DNA samples were
sequenced using Illumina. One sample contained ~14.6 million reads, and the other contained
~25.7 million reads.

2.3 Simulation Approaches

We performed simulation studies to investigate the performance of the proposed EER and
compare it with the SRER. We used two approaches to perform the simulation: (1) Wang et al.’s
simulation approach and (2) a new frequency-based simulation approach described below.

2.3.1 Wang et al. Simulation Approach
In the Wang et al. study (83), the simulation was conducted based on a sample from the MAQC
brain experiment 2 (SRR037440) using calibration. The authors considered reads uniquely
mapped to the reference genome with no mismatches as error-free reads and then added
substitution errors based on pre-specified base-specific error rates, which were estimated from
the sample SRR037440 by counting the number of mismatches to the reference genome at each
base. To mimic the Wang et al. simulation procedure, we used the same sample (SRR037440) to
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retrieve the error-free reads and estimate the pre-specified base-specific error rates. In particular,
we retrieved ~4.4 million perfectly matched reads from the SRR037440 sample, which originally
had ~12 million reads. We used several approaches to estimate the pre-specified base-specific
error rates. In our first approach, we aligned the reads to the reference genome, marked the
mismatch locations, and then calculated base-specific error rates as a percentage of the mismatch
nucleotides at each location (Additional file 3(C)). In our second approach, we located all
unprocessed reads for each sequence, recorded locations and numbers of mismatch nucleotides,
and calculated the base-specific error rates from the total number of mismatch nucleotides at
each location (Additional file 3(D)). However, we found that neither of these approaches could
obtain the same base-specific error rates shown in the Wang et al. study. Thus, we included the
pre-specified base-specific error rates used in their study, which we extracted approximately
from the figures in the article (83) (Additional file 3(E)). In addition, we used the base-specific
error rates for sample SRR037440 obtained from the shadow regression software developed by
Wang et al. (83) as another set of pre-specified base-specific error rates (Additional file 3(F)).

The Wang et al. simulation approach assumed an underlying linear relationship between the
error-free read counts and shadow counts, no matter which base-specific error rate was used.
Therefore, the data simulated by using the Wang et al. simulation approach would not reflect the
non-linear relationships between error-free read counts and shadow counts (Additional file 3(A)).
For example, in some samples, when the number of error-free read counts is low, the shadow
counts may decrease as the error-free read counts increase. Therefore, we proposed a frequencybased simulation approach to generate the error-free read counts and shadow counts directly,
which can mimic the real sequence counts of the data structure.
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2.3.2 Frequency-based Simulation Approach
Given the counts of all sequence reads in a real sample, we followed the same procedure
described in Wang et al. to obtain the error-free read counts (ni) and shadow counts (si) for N
sequence reads, i = 1, 2, … N and n1 < n2, …, nN-1 < nN. We selected the top N reads with the
highest frequencies to be the error-free reads and obtained the corresponding read counts (ni); we
then mapped all the rest of the sequences in the sample to the error-free reads to identify the
corresponding shadow counts (si). We used N=1,000, as suggested in Wang et al. Based on the
read counts and shadow counts in the real sample, we first constructed a frequency table for the
error-free read counts (ni) using pre-specified bin widths. Because in most of the samples we
investigated, the error-free read counts became very sparse when they were large, we used
unequal bin widths to avoid having almost empty bins. Within each bin of the error-free read
counts, we then constructed a frequency table for the shadow counts (si) using pre-specified
equal bin widths. Given M bins for error-free read counts and L bins for shadow counts within
each of the error-free read count bins, the frequencies can be written as pj, j = 1, 2, …, M, for
error-free read counts and qkj, k = 1, 2, …., L and j = 1, 2, …, M, for shadow counts. To sample a
pair of observations (nnew, snew), we first sampled two independent random numbers, U ~
𝑗

𝑗+1

uniform(0, 1) and V ~ uniform(0,1). If 𝑈 ∈ [∑𝑖=1 𝑝𝑖 , ∑𝑖=1 𝑝𝑖 ), we sampled nnew ~ uniform(nj,
nj+1), where nj and nj+1 are the endpoints for the corresponding bin j of read counts. Further,
within the read counts bin j, if 𝑉 ∈ [∑𝑘𝑖=1 𝑞𝑖𝑗 , ∑𝑘+1
𝑖=1 𝑞𝑖𝑗 ), we sampled snew ~ uniform(sk, sk+1),
where sk and sk+1 are the endpoints for the corresponding bin k of shadow counts. With this
approach, we can generate more pairs of error-free read and shadow counts (i.e., > 1,000).
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2.3.3 Comparisons of Different Simulation Approaches
We performed a simulation study to compare the Wang et al. simulation approach with our
proposed frequency-based simulation approach using information from sample SRR037440 in
Wang et al.’s study (83). Figure 1 shows the relationships between the shadow counts and errorfree read counts for the original SRR037440 sample data (panel A), as well as the simulated data
generated using the frequency-based simulation approach (panel B) and the Wang et al.
simulation approach using different pre-specified base-specific error rates ( as described in the
Method; panels C-F). As expected, the data generated using the Wang et al. simulation approach
showed that the shadow counts increase linearly as the read counts increase, which does not
reflect the true pattern of the original data (panel A). Also, different pre-specified base-specific
error rates had very similar performance. On the other hand, the data generated using the
frequency-based simulation approach (panel B) showed a pattern very similar to that of the
original data. We also plotted the fitted shadow linear regression lines, cubic smoothing spline
curves, and robust smoothing spline curves in Figure 1 for the original and simulated data,
respectively. It should be noted that the shadow linear regression lines and the smoothing spline
curves performed similarly when the data were generated using the Wang et al. simulation
approach because the approach generated data using a linear relationship. However, compared to
the linear lines, the smoothing spline curves captured more features when both the original data
and the data generated using the frequency-based simulation approach were used (panels A and
B).
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Figure 1. Sample SRR037440 from the MAQC brain experiment 2 data set and
corresponding simulated data using frequency-based and Wang et al. simulation
approaches

34

Figure 2. Read counts for the SRR032577 sample in the mutation screening re sequencing study
CAAAGCAACTTATGGGACTTGGTTGGCTTCTGTTTG 22010
CCAGACTTCTCCTCAAGTTATGCAAATCTTATGTCA 17456
GATCGGAAGAGCTCGTATGCCGTCTTCTGCTTGAAA 14515
ACTCATACAGGAGAGAAACCTTATGAATGCAGAGAC 13720
GAGACAGAGCTGTAGAGAAACAAAAAGAGAAAGATG 12759
GATCGGAAGAGCTCGTATGCCGTCTTCTGCTTAGAT 9832
GAACAAATGCTTTTCCAACCCATGAGTGCTAAGAGC 9192
CTCGCCATGATTATTTGACAAATAATGAGACTAGTA 7583
GTATTCATCAAGCTGACTGGATCCATTTGTCCGGGT 7357
GATGACAATCTCCAAGTGACATTTCACTGTGTTCCT 7039
AGATCGGAAGAGCTCGTATGCCGTCTTCTGCTTGAA 6887
GGTATCTAATAGCAGGGAGGAGGAAGGCCTGTTGCT 6846
AGCAACATGCTATGAACAAAGACCCTTCTGTAACAA 6700
GGTGATGTCCTATCACACTAAACATCGATTGGAGTG 6399
AAGAAGCAGTTTTAGCTTCTTAGATCGGAAGAGCTC 6224
GATAATTGAGCTGTGCATGAATGTTAACTCTTAAAA 6136
GGTAGTGGATCTTTCTGTCTATCAAGAACAGGCCTG 6022
GGTATGAGCTTGACTGAGAGGCCTCTCCTGACTATC 5894
ATCACAGAATCACAAAGCTGGTAAGGAGCCTCCCAA 5702
AGCAAACTGAAATTTTCCCATACTGAGTCATTCATG 5670
GCAGTTCTAGTCAAGCATACAATATCCAGAACCACC 5599
GTACATAGTAGGTGCTCGATGAATGGTTATTTCCTC 5596
AATTTTATGACCAGGCAGTGTTAAAATTAATACTTA 5489
GTGCTCTTTCTTGAGAAGTCTTCCAGTTATTCAACT 5361
GTTACACAACACATGTCAGTTGCAGGGGCAGGAACT 5279
GATTCTCTTTGCCAGCTTAGATGGCTTCGGTTTCAG 5193
……
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We have also evaluated the error rates for the original sample SRR037440 and the simulated data
generated using different simulation approaches and different error rate estimation approaches,
including shadow linear regression (SRER), cubic smoothing spline (EER_CS), and robust
smoothing spline (EER_RS) approaches. When the data sets were generated using the Wang et
al. approach, the estimated error rates obtained using the different approaches were very similar
and were close to the expected error rate, which was consistent with the results shown in Figure
1. For example, when the first pre-specified base-specific error rate (R1) was used, the expected
per-read error rate was 0.1308 and the estimated error rates were 0.1313, 0.1328, and 0.1319 for
SRER, EER_CS, and EER_RS, respectively. In the data set generated using the frequency-based
simulation approach, the approaches using smoothing splines provided more accurate
estimations for the per-read error rates than the shadow linear regression approach: the expected
error rate was 0.2436, and the estimated error rates were 0.1614, 0.2157, and 0.2166 for SRER,
EER_CS, and EER_RS, respectively.
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Table 1. Comparison of the Wang et al. and proposed frequency-based simulation
approaches using sample SRR037440*
Simulation Approaches

Expected ER

SRER

EER_CS

EER_RS

Original sample

-

0.1910

0.2297

0.2409

0.1308
0.2563
0.2135
0.1702
0.2436

0.1313
0.2548
0.2149
0.1692
0.1614

0.1328
0.2560
0.2173
0.1704
0.2157

0.1319
0.2553
0.2153
0.1718
0.2166

R1
R2
Wang et al.
R3
R4
Frequency_based

* For the frequency-based simulation approach, we considered the top 1,000 reads of sample SRR037440 with the highest
frequencies as the error-free reads and generated 1,000 pairs of error-free read and shadow counts.
Expected ER: expected error rate in simulation studies
SRER: error rate estimated using shadow regression
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_RS: empirical error rate estimated using robust smoothing spline
R1, R2, R3 and R4: different pre-specified base-specific error rates used in the simulation as described in the Methods section
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Figure 3. Sample sequencing data from MAQC, Mutation Screening Re-Sequencing,
ENCODE, and PhiX DNA data sets
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A comparison between the Wang et al. simulation approach and our proposed frequency-based
simulation approach, using the SRR037440 sample, showed that unlike the frequency-based
approach, the Wang et al. simulation approach does not mimic the observed non-linear data
relationship between error-free read and shadow counts. Therefore, we applied only the proposed
frequency-based simulation approach in the simulation studies. We generated data based on the
information from samples from the four data sets described above. For each sample, the median
EER was calculated based on 1,000 replicates and compared with the median SRER. For all the
simulations, we considered the top 1,000 reads of the sample of interest with the highest
frequencies as the error-free reads and then determined the shadow counts accordingly, which
were then used to generate the frequency tables for the simulations. Based on the frequency
tables, we generated 1,000 pairs of error-free reads and shadow counts for each replicate. For the
simulation data sets, we also defined an expected per-read error rate as ∑𝑖 𝑠𝑖 ⁄(∑𝑖 𝑠𝑖 + ∑𝑖 𝑛𝑖 ),
where si and ni are the shadow count and error-free read count, respectively, for sequence i, i =
1, …, M. Note that M = 1,000 in the simulation studies, as we generated 1,000 pairs of error-free
read and shadow counts.

39

2.4 Results

2.4.1 Simulation Results

As shown in figure 1 and table 1, using the frequency-based simulation approach can better
capture the relationship between error-free read and shadow counts, therefore, we used this
simulation approach to perform further simulations based on next-generation sequencing data
from the MAQC, mutation screening, ENCODE, and PhiX DNA sample data sets. We compared
the performance of our proposed EER approach using the cubic or robust smoothing spline
method (EER_CS or EER_RS, respectively) with that of the SRER approach.

2.4.1.1 Simulation Results for MAQC Data

Table 2 shows the median error rates (based on 1,000 replicates) obtained using the shadow
linear regression approach and the proposed smoothing spline approaches, based on the nextgeneration sequencing data from the MAQC study. We have also reported the expected error
rates (calculated as described above) and the estimation biases, which were calculated as the
absolute differences between the estimated error rates and the expected error rates. For all 14
samples of MAQC data, both smoothing spline approaches provided more accurate estimations
of the error rates with less bias than the shadow linear regression approach. Both smoothing
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spline approaches performed very similarly. For example, for sample SRR037452, the median
expected error rate in the simulation was 0.3305. Using SRER, the median estimated error rate
was 0.2578, with a bias of 0.0727 compared to the expected error rate. In contrast, EER_CS and
EER_RS had median estimated error rates of 0.3104 and 0.3096, respectively, with biases of
0.0201 and 0.0209, respectively. From these results, we can observe that the SRER approach
underestimated the error rates, while the smoothing spline approaches provided more accurate
estimated error rates.
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Table 2. Median error rates in MAQC data using shadow linear regression and smoothing
spline approaches*

Samples

Expected
ER

SRER

SRER
Bias

EER_CS

EER_C
S Bias

EER_R
S

EER_RS
Bias

SRR037452
SRR037453
SRR037454
SRR037455
SRR037456
SRR037457
SRR037458
SRR037459
SRR037460
SRR037461
SRR037462
SRR037463
SRR037464
SRR037465

0.3305
0.1917
0.2354
0.1759
0.2312
0.1841
0.2653
0.2371
0.2530
0.2180
0.2443
0.2154
0.2624
0.2145

0.2578
0.1584
0.1515
0.1448
0.1622
0.1480
0.2321
0.1943
0.2018
0.1704
0.1734
0.1654
0.1666
0.1742

0.0727
0.0333
0.0839
0.0311
0.0690
0.0361
0.0332
0.0428
0.0512
0.0476
0.0709
0.0500
0.0958
0.0403

0.3104
0.1824
0.2060
0.1675
0.2037
0.1777
0.2582
0.2202
0.2503
0.2105
0.2322
0.2023
0.2392
0.2038

0.0201
0.0093
0.0294
0.0084
0.0275
0.0064
0.0071
0.0169
0.0027
0.0075
0.0121
0.0131
0.0232
0.0107

0.3096
0.1818
0.2059
0.1668
0.2035
0.1771
0.2575
0.2203
0.2490
0.2104
0.2308
0.2045
0.2403
0.2037

0.0209
0.0099
0.0295
0.0091
0.0277
0.0070
0.0078
0.0168
0.0040
0.0076
0.0135
0.0109
0.0221
0.0108

* Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts
and shadow counts.

Expected ER: expected error rate in simulation studies
SRER: error rate estimated using shadow regression
SRER Bias: the absolute value of the difference between SRER and Expected ER
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER
EER_RS: empirical error rate estimated using robust smoothing spline
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER
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2.4.1.2 Simulation Results for Mutation Screening Resequencing Data
Table 3 reports the median error rates obtained using the SRER approach and the two EER
approaches, based on next-generation sequencing data from a mutation screening study. Similar
to the results from the MAQC samples, all 24 mutation screening resequencing samples yielded
error rates for the smoothing spline approaches that were more accurate than or comparable to
the estimations of error rates for SRER. For example, in sample SRR032566, the median of the
expected error rate in the simulation was 0.0734. Using SRER, the median of the estimated error
rate was 0.0412, with a bias of 0.0323 compared with the expected error rate. Using the
smoothing spline approaches, the median of the estimated error rate was 0.0705 for both
approaches, with a very small bias of 0.0029.

43

Table 3. Median error rates in mutation screening data using shadow linear regression
and smoothing spline approaches*

Samples

Expected
ER

SRER

SRER
Bias

EER_CS

EER_C
S Bias

EER_R
S

EER_RS
Bias

SRR032565
SRR032566
SRR032567
SRR032568
SRR032569
SRR032570
SRR032571
SRR032572
SRR032573
SRR032574
SRR032575
SRR032576
SRR032577
SRR032578
SRR032580
SRR032581
SRR032582
SRR032583
SRR032584
SRR032586
SRR032587
SRR032588
SRR033543
SRR033544

0.1991
0.0734
0.2003
0.2040
0.1598
0.0985
0.1236
0.1495
0.1779
0.0986
0.1169
0.1554
0.1052
0.1143
0.0870
0.0770
0.0400
0.1224
0.1290
0.0445
0.1486
0.1240
0.1151
0.1267

0.0493
0.0412
0.0542
0.0437
0.0509
0.0641
0.0575
0.0530
0.0912
0.0384
0.0839
0.0945
0.0694
0.0448
0.0619
0.0347
0.0041
0.0707
0.0540
0.0102
0.0786
0.0470
0.0587
0.0524

0.1498
0.0323
0.1461
0.1603
0.1089
0.0345
0.0661
0.0965
0.0867
0.0602
0.0330
0.0609
0.0359
0.0695
0.0251
0.0424
0.0359
0.0517
0.0750
0.0343
0.0700
0.0770
0.0564
0.0743

0.1080
0.0705
0.1111
0.1057
0.1018
0.0959
0.1406
0.1181
0.1518
0.0626
0.1228
0.1887
0.1054
0.1077
0.1169
0.0752
0.0309
0.1279
0.1052
0.0287
0.1562
0.1024
0.0828
0.1086

0.0911
0.0029
0.0892
0.0984
0.0580
0.0026
0.0170
0.0314
0.0261
0.0361
0.0059
0.0333
0.0002
0.0067
0.0298
0.0018
0.0091
0.0055
0.0238
0.0158
0.0076
0.0216
0.0323
0.0181

0.1082
0.0705
0.1111
0.1072
0.1014
0.0954
0.1406
0.1173
0.1506
0.0618
0.1227
0.1880
0.1055
0.1076
0.1163
0.0751
0.0310
0.1280
0.1032
0.0287
0.1552
0.1021
0.0832
0.1085

0.0910
0.0029
0.0893
0.0968
0.0585
0.0032
0.0170
0.0323
0.0273
0.0368
0.0058
0.0326
0.0002
0.0067
0.0292
0.0019
0.0090
0.0056
0.0259
0.0159
0.0066
0.0220
0.0318
0.0182

*Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts
and shadow counts.

Expected ER: expected error rate in simulation studies
SRER: error rate estimated using shadow regression
SRER Bias: the absolute value of the difference between SRER and Expected ER
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER
EER_RS: empirical error rate estimated using robust smoothing spline
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER
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2.4.1.3 Simulation Results for ENCODE Transcriptome Data

Table 4 reports the median error rates obtained using different approaches based on nextgeneration sequencing data from the ENCODE study. The five samples from the ENCODE study
had higher expected error rates than the samples in the MAQC and mutation screening studies,
which might have been due to relatively large shadow counts that corresponded with smaller
error-free read counts (Figure 3, C). In this situation, the smoothing spline approaches still
performed better than shadow linear regression. For example, in sample SRR002056, the
expected error rate was 0.3646, and the estimated error rates were 0.2906, 0.3270, and 0.3233 for
SRER, EER_CS, and EER_RS, respectively, with biases of 0.0740, 0.0376, and 0.0413,
respectively.
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Table 4. Median error rates in ENCODE data using shadow linear regression and
smoothing spline approaches*

Samples

SRR002053
SRR002056
SRR002065
SRR005092
SRR005093

Expected
ER

SRER

SRER
Bias

EER_CS

EER_C
S Bias

EER_R
S

EER_RS
Bias

0.5548
0.3646
0.4578
0.6300
0.4839

0.4153
0.2906
0.3371
0.4047
0.3928

0.1395
0.0740
0.1207
0.2253
0.0911

0.4609
0.3270
0.3740
0.4797
0.4221

0.0939
0.0376
0.0838
0.1503
0.0618

0.4565
0.3233
0.3701
0.4727
0.4173

0.0983
0.0413
0.0877
0.1573
0.0666

*Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts
and shadow counts.

Expected ER: expected error rate in simulation studies
SRER: error rate estimated using shadow regression
SRER Bias: the absolute value of the difference between SRER and Expected ER
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER
EER_RS: empirical error rate estimated using robust smoothing spline
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER
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2.4.1.4 Simulation Results for PhiX DNA Data

Table 5 reports the median error rates obtained using different approaches based on the nextgeneration sequencing data from two PhiX DNA samples. For both samples, the smoothing
spline approaches provided more accurate estimations of the error rates than did shadow linear
regression. For example, in sample 100217, the median of the expected error rate in the
simulation was 0.0323. Using SRER, the median of the estimated error rate was 0.0250, with a
bias of 0.0073 compared to the expected error rate. The median estimated error rate for EER_CS
and EER_RS was 0.0315, resulting in a much smaller bias of 0.0008 for both approaches.
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Table 5. MedianSimulation error rates in PhiX DNA data using shadow linear regression
and smoothing spline approaches*

Samples

Expected
ER

SRER

SRER
Bias

EER_CS

100217
100514

0.0323
0.0152

0.0250
0.0143

0.0073
0.0009

0.0315
0.0152

EER_CS
EER_RS
EER_RS
Bias
Bias
0.0008
0.0000

0.0315
0.0152

0.0008
0.0000

*Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts
and shadow counts.

Expected ER: expected error rate in simulation studies
SRER: error rate estimated using shadow regression
SRER Bias: the absolute value of the difference between SRER and Expected ER
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER
EER_RS: empirical error rate estimated using robust smoothing spline
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER
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2.4.2 Next-Generation Sequencing Data Analysis Results

We applied our smoothing spline approaches to evaluate the error rates for the next-generation
sequencing data from MAQC, mutation screening, ENCODE and PhiX DNA samples, and
compared error rates using our smoothing spline approaches and shadow linear regression. The
estimated error rates are reported in Tables 6, 7, 8, and 9, respectively, for samples from the
MAQC, mutation screening, ENCODE, and PhiX DNA data sets. From the results we can
observe that the smoothing spline approaches always provided relatively higher estimates of the
error rates. For example, in sample SRR037454 from MAQC (Table 5), the estimated error rates
were 0.1596, 0.2041, and 0.2196, respectively, for SRER, EER_CS, and EER_RS. This was
expected given that shadow linear regression tended to underestimate the error rates in the
simulation results.
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Table 6. Error rates in real MAQC data using shadow linear regression and smoothing
spline approaches

Samples

SRER

EER_CS

EER_RS

SRR037452
SRR037453
SRR037454
SRR037455
SRR037456
SRR037457
SRR037458
SRR037459
SRR037460
SRR037461
SRR037462
SRR037463
SRR037464
SRR037465

0.2695
0.1598
0.1596
0.1482
0.1657
0.1541
0.2386
0.1996
0.2027
0.1779
0.1858
0.1771
0.1850
0.1842

0.3124
0.1819
0.2041
0.1694
0.2062
0.1796
0.2573
0.2216
0.2504
0.2058
0.2329
0.2019
0.2377
0.2019

0.3362
0.1822
0.2196
0.1700
0.2162
0.1793
0.2575
0.2233
0.2647
0.2093
0.2319
0.2072
0.2448
0.2070

SRER: error rate estimated using shadow regression
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_RS: empirical error rate estimated using robust smoothing spline
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Table 7. Error rates in real mutation screening data using shadow linear regression and
smoothing spline approaches

Samples

SRER

SRR032565
SRR032566
SRR032567
SRR032568
SRR032569
SRR032570
SRR032571
SRR032572
SRR032573
SRR032574
SRR032575
SRR032576
SRR032577
SRR032578
SRR032580
SRR032581
SRR032582
SRR032583
SRR032584
SRR032586
SRR032587
SRR032588
SRR033543
SRR033544

0.0753
0.0584
0.0846
0.0686
0.0597
0.0691
0.0724
0.0818
0.1602
0.0557
0.0882
0.1101
0.0762
0.1365
0.0727
0.0981
0.0941
0.1141
0.0849
0.0623
0.0857
0.0701
0.0802
0.1175

EER_CS EER_RS

0.1167
0.0746
0.1420
0.1566
0.1015
0.0973
0.1400
0.1611
0.2756
0.1004
0.1191
0.1915
0.1282
0.1874
0.1262
0.0506
0.1689
0.2057
0.0963
0.3606
0.1524
0.1446
0.1084
0.1588

0.1206
0.0745
0.1446
0.1566
0.1020
0.0954
0.1400
0.1593
0.2752
0.1053
0.1179
0.1899
0.1280
0.1873
0.1266
0.0511
0.1679
0.2042
0.0742
0.3621
0.1532
0.1440
0.1102
0.1586

SRER: error rate estimated using shadow regression
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_RS: empirical error rate estimated using robust smoothing spline
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Table 8. Error rates in real ENCODE data using shadow linear regression and smoothing
spline approaches

Samples

SRER

EER_CS

EER_RS

SRR002053
SRR002056
SRR002065
SRR005092
SRR005093

0.4134
0.3225
0.3842
0.4628
0.4090

0.4469
0.3020
0.3918
0.4884
0.4724

0.4453
0.3355
0.3913
0.4776
0.4013

SRER: error rate estimated using shadow regression
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_RS: empirical error rate estimated using robust smoothing spline
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Table 9. Error rates in real PhiX DNA data using shadow linear regression and smoothing
spline approaches

Samples

SRER

100217
100514

0.0261
0.0142

EER_CS EER_RS

0.0317
0.0155

0.0315
0.0157

SRER: error rate estimated using shadow regression
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_RS: empirical error rate estimated using robust smoothing spline
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2.5 Conclusion

In summary, we proposed an empirical error rate estimation approach in which cubic and robust
smoothing splines were used to model the read-shadow relationship. The proposed approach
does not assume a linear relationship between the error-free reads and shadows counts and
provides more accurate estimations of error rates for next-generation, short-read sequencing data
(69).

2.6 Discussion

Next generation sequencing has enabled high throuput capacity of parallel sequencing and
significantly driven down the cost which makes it widely employed to study various biological
phenomena. Nonetheless, due to the high volume of short reads produced in next generation
sequencing, the raw accuracy may impact the downstream analysis for genetic studies.
Therefore, before performing downstream genomic analysis, it is essential to accurately assess
the sequencing error rates. We have developed the empirical error rate estimation approach
which provides more accurate estimation than other available approaches for assessing next
generation sequencing data (69).
In this chapter, we first reviewed the shadow regression error rate estimation approach (83). The
shadow regression approach is under the linearity assumption that the number of shadows
increases linearly with the number of error-free read counts. The linearity assumption might be
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valid if one could obtain and plot the true error-free sequence read counts and the corresponding
shadow counts by using only the reads containing sequencing errors. However, in practice, such
information is not identifiable and the non-linear relationship is not rare. Sequencing data is with
noise. It is critical to estimate the sequencing error rate more accurately and robust. We proposed
a sample-level error rate taking the median of error rates obtained from different sets of errorfree read counts and corresponding fitted shadow read counts, which may provide more robust
estimation (69).
We tested the samples of next generation sequencing data presented in Wang et al. paper (4). The
linearity assumption between the shadow read counts and the error-free read counts might hold
in the PhiX DNA sequencing samples; however, it is not valid for the mutation screening resequencing samples and the mRNA sequencing data (MAQC and ENCODE) samples after
investigation. Therefore, we proposed to employ the non-linear statistical model to estimate the
relationship between the error-free read counts and shadow counts using smoothing spline
approaches. The smoothness can be controlled and adjusted via tuning parameter in the penalty
term, which can reduce the likelihood of overfitting the data (100). Because we desired a
smoother interpolating function, the cubic smoothing spline approach was employed in our
chapter instead of a linear smoothing spline approach. Moreover, in order to improve the
estimation robustness, we also proposed to employ the robust smoothing spline approach, using a
weight equal to the inverse of the absolute value of the residuals to iteratively estimate the reweighted smoothing spline algorithm. In addition, to better investigate the performance of the
proposed approach, we developed the frequency-based simulation approach, which can mimic
the real sequence data structure more realistically than the Wang et al. simulation approach (4).
Under the simulation studies tested, the shadow linear regression underestimated the sequencing
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error rates, whereas the empirical error rate estimation approach provided more accurate
estimation results. The superior performance of empirical error rate estimation approach also
hold for the DNA sequencing data, in which the linear read-shadow relationship might be valid
(69).
In practice, due to polymorphisms or duplications, the true genome sequence sample might differ
from the reference genome. Therefore, in our chapter, we investigated two additional simulation
scenarios: (1) as was assumed in Wang et al. (83), there is one polymorphism for every 1,000
base pairs in the sequence; and (2) there are two base-pair duplications for every 1,000 base pairs
in the sequence, respectively. It is critical to note that these two assumptions are specific in
simulation and are not necessary for shadow-based approaches. Specifically, we mapped the
sample of SRR037440 to a reference and extracted the sequence reads that are uniquely mapped.
We added one polymorphism or two base-pair duplications per 1,000 base pairs in the sequences
and considered the resulting sequence reads as error-free sequence reads. Substitutional errors
were then added according to the pre-specified per-base sequence error rates. After simulation
studies tested in both scenarios, our proposed empirical error rate estimation approach provided
more accurate estimation results. For example, in the simulation scenario under the first
assumption that one polymorphism occurred per 1,000 base pairs, the expected error rate was
0.1977, whereas the estimated error rates were 0.1973 and 0.1989 using the cubic smoothing
spline and robust smoothing spline, respectively. In the simulation scenario under the assumption
that two base-pair duplications occurred per 1,000 base pairs, the expected error rate was 0.1728.
The estimated error rates using the cubic smoothing spline and robust smoothing spline were
0.1722 and 0.1761, respectively. These simulation results showed that the proposed empirical
error rate estimation approach is robust and not affected by polymorphisms or duplications as
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well as the validity of the shadow-based approaches.
We applied the proposed empirical error rate estimation approach to real data analysis in studies
of MAQC, mutation screening, ENCODE, and PhiX DNA, and compared the results with those
obtained using the shadow linear regression approach. The error rates obtained using shadow
regression approached were relatively lower compared with the ones estimated from the
proposed approach. For example, in the samples of MAQC mRNA sequencing study, error rates
yielded in our approach were between ~17% and ~32%, whereas error rates provided in shadow
regression were ~15% to ~27%. As can be seen by even simple visual inspection, the lower error
rates yielded by shadow regression approach may be attributed to the linearity assumption that is
not valid in some real data sets. For the DNA sequence data where the linearity assumption
might be valid, the proposed empirical error rate estimation approach provided similar
estimations with those obtained using shadow linear regression (69).

To further investigate the performance of the proposed approach, simulation analysis was
conducted. As the simulation approach proposed by Wang et al. (83) may not reflect the real
sequence data structure, we developed a frequency-based simulation approach that captures the
nonlinearity association between the number of reads containing errors and the number of errorfree reads according to sequencing read counts from real data sets. These two simulation
approaches were compared. From on the investigation, it showed that the data generated using
the Wang et al. simulation approach followed the pattern that the shadow sequence read counts
increased linearly with the error-free sequence read counts which was different from the real
sequence data structure; compared with it, the data generated using the proposed frequencybased simulation approach mimics the real sequence data structure (69).
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For the proposed approach, we adapted the original definition of per-read error rate that was the
defined to be the proportion of reads containing sequencing errors among all the reads in a
sample in Wang et al. (83). Instead of a fixed slope in the linear regression model, we re-defined
the empirical per-read error rate as a function of error-free read counts that varies based on the
basis of the sequence read. The proposed empirical per-read error rate could provide more
information according to the sequence read counts compared to the original per-read error rate
definition in Wang et al. (4) where a single fixed error rate is estimated for all the sequence reads
in a given sample. We also defined a sample-level error rate that uses the median of the error
rates estimated from different pair sets between the numbers of error-free read counts and
corresponding fitted shadow counts (69).
In the shadow-based approaches, both the proposed error rate estimation approach and shadow
linear regression approach can be impacted by outliers. Therefore, , we suggest to pre-process
the next generation sequence data using standard statistical analysis approaches such as boxplot
rule approach which is based on the upper and lower quartiles of data distribution, chi-square
analysis (118), Dixon test (119), and Grubbs’ test (120). Alternative approaches could be
quantile regression (121) or Akima spline (122, 123) that might be more robust to outliers. In this
chapter, we applied the proposed approaches to multiple next generation sequencing
experiments, such as DNA sequencing, mRNA sequencing and re-sequencing data. We also
showed that under the presence of polymorphisms and duplications, the shadow-bases
approaches are valid. In addition, with the advantage of not requiring a reference genome in
shadow-based approaches (i.e., shadow regression and our proposed approaches), it can be
applicable to other types of sequencing studies, such as extensive polymorphisms, isoforms, or
the microbiome. Specifically, the shadows (i.e., reads with errors) defined in the shadow-based
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approaches are the sequence reads with up to two bases different from the error-free sequencing
reads. The sequencing reads will not be counted as shadows with many differences, such as
extensive polymorphisms, isoforms or microbiome data in the analysis (69).
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Chapter 3
Extension Studies of Empirical Error Rate Estimation Approach
for Substitution, Deletion, and Insertion Sequencing Errors

3.1 Introduction

Despite the growing number of sequenced genomes, our knowledge of mutation rate in insertion
and deletions (indels) has only recently started to be explored (124, 125). In comparison, SNP
has been deeply studied in most biological processes including genetic disease, species
divergence, genetic evolution, and adaptation. Recent study showed that indels are associated
with these processes and play an important role as well. Previous studies revealed that insertions
radically increase frequency of ectopic recombination, which may lead to chromosome
instability and genetic variation. Indels are mutational components of gene and pseudogene
evolution and play an essential role in long-term evolution of genome size. Previous studies
compared the ratio of nucleotide substitutions to the ratio of indels and showed that indels
dominate the early divergence process (126). In addition, indels have been shown being
associated with human disease, apoptosis mechanisms, phenotypic change, activity of surface
antigen (124, 127-136). Recent study also found important association between indels and
human cancer genes. For example, Yang et al. (2010) studied the somatic mutations in cancer
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and found that one of the most significant characteristics of cancer related mutations is the high
frequency of indels. (137)

Indels also happened to next generation sequencing data. To our knowledge, the majority
existing sequencing error rate estimation approaches focused on substitution error rates. In
shadow regression, the sequences containing errors were defined to be the sequences with up to
two bases different from error free sequence reads for the short read next generation sequence
data (4). However, the indel error rates also play an essential role that may negatively impact the
quality of downstream genomic analysis. In genetics, sequencing deletion is a type of mutation
that occurs when some genetic material is lost; whereas sequencing insertion occurs when extra
genetic material inserted to a sequence (138, 139).

Conventional approaches (140-143) to study indels using a reference genome has the limitation
when sequence a new genome as it may not be available to find a well-established reference for
the new genome. It is critical to estimate the sequencing error rates more accurate and for more
diverse sequencing error definitions including different bases in substitution, insertion, and
deletion for next generation sequencing data. In this study, we extend the shadow definition by
different bases in substitution and also study the indels without using reference based on the
study in Wang et al. (4).

61

3.2 Method

In both previous chapter and shadow regression study to estimate short read sequencing error
rates, the shadows were the sequences with up to two bases different from error-free reads for
short reads sequencing data by substitution (4, 69). To better investigate the performance of the
empirical error rate estimation approach (69) in more diverse scenarios, in this chapter, I adjusted
the original shadow definition (4) to different bases of substitution, deletion, and insertion,
respectively. Empirical error rate estimation approach was applied to multiple sequencing data in
both simulation study and real data analysis, and compared with the estimation results obtained
from shadow regression approach.

Shadows were the sequences containing errors. Different definitions of shadow would lead to
different quality assessment results for next generation sequencing data. Based on Wang et al.
(4), using shadows defined as sequence reads with up to two bases different from error-free reads
provides enough estimation accuracy without excessive computational cost. In order to validate
this statement, I adjusted the shadow definition to be only one base different, only two base
different, only three bases different, and up to three bases different from error-free sequences in
substitution, respectively.

As described in Chapter 2, both the empirical error rate estimation approach and shadow
regression approach do not require using a reference genome. In the shadow-based approaches,
the frequency of each sequence was first calculated according to the sequence read counts. Based
on the frequency of each sequence read, the top 1000 sequences with the highest frequencies
were selected as the error-free sequence reads (4, 69). All the possible sequences with only one
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base different, only two bases different, only three bases different, up to two bases different, and
up to three bases different from error-free reads in substitution were set out and generated as
pseudo shadows, respectively. The corresponding pseudo shadows were then mapped to the
remaining sequence reads that have not been selected as error-free sequences in the sample, to
obtain the number of shadows of only one base different, only two bases different, only three
bases different, up to two bases different, and up to three bases different from error-free reads in
substitution for each sequence read. In this way, we can obtain the number of error-free
sequences and corresponding shadow counts in different shadow definitions accordingly.

I applied the empirical error rate estimation approach using smoothing spline and robust
smoothing spline data samples in DNA (sample 100217) and mRNA (sample SRR002053,
SRR032586, SRR037456) and compared the results with those obtained from shadow regression
approach to estimate the error rates in different substitution shadow definitions.

In addition to substitution, I also extent the study to deletion error rates. The shadows for
deletion were computed differently from those by substitution. In the sequences data we were
investigating, all the sequence reads are with the same lengths. Specifically, given a particular
read in the sample, if one base is deleted from the original sequence, an extra base would be
added to the end of the read to keep the length of number of bases in each sequence.

There are three approaches to count the deletion shadows in this study, which are left side
deletion, right side deletion, and two-side deletion, respectively. In a forward direction sequence,
suppose there is a base deleted from the original sequence, given that all the sequences are with
the same lengths, the left side deletion is to add the extra base to the left end side of the read with
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one of the four possible alleles (“A”, “T”, “G”, and “C”). Another way to estimate the deletion
error rate is the right side deletion. In a forward direction sequence, the right side deletion error
occurs when there is a base deleted from the original sequence, an extra base is added to the right
end side of the read with one of the four possible alleles (“A”, “T”, “G”, and “C”). Furthermore,
the third deletion error rate is two-side deletion. When one base is deleted from the original
sequence, if the extra base is added to either left end side or right end side of the read, we called
it two-side deletion. For example, given that the original sequence is ATGAC and all the
sequences are with the same length, if the 3rd base was deleted, then the remaining sequence
read would be ATAC. Since there were four passible alleles (“A”, “T”, “G”, and “C”), then the
left side deletion is to add the extra base to the left side resulting the possible shadows as
AATAC, TATAC, GATAC, and CATAC. The possible shadows in the right side deletion
approach would then become ATACA, ATACT, ATACG, and ATACC. Moreover, for two side
deletion, the possible shadows would become AATAC, TATAC, GATAC, CATAC, ATACA,
ATACT, ATACG, and ATACC.

In addition to deletion and substitution errors, the third type of sequencing error refers to
insertion. There are three types of sequencing insertion, which are left side insertion, right side
insertion, and two-side insertion. In the data we investigated, all the sequences are with the same
lengths. Suppose there is a base inserted into the original sequence, then an extra base will be
removed from the end of the original sequence read. In a forward direction sequence, if the extra
base is removed from the right end side, this insertion is defined as left side insertion. The base
inserting to the last base in a forward sequence direction is not accounted for the left side
insertion. The second type of insertion is right side insertion that supposing there is a base
inserted to the original sequence, then an extra base will be removed from the left end side to
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keep the sequence length same over all the sequences. In the right side insertion, the base
inserting to the first base in a forward sequence direction is not accounted. In addition, there is
also a two-side insertion approach, which refers to the scenario when a base inserted into the
original sequence, given all the sequences are with the same lengths, an extra base removed from
either left end side or right end side of the read.

I applied simulation study as in Chapter 2 and real data analysis using empirical error rate
estimation approach and compared the results with those obtained from shadow regression
approach with the use of different shadow definitions to investigate the performance of the
proposed empirical approach.

3.3 Result

In order to better understand the error rate estimation performances when shadows varied,
simulation studies were investigated for deletion and insertion error rates for different shadows
of only one base different, only two bases different, and up to two bases different using empirical
error rate estimation approach, and compared with the results from shadow regression approach.

Deletion error rates from left side, right side, and two sides in the simulation studies were
investigated. Table 10 shows the median deletion error rates from simulation study based on the
next-generation sequencing data samples, for shadows defining to be only one base different,
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only two bases different, and up to two bases different from error-free sequences, (based on
1,000 replicates) obtained using the shadow regression approach and the proposed empirical
error rate estimation approaches. The expected error rates was calculated as
∑𝑖 𝑠𝑖 ⁄(∑𝑖 𝑠𝑖 + ∑𝑖 𝑛𝑖 ), where 𝑠𝑖 and 𝑛𝑖 are the shadow count and error-free read count,
respectively, for sequence i, i = 1, …, M, and M = 1,000 in the simulation studies, where we
generated 1,000 pairs of error-free read and shadow counts (69). The estimation biases were
calculated as the absolute differences between the estimated error rates and the expected error
rates.
The empirical error rate estimation approaches provided more accurate error rate estimations
with less bias than the shadow regression approach. Both empirical error rate estimation
approaches using cubic smoothing spline and robust smoothing spline performed very similarly.
For example, for sample SRR037452, the median expected left side deletion error rate with only
one base different from error-free sequences in the simulation was 0.0453. Using SRER, the
median estimated error rate was 0.0072, with a bias of 0.0382 compared to the expected error
rate. In contrast, EER_CS and EER_RS had median estimated error rates of 0.0354 and 0.0351,
respectively, with biases of 0.0099 and 0.0102, respectively. From these results, we can observe
that the SRER approach underestimated the error rates, while the smoothing spline approaches
provided more accurate estimated error rates.
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Table 10 Simulation studies for deletion by testing shadows to be only 1 base, only 2 bases,
and up to 2 bases deletion.
Shadow

Deletion

only 1
deletion

left side

only 2
deletion

up to 2
deletion

only 1
deletion

only 2
deletion

Per-read ER
Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

SRR037452
0.0453
0.0072
0.0382
0.0354
0.0099
0.0351
0.0102

SRR037456
0.0430
0.0042
0.0387
0.0304
0.0125
0.0306
0.0124

SRR002053
0.0622
0.0080
0.0542
0.0337
0.0285
0.0329
0.0293

SRR032586
0.0013
0.0001
0.0012
0.0006
0.0007
0.0006
0.0007

left side

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.0250
0.0018
0.0232
0.0178
0.0072
0.0180
0.0069

0.0206
0.0006
0.0200
0.0142
0.0064
0.0146
0.0060

0.0423
0.0036
0.0387
0.0197
0.0226
0.0188
0.0236

0.0008
0.0000
0.0008
0.0003
0.0005
0.0003
0.0005

left side

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.0659
0.0113
0.0545
0.0513
0.0146
0.0508
0.0150

0.0581
0.0065
0.0516
0.0424
0.0157
0.0424
0.0157

0.1010
0.0141
0.0869
0.0543
0.0467
0.0515
0.0496

0.0020
0.0001
0.0019
0.0008
0.0011
0.0008
0.0011

right side

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.0647
0.0124
0.0523
0.0507
0.0140
0.0503
0.0144

0.0640
0.0082
0.0558
0.0473
0.0167
0.0474
0.0166

0.1886
0.0246
0.1640
0.1028
0.0858
0.1006
0.0880

0.0032
0.0003
0.0029
0.0022
0.0009
0.0022
0.0009

right side

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.1352
0.0205
0.1147
0.1004
0.0348
0.1011
0.0341

0.1303
0.0232
0.1072
0.1024
0.0280
0.1023
0.0280

0.2482
0.0425
0.2058
0.1455
0.1027
0.1427
0.1055

0.0043
0.0003
0.0040
0.0028
0.0015
0.0028
0.0015

67

up to 2
deletion

only 1
deletion

only 2
deletion

up to 2
deletion

right side

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.1808
0.0406
0.1402
0.1419
0.0389
0.1416
0.0392

0.1765
0.0374
0.1391
0.1398
0.0367
0.1391
0.0374

0.3615
0.0693
0.2922
0.2222
0.1394
0.2195
0.1421

0.0073
0.0008
0.0065
0.0050
0.0023
0.0050
0.0023

two sides

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.0956
0.0172
0.0784
0.0753
0.0203
0.0745
0.0211

0.0924
0.0124
0.0799
0.0680
0.0244
0.0678
0.0246

0.2162
0.0246
0.1916
0.1119
0.1043
0.1098
0.1064

0.0037
0.0003
0.0034
0.0023
0.0014
0.0023
0.0014

two sides

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.1974
0.0292
0.1682
0.1472
0.0502
0.1479
0.0495

0.1922
0.0261
0.1661
0.1469
0.0453
0.1466
0.0457

0.3041
0.0368
0.2674
0.1613
0.1428
0.1576
0.1466

0.0051
0.0003
0.0047
0.0031
0.0020
0.0031
0.0020

two sides

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.2576
0.0555
0.2022
0.2016
0.0560
0.2021
0.0556

0.2511
0.0433
0.2079
0.1966
0.0545
0.1956
0.0556

0.4177
0.0611
0.3566
0.2411
0.1766
0.2373
0.1804

0.0085
0.0008
0.0077
0.0055
0.0030
0.0056
0.0030

*Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts
and shadow counts.

Expected ER: expected error rate in simulation studies
SRER: error rate estimated using shadow regression
SRER Bias: the absolute value of the difference between SRER and Expected ER
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER
EER_RS: empirical error rate estimated using robust smoothing spline
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER
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Table 11 reports the median insertion error rates from simulation study for shadows defining to
be only one base different, only two bases different, and up to two bases different from error-free
sequences, obtained using the SRER approach and the two EER approaches, based on nextgeneration sequencing data samples. Insertion error rates from left side, right side, and two sides
in the simulation studies were investigated. Similar to the simulation results from the deletion
investigation, all samples in the insertion studies yielded error rates for the smoothing spline
approaches that were more accurate than the estimations of error rates for SRER. For example, in
sample SRR037452, the median of the left side insertion expected error rate with shadows
defined as sequences of up to two bases different from error-free sequence reads in the
simulation was 0.1930. Using SRER, the median of the estimated error rate was 0.0197, with a
bias of 0.1733 compared with the expected error rate. Using the smoothing spline approaches,
the median of the estimated error rates were 0.1689 for cubic smoothing spline with a very small
bias of 0.0241, and 0.1783 for robust smoothing spline with a bias of 0.0147, respectively.

69

Table 11 Simulation studies for insertion by testing shadow to be only 1 base insertion, only
2 bases insertion, and up to 2 bases insertion.
Shadow

Insertion

only 1
insertion

left side

only 2
insertion

up to 2
insertion

only 1
insertion

only 2
insertion

Per-read ER
Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

SRR037452
0.1192
0.0125
0.1067
0.1029
0.0163
0.1068
0.0124

SRR037456
0.0886
0.0056
0.0830
0.0581
0.0305
0.0579
0.0306

SRR002053
0.1692
0.0204
0.1487
0.0873
0.0819
0.0854
0.0838

SRR032586
0.0028
0.0002
0.0026
0.0022
0.0006
0.0022
0.0006

left side

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.1141
0.0122
0.1019
0.0987
0.0154
0.1091
0.0051

0.0856
0.0009
0.0848
0.0490
0.0366
0.0462
0.0395

0.1412
0.0109
0.1303
0.0566
0.0846
0.0612
0.0799

0.0027
0.0001
0.0026
0.0015
0.0012
0.0015
0.0012

left side

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.1930
0.0197
0.1733
0.1689
0.0241
0.1783
0.0147

0.1554
0.0083
0.1471
0.1002
0.0552
0.0962
0.0593

0.2682
0.0368
0.2313
0.1452
0.1230
0.1398
0.1284

0.0053
0.0003
0.0050
0.0037
0.0016
0.0037
0.0016

right side

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.1532
0.0240
0.1292
0.1217
0.0315
0.1214
0.0318

0.1460
0.0182
0.1278
0.1058
0.0402
0.1056
0.0404

0.1501
0.0182
0.1319
0.0805
0.0695
0.0778
0.0723

0.0020
0.0002
0.0018
0.0011
0.0009
0.0011
0.0009

right side

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.1573
0.0262
0.1311
0.1217
0.0356
0.1237
0.0336

0.1538
0.0043
0.1495
0.1006
0.0532
0.1011
0.0527

0.1892
0.0325
0.1566
0.1188
0.0704
0.1147
0.0745

0.0018
0.0001
0.0016
0.0008
0.0009
0.0008
0.0009
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up to 2
insertion

only 1
insertion

only 2
insertion

up to 2
insertion

right side

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.2677
0.0554
0.2123
0.2173
0.0504
0.2170
0.0507

0.2537
0.0317
0.2220
0.1841
0.0696
0.1861
0.0676

0.2924
0.0494
0.2430
0.1808
0.1116
0.1770
0.1154

0.0035
0.0004
0.0031
0.0019
0.0016
0.0019
0.0016

two sides

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.2245
0.0330
0.1915
0.1737
0.0509
0.1759
0.0486

0.2074
0.0237
0.1838
0.1533
0.0541
0.1532
0.0542

0.2385
0.0166
0.2219
0.1082
0.1303
0.1047
0.1338

0.0039
0.0003
0.0036
0.0027
0.0012
0.0027
0.0012

two sides

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.2521
0.0590
0.1930
0.2251
0.0270
0.2310
0.0211

0.2316
0.0286
0.2031
0.1706
0.0610
0.1707
0.0609

0.3539
0.0349
0.3190
0.1759
0.1780
0.1711
0.1828

0.0053
0.0004
0.0049
0.0030
0.0023
0.0030
0.0023

two sides

Expected ER
SRER
SRER Bias
EER-CS
EER-CS Bias
EER-RS
EER-RS Bias

0.3834
0.0873
0.2961
0.3319
0.0515
0.3321
0.0513

0.3577
0.0557
0.3019
0.2783
0.0794
0.2782
0.0795

0.4631
0.0498
0.4133
0.2509
0.2122
0.2467
0.2164

0.0089
0.0008
0.0080
0.0056
0.0032
0.0057
0.0032

*Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts
and shadow counts.

Expected ER: expected error rate in simulation studies
SRER: error rate estimated using shadow regression
SRER Bias: the absolute value of the difference between SRER and Expected ER
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER
EER_RS: empirical error rate estimated using robust smoothing spline
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER
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In order to know the error rates by varying shadow definitions, the real data analysis is
performed. Table 12 shows the error rates in real data analysis obtained using shadow linear
regression approach and empirical error rate approach in smoothing spline and robust smoothing
spline when shadows are defined to be only one base different, only two bases different, only
three bases different, up to two bases different, and up to three bases different from error-free
reads in substitutions. The sample 100217 is a PhiX DNA sample, which were generated from
the Center for Cancer Computational Biology at Dana-Farber and provided by Wang et al. (4).
The PhiX 174 is an icosahedral virus containing a closed circular single-stranded DNA (144).
The sample SRR002053 is a sample from ENCODE project transcriptome data with around 12
million reads. Sample SRR002053 is human mRNA sequence data from human cell line K562
running on Illumina 1G Genome Analyzer(145). The sample SRR037452 and sample
SRR037456 are mRNA data from MAQC brain experiment 2, which contains about 12 million
reads for each sample (145). The sample SRR032586 is mutation screening resequencing data
from patient with X-linked mental retardation (XLMR) for mutations in 86 previously identified
XLMR genes(145). Sample SRR032586 was applied to data analysis study after the outliers
were removed in Table 12.

From the results in Table 12, the error rates of only one base different are generally greater than
the ones of only two bases different. The error rates of only two bases different are generally
greater than the ones of only three bases different. For example, in sample 100217, the estimated
error rates by shadow regression were 0.0246, 0.0015, and 0.0004 for only one, only two, only
three bases different in substitution, respectively. The error rates were 0.0289, 0.0030, and
0.0011 by using cubic smoothing spline, and 0.0289, 0.0030, and 0.0012 by using robust
smoothing spline, for only one, only two, only three bases different in substitution, respectively.
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Based on previous studies (4, 146), using shadows with up to two bases different provides
accurate estimation without too much computational cost. Using shadow with up to three bases
different may have higher possibility of identifying more errors, but it may also count
polymorphism as sequence errors and take excessive computational cost. In addition, the error
rates with up to two bases different from error-free reads in substitution are similar with the ones
of up to three bases different. For example, in sample 100217, the estimated error rates were
0.0261 for up to two bases different, and 0.0251 for up to three bases different using shadow
regression, and 0.0317 for up to two bases different, and 0.0322 for up to three bases different
using cubic smoothing spline, and 0.0315 for up to two bases different and 0.0322 for up to three
bases different using robust smoothing spline, respectively. Therefore, we confirmed with
previous studies that using the shadow with up to two bases different is good enough without
excessive computational cost.
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Table 12. Real data application for substitution by varying shadow to be only 1 base
different, only 2 bases different, only 3 bases different, up to 2 bases different, and up to 3
bases different.

Samples

Substitution ER
Estimation

only 1

only2

only3

sub2

sub3

100217

SRER
EER-CS
EER-RS

0.0246
0.0289
0.0289

0.0015
0.003
0.003

0.0004
0.0011
0.0012

0.0261
0.0317
0.0315

0.0251
0.0322
0.0322

SRR002053

SRER
EER-CS
EER-RS

0.2832
0.369
0.3084

0.2344
0.2945
0.2868

0.178
0.2303
0.2252

0.4134
0.4469
0.4453

0.269
0.4308
0.4266

SRR032586

SRER
EER-CS
EER-RS

0.0707
0.1199
0.1193

0.0113
0.0689
0.0684

0.0054
0.0659
0.0663

0.0954
0.1729
0.1725

0.0696
0.1353
0.1386

SRR037456

SRER
EER-CS
EER-RS

0.1238
0.1538
0.1605

0.0548
0.085
0.1126

0.0331
0.0624
0.092

0.1657
0.2062
0.2162

0.1451
0.2413
0.2751

SRER: error rate estimated using shadow regression
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_RS: empirical error rate estimated using robust smoothing spline

74

Table 13 shows the error rates from real data analysis result in deletion. Different deletion error
rates were investigated by defining the shadows to be only one base different, only two bases
different, and up to two bases different in left side deletion, right side deletion, and two side
deletion, respectively. For sample SRR037452, when the shadow is defined to be only one base
different from error-free read in deletion, the error rates from left side deletion is 0.0121, 0.0386,
and 0.0404 using shadow regression, cubic smoothing spline, and robust smoothing spline,
respectively. When the shadow is defined to be only two bases deletion, the error rates of left
side deletion for sample SRR037452 is 0.0037, 0.0185 and 0.0348 using shadow regression,
cubic smoothing spline, and robust smoothing spline, respectively. When the shadow is defined
to be up to two bases different from error-free reads in deletion, the error rates of left side
deletion for sample SRR037452 is 0.0184, 0.0550 and 0.0782 using shadow regression, cubic
smoothing spline, and robust smoothing spline, respectively. The right side deletion is the
deletion adding the extra base to the right end side of the read when some base is deleted from
the original sequence, given that all the sequences are with the same lengths. The right side
deletion is relatively greater than the left side deletion in the samples studied. For sample
SRR037452, when the shadow is defined to be only one base in deletion, the error rates of right
side deletion is 0.0201, 0.0573, and 0.0687 by using shadow regression, cubic smoothing spline,
and robust smoothing spline, respectively. When the shadow is defined to be only two bases
different in deletion, the error rates of right side deletion for sample SRR037452 is 0.0318,
0.1118 and 0.1120 by using shadow regression, cubic smoothing spline, and robust smoothing
spline, respectively. When the shadow is defined to be up to two bases deletion, the error rates of
right side deletion for sample SRR037452 is 0.0680, 0.1559, and 0.1684 by using shadow
regression, cubic smoothing spline, and robust smoothing spline, respectively. Another way of
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deletion is two-side deletion. Suppose one or two bases are deleted from an original sequence
read, given that all the sequences are with the same lengths, an extra base from one of the alleles
(“A”, “T”, “G”, “C”) will be added to either left or right end side of the read. For sample
SRR037452, the error rates for only one base in two-side deletion are 0.0288, 0.0829, and 0.0910
using shadow regression, cubic smoothing spline, and robust smoothing spline, respectively.
When the deletion shadow is defined to be only two bases different from error-free reads, the
error rates of two-side deletion for sample SRR037452 are 0.0439, 0.1635, and 0.1639 by using
shadow regression, cubic smoothing spline, and robust smoothing spline, respectively. When the
deletion shadow is defined to be up to two bases different from error-free sequences, the error
rates of two-side deletion for sample SRR037452 are 0.0876, 0.2213, and 0.2269 by using
shadow regression, cubic smoothing spline, and robust smoothing spline, respectively.
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Table 13. Real data application for deletion by varying shadow to be only 1 base deletion,
only 2 bases deletion, and up to 2 bases deletion.

Shadow

Deletion

only 1
deletion

left side

only 2
deletion

left side

SRER
EER-CS
EER-RS

0.0037
0.0185
0.0348

0.0023
0.0139
0.0198

0.0151
0.0294
0.0381

0.0002
-0.0277
-0.0223

up to 2
deletion

left side

SRER
EER-CS
EER-RS

0.0184
0.0550
0.0782

0.0124
0.0472
0.0587

0.0475
0.0761
0.0866

0.0030
0.0080
0.0078

only 1
deletion

right side

SRER
EER-CS
EER-RS

0.0201
0.0573
0.0687

0.0143
0.0557
0.0637

0.0674
0.1311
0.1332

0.0045
0.1224
0.1157

only 2
deletion

right side

SRER
EER-CS
EER-RS

0.0318
0.1118
0.1120

0.0365
0.1109
0.1126

0.1147
0.1834
0.1794

0.0035
0.0880
0.0835

up to 2
deletion

right side

SRER
EER-CS
EER-RS

0.0680
0.1559
0.1684

0.0596
0.1539
0.1634

0.1752
0.2670
0.2645

0.0140
0.1823
0.1778

only 1
deletion

two sides

SRER
EER-CS
EER-RS

0.0288
0.0829
0.0910

0.0217
0.0792
0.0861

0.0681
0.1434
0.1426

0.0052
0.1190
0.1181

two sides

SRER
EER-CS
EER-RS

0.0439
0.1635
0.1639

0.0482
0.1627
0.1623

0.0931
0.1991
0.1967

0.0045
0.0276
0.0266

two sides

SRER
EER-CS
EER-RS

0.0876
0.2213
0.2269

0.0777
0.2158
0.2219

0.1558
0.2855
0.2816

0.0159
0.1406
0.1378

only 2
deletion

up to 2
deletion

Per-read ER
SRER
EER-CS
EER-RS

SRR037452 SRR037456 SRR002053 SRR032586
0.0121
0.0082
0.0307
0.0028
0.0386
0.0352
0.0505
0.0136
0.0404
0.0386
0.0519
0.0121

SRER: error rate estimated using shadow regression
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_RS: empirical error rate estimated using robust smoothing spline
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Table 14 shows the insertion error rates from real data analysis by using shadow regression,
cubic smoothing spline, robust smoothing spline and varying definition of insertion shadows to
be only one base different, only two bases different, and up to two bases different from error-free
sequences. The left side insertion is the insertion when some base is inserted from an original
sequence, given that all the sequences are with the same length, an extra base is then removed
from the right end side of the read. For sample SRR037452, when the shadow is defined to be
only one base in insertion, the error rates of left side insertion is 0.0137, 0.1064, and 0.1267 by
using shadow regression, cubic smoothing spline, and robust smoothing spline, respectively.
When the insertion shadow is defined to be only two bases different from error-free reads, the
error rates of left side insertion for sample SRR037452 is 0.0032, 0.0797, and 0.1367 by using
shadow regression, cubic smoothing spline, and robust smoothing spline, respectively. When the
shadow is defined to be up to two bases insertion, the error rates of left side insertion for sample
SRR037452 is 0.0234, 0.1682, and 0.2209 using shadow regression, cubic smoothing spline, and
robust smoothing spline, respectively. The right side insertion is the insertion when some base is
inserted from an original sequence, given that all the sequences are with the same length, an
extra base is removed from the left end side of the read. For sample SRR037452, when the
shadow is defined to be only one base in insertion, the error rates of right side insertion is
0.0417, 0.1275, and 0.1472 using shadow regression, cubic smoothing spline, and robust
smoothing spline, respectively. When the insertion shadow is defined to be only two bases
difference, the error rates of right side insertion for sample SRR037452 is 0.0405, 0.1284, and
0.1534 using shadow regression, cubic smoothing spline, and robust smoothing spline,
respectively. When the insertion shadow is defined to be up to two bases difference, the error
rates of right side insertion for sample SRR037452 is 0.0847, 0.2254, and 0.2581 by using
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shadow regression, cubic smoothing spline, and robust smoothing spline, respectively. Another
way of insertion is two-side insertion. Suppose one or two bases are inserted to a sequence read,
given that all the sequences are with the same lengths, extra base(s) will be removed from either
left or right end side of the read. For sample SRR037452, the error rates for only one base
difference of two-side insertion approach are 0.0381, 0.1502, and 0.1631 by using shadow
regression, cubic smoothing spline, and robust smoothing spline, respectively. When the shadow
is defined to be only two bases difference, the error rates of two-side insertion for sample
SRR037452 are 0.0045, 0.1008, and 0.1569 using shadow regression, cubic smoothing spline,
and robust smoothing spline, respectively. When the shadow is defined to be up to two bases
difference, the error rates of two-side insertion for sample SRR037452 are 0.0463, 0.2222,and
0.2656 by using shadow regression, cubic smoothing spline, and robust smoothing spline,
respectively.
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Table 14. Real data application for insertion by varying shadow to be only 1 base insertion,
only 2 bases insertion, and up to 2 bases insertion.

Shadow

Insertion

only 1 insertion

left side

Per-read ER
SRER
EER-CS
EER-RS

SRR037452 SRR037456 SRR002053 SRR032586
0.0137
0.0085
0.0539
0.0017
0.1064
0.0604
0.1113
0.0332
0.1267
0.0813
0.1123
0.0289

only 2 insertion

left side

SRER
EER-CS
EER-RS

up to 2 insertion

left side

SRER
EER-CS
EER-RS

0.0234
0.1682
0.2209

0.0137
0.0945
0.1484

0.0937
0.1774
0.1446

0.0039
0.0275
0.0279

only 1 insertion

right side

SRER
EER-CS
EER-RS

0.0417
0.1275
0.1472

0.0289
0.1157
0.1161

0.0538
0.1040
0.1045

0.0024
0.0235
0.0236

only 2 insertion

right side

SRER
EER-CS
EER-RS

0.0405
0.1284
0.1534

0.0267
0.1124
0.1389

0.0945
0.1494
0.1600

0.0007
0.0132
0.0144

right side

SRER
EER-CS
EER-RS

0.0847
0.2254
0.2581

0.0592
0.2028
0.2218

0.1512
0.2202
0.2286

0.0056
0.0362
0.0393

only 1 insertion

two sides

SRER
EER-CS
EER-RS

0.0381
0.1502
0.1631

0.0248
0.1089
0.1238

0.0505
0.1237
0.1265

0.0025
0.0546
0.0470

only 2 insertion

two sides

SRER
EER-CS
EER-RS

0.0045
0.1008
0.1569

0.0033
0.0681
0.1052

0.0435
0.1131
-0.0045

0.0027
0.0003
0.0021

two sides

SRER
EER-CS
EER-RS

0.0463
0.2222
0.2656

0.0349
0.1578
0.2021

0.0970
0.2050
0.1298

0.0043
0.0458
0.0449

up to 2 insertion

up to 2 insertion

0.0032
0.0797
0.1367

0.0035
0.0454
0.0822

0.0364
0.0884
0.0407

0.0024
-0.0022
-0.0004

SRER: error rate estimated using shadow regression
EER_CS: empirical error rate estimated using cubic smoothing spline
EER_RS: empirical error rate estimated using robust smoothing spline
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3.4 Conclusion

The empirical error rate estimation approach for insertion and deletion do not require using a
reference genome in estimating sequencing error rates and are also adjustable to various base
error estimation for next generation sequencing data. We estimated the substitution error rates by
varying different bases and confirm that using shadows of up to two base different is good
enough for short read sequences without excessive computational cost. We performed simulation
studies and investigated the performance of empirical error rate estimation approaches when
defining shadows to be deletion and insertion with only one base different, only two bases
different, and up to two bases different from error-free sequences for left side, right side, two
sides approaches, respectively, and compared with the results using shadow regression approach.
Under the simulation scenarios tested, the empirical error rate estimation approach using splines
provided more accurate estimation for both insertion and deletion error rates with less bias than
the shadow regression approach. The proposed empirical error rate approaches were also applied
to real data analysis and compared with the shadow regression approach.
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Chapter 4
Statistical Approaches for Processing and Analyzing
Microbiome Data

4. 1. Introduction

The human microbiome refers to the totality of all microbes consisting of prokaryotes (bacteria),
archaea, fungi, and viruses in and on the human body (147). Microbiomes rarely live alone in
nature as they function in a complex microbial community by processing energy and materials or
constituting an extended human genome (148, 149). The human microbial partners carry out a
number of metabolic reactions that are essential for human health, but are not encoded in the
human genome (150)[150].

Advances in sequencing technology have allowed us to generate large amounts of microbiome
data. Sequencing of the microbiome provides a great opportunity to assess the organismal and
functional novelty to be discovered, which plays an essential role in human health and disease
(150)[150]. The composition of the human microbiome varies as a result of one’s health, diet,
lifestyle, social interactions, early antibiotic therapy, genotype, and environmental chemicals
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(148, 151). In addition, the microbiome produces beneficial compounds in our body such as
vitamins and anti-inflammatories that our human genome cannot produce (152). The
relationships between components of the microbiome are often referred to as commensal, where
one partner benefits and the other is apparently unaffected, as opposed to mutualistic, where both
partners experience increased fitness (149). Recent studies have shown the microbiome to be
associated with complex diseases, including obesity (51), cardiovascular disease (153), type 2
diabetes (51), and colorectal cancer (154). Also, the gut microbiome was shown to modulate
behavioral and physiological abnormalities associated with neurodevelopmental disorders via
circulating metabolites. Commensal bacteria were also shown to control the response of cancer
to therapy by modulating the tumor microenvironment (148). This chapter discusses approaches
for analyzing microbiome data, from the initial steps of processing raw sequencing data to the
downstream analysis, including assessing community-level diversities and their association with
outcomes of interest.
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4.2 Methods in Human Microbiome Analysis

4.2.1 Next-generation Sequencing Methods for the Human Microbiome

Commonly used next-generation sequencing methods for analyzing the human microbiome
include shotgun metagenomic sequencing and 16S ribosomal RNA (rRNA) sequencing (49)[49].
The shotgun metagenomic sequencing technique enables comprehensive sampling of all the
genes over all organisms in a complex microbial sample; while the 16S rRNA sequencing
approach focuses on identifying and comparing bacteria within a given sample (49)[49]. Over
the last decade, 16S rRNA sequencing has become a popular technique to accurately identify
bacterial isolates and discover novel bacteria in clinical studies of the microbiome (155). In
particular, the 16S rRNA gene can be compared not only among all bacteria but also with the
16S rRNA gene of archeobacteria and the 18S rRNA gene of eukaryotes (50). The 16S rRNA
gene can be used as a stable phylogenetic marker to study the lineage relationships in the sample
(156). The 16S rRNA gene has been identified for a large number of strains and is universal in
bacteria. According to previous studies (50), identifying the bacteria isolated by a sequencing
technique has the potential to better identify strains that are poorly described, rarely isolated or
biochemically aberrant. The 16S rRNA sequencing technique can identify novel pathogens and
lead to the discovery of noncultured bacteria (157, 158). Most importantly, although microbiome
data can be generated using multiple methods, 16S rRNA sequencing is more efficient and less
expensive compared to other methods and, thus, is still the most popular approach for generating
such data (157, 158). Therefore, we focus on data processing and analysis for microbiome data
generated by the 16S rRNA sequencing approach.
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4.2.1.1 Foregut Esophageal Adenocarcinoma Study

We use the dataset from a study of esophageal adenocarcinoma in the foregut (159) to illustrate
data analysis and interpretation for a microbiome study. That study sought to uncover the
associations between esophageal adenocarcinoma risk and the composition of the microbiome.
The project studied the microbiome at multiple stages of disease development, from normal to
inflammation, metaplasia, and neoplasia, and also used invasive endoscopic procedures to
sample the microbiome deep inside the human body. Esophageal adenocarcinoma is a rare but
aggressive cancer that has been increasing in incidence, especially among white males.
Esophageal adenocarcinoma develops in the distal esophagus in response to mucosal injury
(159). Risk factors for esophageal adenocarcinoma include gastroesophageal reflux disease,
cigarette smoking, obesity and low fruit or vegetable consumption, which together represent
~80% of the population attributable risk. The characteristics of the esophageal microbiome may
facilitate the development of disease (159). The study evaluated 104 individuals (16 females and
88 males) and collected fecal and oral samples, as well as samples from the esophagus and
stomach, for a total of 555 microbiome samples from different sites and different individuals.
The sequencing data for all the microbiome samples were generated using the Roche 454 GS
FLX Titanium platform (160) and Illumina HiSeq 2000 platform (161). For the purpose of the
illustration, we randomly selected 40 oral samples, among which 20 samples were from healthy
subjects and the other 20 samples were from the esophageal adenocarcinoma patients, for which
the sequencing data were generated using the Roche 454 GS FLX Titanium platform.
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4.2.1.2 Processing Raw Microbiome Sequencing Data

Several pipelines are available to process raw microbiome data with millions of sequencing reads
before assessing the association between microbial community profiles and outcomes of interest,
among which the most popular pipelines are mothur (162) and Quantitative Insights into
Microbial Ecology (QIIME, pronounced “chime”) (148, 162, 163). Mothur is an open-source,
platform-independent, community-supported software that describes and compares microbiome
communities (162).QIIME is a free and open-source analytic tool to process high-dimensional
sequencing data (163). It has been shown that QIIME and mothur have similar statistical
capabilities and user freedom; however, QIIME is more user-friendly than mothur as it is easier
to understand and interpret the commands in QIIME than those in mothur (164). QIIME is
available for analyzing whole metagenomic shotgun sequencing data, while mothur does not
have this function (164). QIIME is preferred for analyzing large datasets due to the efficiency
gain in computational time and the user-friendly interface. More importantly, the taxonomic
summary table generated using QIIME is more easily adapted to the downstream analyses in
statistical packages such as R (164). Therefore, in this study, we use QIIME to process the raw
microbiome sequencing data and generate the operational taxonomic units (OTUs) for the
downstream microbiome data analysis. QIIME can process raw sequencing data generated from
different platforms, such as Illumina and 454 platforms (163).

We describe the data processing procedure for data generated using the 454 platform. Typically
the raw sequencing data are available in fasta and fastq formats. We review the commands for
data processing, quality checking and OTU extraction based on these two data formats. In
addition to the sequencing read files, a metadata mapping file is required for the purpose of data
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processing. The metadata mapping file usually contains the following information: the name of
each sample, barcode sequence for each sample, primer sequence used to amplify the sample,
and a descriptive column (for example, health status, sampling site, or which medications a
patient was taking at the time of sampling) (163).

Figure 4 shows the basic procedure for processing the raw microbiome sequencing data.
Specifically, we need to perform the steps described below, including demultiplexing, removing
barcodes and primers and quality control checks, before generating OTUs for downstream
analysis. The commands for processing the raw microbiome sequencing data and extracting the
OTUs using QIIME are provided in the Methods section.

(a) Demultiplexing: If multiple samples are pooled in one single lane by using the sample
index or barcode adapters, then the step of demultiplexing is needed to divide one file of
sequencing reads into separate files, where one file corresponds to one sample (163).

(b) Removing barcodes: High-throughput sequencing allows multiple different independent

samples to be sequenced during a single run. In this situation, each sample is tagged with
a unique sequence that is referred to as a barcode. The QIIME software utilizes barcodes
to demultiplex and assign sequences to each sample (165, 166). However, the barcodes
incorporated in the sequencing reads need to be removed because the reads containing
barcodes can lead to a mismatching issue in the downstream procedures (167).

(c) Removing primers: The primer is a starting point for DNA synthesis, which consists of a
short nucleic acid sequence. For living organisms, primers are short strands of RNA that
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enzymes synthesize as a type of RNA polymerase before DNA replication occurs (168).
It is a necessary step for the primer synthesis as DNA polymerases can only attach new
DNA nucleotides to an existing strand of nucleotides (168). However, to avoid a
mismatching issue when converting data into OTUs, it is necessary to remove the
primers. We note that for some sequencing data downloaded from dbGaP, such as the
data from the foregut esophageal adenocarcinoma study used here, the barcodes and
primers have been removed before the investigators uploaded the data. In this situation,
we do not need to conduct these two steps of removing barcodes and primers.

(d) Quality filtering: The quality filtering step is used to remove any low-quality or
ambiguous reads according to the quality scores provided in the sequencing. In the 454
sequencing pipeline, the quality score assigned to each called base is the flowgram values
rounded to the nearest integer in the Phred format. The Phred score is the probability that
each nucleotide was incorrectly read (169). Based on the Phred score and a pre-specified
threshold parameter, we can remove sequences that do not satisfy the desired quality
(165).

(e) Additional quality-control procedures: Sequencing platforms can produce characteristic
sequencing errors, such as imprecise signals for longer homopolymer runs. The denoising procedure removes such errors and thereby improves the accuracy of the OTU
generation. In addition, the raw sequencing data may contain chimeras generated by
abnormal amplification during the process of polymerase chain reaction (PCR); these
chimeras also need to be removed before generating OTUs.
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Figure 4. Flowchart of basic steps in handling raw microbiome sequencing data
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4.3 Diversity Measures of the Microbiome

As stated previously, different species of microbes live as interacting communities, and the
abundance and diversity of the microbiome is essential for maintaining human health (148).
Measures of diversity, richness, and abundance are often used to summarize microbiome
communities and compare them in different groups (148), among which the alpha (α) and beta
(β) diversities are most commonly used. The alpha diversity measure shows the spatial patterns
of biological diversity within a sample; thus, it evaluates the within-sample diversity (170). The
beta diversity measure assesses the change in species composition between samples (170),
evaluating the between-sample diversity. We describe several alpha and beta diversity measures
commonly used in studies of the microbiome, with illustrations in the Methods section using the
R package “phyloseq” (171), based on the data from the foregut esophageal adenocarcinoma
study described previously.

4.3.1 The 𝛂 Diversity of the Microbiome

On the level of the microbial community, the clustering of OTUs allows us to measure the
within-sample diversity (α diversity) of the microbiome. The observed richness, which is the
simplest measure, refers to the number of species within a sample (172), but does not incorporate
information about their relative abundance. Here, we introduce several commonly used measures
for assessing 𝛼 diversity.
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4.3.1.1 Shannon diversity index

The Shannon diversity index is a popular measure of species diversity that measures the entropy
and uncertainty of the sampling outcome (56). The Shannon diversity index is calculated as
follows: Suppose 𝑛 is the total number of species, and pi is the proportion of species i relative to
the total number of species in a community (173), then the Shannon diversity index is H = −
∑ni=1(pi × ln pi ). Higher values of the Shannon diversity index represent more diversity within a
community; a value of 0 means the community has only one species. The Shannon diversity
index is nonparametric, which allows for the simultaneous measurement of a richness estimation
from heterogeneous samples (58) and takes into account both the relative abundance and total
number of species in a microbiome community (173-175).

4.3.1.2 Simpson’s diversity index

The Shannon index emphasizes the richness component, while Simpson’s index stresses the
evenness component (57). Simpson’s diversity index describes the probability that two randomly
drawn reads from a sample are from the same taxon (56). Simpson’s diversity index is given as
𝜆 = ∑𝑛𝑖=1 𝑝𝑖2 , where 𝑛 is the total number of species, and pi is the proportion of species i relative
to the total number of species in a community (173). Simpson’s diversity index is between 0 and
1, where 0 represents infinite diversity and 1 implies no diversity. The higher the value of
Simpson’s diversity index, the lower the diversity within the community.
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For easier interpretation, the inverse Simpson’s diversity index, calculated as 1⁄𝜆, estimates the
probability that two randomly chosen reads from a sample of the given community come from
different taxa. A higher value for the inverse Simpson’s diversity index represents greater
diversity. A previous study showed that Simpson’s diversity index has a small standard
deviation, and for moderately large samples the bias is small (173). However, the inverse
Simpson’s diversity index is biased when estimating numerous species that have low abundance
within a community (56).

4.3.1.3 Fisher’s 𝜶 diversity index

Fisher’s 𝛼 diversity index describes the relationship between the number of species and the
number of individuals of the corresponding species by logarithmic distribution. Compared with
the Shannon index and Simpson’s index, Fisher’s 𝛼 diversity index is not influenced by the
sample size and is less affected by the abundance of the most common species. Fisher’s 𝛼 index
depends more on the number of species of intermediate abundance (174, 176).

Fisher’s 𝛼 index is used to iteratively fit the logarithmic-series distribution (177, 178). According
to Fisher’s theory, any population should have a constant value α for samples of any size taken
from it under identical conditions (179). Suppose 𝑆 is the total number of species in the sample,
and 𝑛 is the total number of individuals. The relative abundance is derived from the logarithmicseries formed as 𝛼𝑥, 𝛼𝑥 2 ⁄2 , 𝛼𝑥 3 ⁄3 , … , 𝛼𝑥 𝑛 ⁄𝑛, where the successive terms represent the
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number of species predicted to have the corresponding 1, 2, 3, … , 𝑛 individuals. The parameter 𝑥
is estimated by an iterative solution of 𝑆⁄𝑁 = (1 − 𝑥)⁄𝑥(− ln(1 − 𝑥)), and the parameter 𝛼 is
the log-series index of diversity. The two parameters 𝛼 and n summarize the distribution
completely and are related by 𝑆 = 𝛼 ln(1 + 𝑛⁄𝛼 ). The 𝛼 index can also be obtained by 𝛼 =
𝑛(1 − 𝑥)⁄𝑥 (84, 178, 179). A higher value of Fisher’s 𝛼 index represents more diversity within
the sample. The estimation of Fisher’s 𝛼 index gives an unbiased estimation of diversity (179).
However, this approach is computationally intensive when the sample size is large.

4.3.1.4 Chao1 𝜶 diversity index

Because the abundance in microbiome OTU data is often low for many species, the Chao1 𝛼
diversity index is defined as the number of species represented by just one or two individuals
(58). The Chao1 𝛼 diversity index stresses the “singletons” (i.e., the number of species with only
a single occurrence in the sample) and “doubletons” (i.e., the number of species with exactly two
occurrences in the sample) and is calculated as follows: Suppose 𝑆𝑜𝑏𝑠 is the number of species
for the sample, 𝐴1 is the number of singletons, and 𝐴2 is the number of doubletons, then
𝐴 2

𝐶ℎ𝑎𝑜1𝛼 = 𝑆𝑜𝑏𝑠 + 2𝐴1 2. A higher estimated value represents more diversity within the sample.
2

The Chao1 𝛼 diversity index is particularly useful for microbiome datasets skewed to low
abundance classes; while a drawback of the Chao1 𝛼 diversity index is that when the sample size
is low, it underestimates the true value (180).
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4.3.1.5 Abundance-based coverage estimator

The abundance-based coverage estimator (ACE) (181, 182) measures the α diversity by
separating the species into two groups: an abundant species group and a rare species group.
Given a prespecified threshold 𝑘, the abundant species are those with more than 𝑘 taxa, and the
rare species are those with less than or equal to 𝑘 taxa. A value of 𝑘 = 10 is suggested based on
empirical evidence from previous studies (182, 183). The calculation of the ACE is described
below (182).

Given that 𝑓1 is the number of singleton species, 𝑓k is the number of species with exactly 𝑘 taxa,
and 𝑆𝑜𝑏𝑠 is the total number of species in the sample, the number of rare species is described as
𝑆

𝑜𝑏𝑠
𝑆𝑟𝑎𝑟𝑒 = ∑10
𝑘=1 𝑓𝑘 , and the number of abundant species is denoted as 𝑆𝑎𝑏𝑢𝑛𝑑 = ∑𝑘=11 𝑓𝑘 , assuming

the value of 10 is the threshold. The total number of taxa in the rare species is 𝑛𝑟𝑎𝑟𝑒 =
∑10
𝑘=1 𝑘𝑓𝑘 , and 𝐶𝐴𝐶𝐸 = 1 − 𝑛

𝑓1

𝑟𝑎𝑟𝑒

is the proportion of all non-singleton taxa in the rare species.

∑10 𝑘(𝑘−1)fk

𝑆

2
Let 𝛾𝐴𝐶𝐸
= 𝑚𝑎𝑥 [ 𝐶𝑟𝑎𝑟𝑒 (𝑁 𝑘=1)(𝑁
𝐴𝐶𝐸

𝑟𝑎𝑟𝑒

𝑟𝑎𝑟𝑒 −1)

− 1,0] be the coefficient of variation. The ACE of the
𝑆

species richness function is then 𝐴𝐶𝐸 = 𝑆𝑎𝑏𝑢𝑛 + 𝐶𝑟𝑎𝑟𝑒 + 𝐶
𝐴𝐶𝐸

f1

𝐴𝐶𝐸

𝛾 2𝐴𝐶𝐸 . A higher ACE value

implies more diversity within the sample. The ACE takes into account both the abundant and
rare species. However, the ACE underestimates the true richness at low sample sizes (180).
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4.3.2 Microbiome 𝛃 Diversity

The β diversity measure represents the species community composition between two or more
samples. β diversity also refers to the turnover of the community composition from place to
place or from time to time (184, 185). The species turnover is the change in species composition
resulting from species extinction and immigration (186)[186]. Various metrics can be used to
measure the β diversity, such as the Manhattan index (187), Canberra index (188, 189), Jaccard
distance (190), Kulczynski distance (190), binomial deviance (191), Morisita (192), Horn’s
index (192), Bray-Curtis (59), Cao dissimilarity index (60), and UniFrac (61).
The Manhattan index is the sum of absolute value of difference in the corresponding taxa counts
between two samples, which is simple to utilize, whereas it may be sensitive to outliers and the
lack of information about relative abundance. (193) The Canberra index overcomes this
limitation and uses the proportion of difference to estimate diversity. Canberra distance is a
weighted version of Manhattan distance (194, 195). However, according to Emran & Ye(2002)
(194), when noise level increases, the performance in Canberra distance may drop as it is
sensitive to random error. Another index is the Jaccard distance (196) measuring the
dissimilarity between finite sample sets. Jaccard distance uses the size of the intersection divided
by the size of the union of sample sets and measures the proportion of units not shared by the
two observed samples. (197) The Kulczynski distance gives both species the same influence and
improve the dominance of common absences from Jaccard distance. However, there is a
limitation in Kulczynski distance that if the two samples are very disparate in size and if all the
elements on the smaller sample appear in the larger, then the minimum value of the coefficient is
0.5 in which the coefficient’s value is very unsatisfactory. Anderson & Millar (2004) (198)
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proposed binomial deviance as a dissimilarity measure for the abundance data based on
likelihood theory. This measure assumes the null hypothesis that two samples do not differ in
composition and relative abundance of species. That is, for each species, they expect that half of
the counts will fall into each transect. (198) Thus, a useful measure of dissimilarity between two
transects is the sum of these deviances across all species. To take account of the fact that
different species may be varying on different scales, a scale-invariance measure may be obtained
by considering this quantity on a per-observation basis. The null hypothesis for this metric is to
check if the two compared communities are equal, which can be quantified by using the chisquare test statistics. It should be able to handle variable sample sizes. The index does not have a
fixed upper limit, but can vary among sites with no shared species. More details and discussions
could be found in Anderson & Millar (2004) (198). Note that this binomial deviance
dissimilarity is an improvement metric on the Bray-Curtis measure in terms of the likelihood
theory. Here, the chi-square test statistic is equivalent to the dissimilarity measure known as the
coefficient of divergence (Clark, 1952) (199). Hence, the binomial deviance has similar
properties to the coefficient of divergence for use with species abundance data (198). Morisita
proposed an index of similarity between communities. The Morisita metric is a statistical
measure of dispersion of individuals in a population, and its extension (200) (Horn-Morisita
variant) can be used to handle any abundance data. This is interpreted as the probability where
two samples drawn randomly from two populations will belong to the same species, relative to
the probability of randomly drawing two individuals of the same species alone (201). The
Morisita’s measure is useful as an empirical measure though the probability interpretation is only
rigorous when particular species counts are very large. Horn’s index is also an empirical
measuring approach that utilizes different scaling factors based on Morisita metric. Horn index
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improves from the Morisita’s index that the upper limit is exactly 1, which makes it easier to
interpret (201). Horn’s index can also apply for clinical study and has been shown as a simple,
useful, and aggregate scoring measure that enables combning disease severity and underlying
comorbid conditions of the patient together (202). Specifically, we investigated the three widely
used β diversity approaches in details, which are Bray-Curtis, Cao, and UniFrac.

4.3.2.1 Bray-Curtis dissimilarity index

The Bray-Curtis dissimilarity index measures the distance between two microbiome samples A
and B by accounting for the abundance information (59). This approach does not require
phylogenetic information. Given that nAj and nBj are the counts of the taxa in species j in samples
A and B, and NA and NB are the total counts of all taxa in samples A and B, the Bray–Curtis
dissimilarity index to measure the beta diversity between samples A and B is defined as (148)
|𝑛

|

−𝑛

𝛽𝐵𝑟𝑎𝑦−𝐶𝑢𝑟𝑡𝑖𝑠 = ∑𝑝𝑗=1 (𝑁𝐴𝑗 +𝑁𝐵𝑗) ,
𝐴

𝐵

where p is the number of taxa in the samples. The Bray-Curtis index varies between 0 and 1. If
the two microbiome samples A and B are identical in composition, then the index is 0 (i.e.,
coincidence). If there are no species in common between the two samples, then the index is 1
(i.e., complementarity) (203).
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One of the advantages of the Bray-Curtis index is the explicit meaning in the definition. The
other advantage is the relative invariant characteristic that the relative values of a set of
resemblances between two samples are not affected by a simple multiplicative scaling change
(203). Also, the index is independent of joint absence, that is, the resemblance between two
samples is not affected by the exclusion or inclusion of taxa that are absent (203). On the other
hand, a common criticism of the Bray-Curtis index is its increasingly erratic behavior as values
within samples become vanishingly sparse. When there are no taxa in both samples, the BrayCurtis index does not work because the denominator is zero. Furthermore, even if the taxa in the
two samples are from different species, the two samples, which are not empty but nearly so, are
considered similar when using the Bray-Curtis index (203).

4.3.2.2 Cao dissimilarity index

To overcome the shortcomings of the traditional measures for β diversity, such as the BrayCurtis index, Cao et al. (60) proposed a dissimilarity-similarity measure to respond to all of the
types of variation with minimum bias in the weighting. The new dissimilarity measure, CY
dissimilarity measure (CYd), is calculated as (60)

𝐶𝑌𝑑 =

1

∑(
𝑁

𝑛𝐴𝑗 +𝑛𝐵𝑗
)−𝑛𝐴𝑗
2

(𝑛𝐴𝑗 +𝑛𝐵𝑗 ) log10 (

log10 𝑛𝐵𝑗 −𝑛𝐵𝑗 log10 𝑛𝐴𝑗

𝑛𝐴𝑗 +𝑛𝐵𝑗

),

where 𝑛𝐴𝑗 is the counts of taxa for species 𝑗 in sample 𝐴; 𝑛𝐵𝑗 is the counts of taxa for species 𝑗 in
sample 𝐵, and 𝑁 is the total number of species present in the two samples.
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𝑛𝐴𝑗 +𝑛𝐵𝑗

In this formula, the numerator summand (𝑛𝐴𝑗 + 𝑛𝐵𝑗 ) log10 (

2

) − 𝑛𝐴𝑗 log10 𝑛𝐵𝑗 −

𝑛𝐵𝑗 log10 𝑛𝐴𝑗 is used to measure the dissimilarity between two samples. Caution should be taken
when 𝑛𝐴𝑗 = 0 or 𝑛𝐵𝑗 = 0; a small constant value (e.g., 0.1) can be assigned to avoid a
mathematical paradox. In this way, the measure can sensitively respond to all significant
variations and weight them with minimum bias (60). The denominator 𝑛𝐴𝑗 + 𝑛𝐵𝑗 is used to
eliminate the effect of absolute abundance of species. The 1/𝑁 term is used to yield an average
value and reduces the effect from the monotonicity of the total dissimilarity measure with respect
to the species number. If the Cao dissimilarity index is 0, then the two samples are identical
overall. This metric ranges from 0 to ∞, with no fixed upper limit. A higher value of the Cao
index means more dissimilarity between the samples. The Cao index (60) is considered to have a
minimal bias in cases of high beta diversity and variable sampling intensity. This approach does
not account for the phylogenetic information.

4.3.2.3 Unique fraction measures

The unique fraction (UniFrac) measures the difference between microbial samples by
incorporating the phylogenetic information. The phylogenetic distance is measured between sets
of taxa as the fraction of branch length in the phylogenetic tree that leads to descendants from
either sample A or B, but not both (61). The UniFrac distance considers whether an OTU is
present or absent in a sample but not the abundance information (204). To account for the
corresponding phylogenetic information, we have a rooted phylogenetic tree for which 𝑛 is the
99

total number of branches, ℎ𝑘 is the length for branch k, and 𝑝𝐴𝑘 and 𝑝𝐵𝑘 are the taxa proportions
descending from branch k for samples A and B, respectively. The unweighted UniFrac metric is
then defined as (148)
𝑛
𝑈

𝑑 =∑
𝑘=1

ℎ𝑘 |𝐼(𝑝𝐴𝑘 > 0) − 𝐼(𝑝𝐵𝑘 > 0)|
∑𝑛𝑘=1 ℎ𝑘

where 𝐼(∙) is the indicator function that is used to indicate the presence or absence of a species
from branch k with branch length ℎ𝑘 .

To account for the abundance information of taxa sets, a weighted UniFrac was proposed by
weighting the branch lengths with differences in abundance as (148)

𝑑𝑊 =

∑𝑛𝑘=1 ℎ𝑘 |𝑝𝐴𝑘 − 𝑝𝐵𝑘 |
∑𝑛𝑘=1 ℎ𝑘 (𝑝𝐴𝑘 + 𝑝𝐵𝑘 )

where 𝑝𝐴𝑘 and 𝑝𝐵𝑘 are the taxa proportions descending from branch k for samples A and B,
respectively, and ℎ𝑘 is the branch length. The weighted UniFrac not only detects changes in the
number of sequences present for each lineage, but also detects changes in which taxa are present
(205). The weighted UniFrac can be normalized by the average distance for members in the two
samples to the root, which corrects the unequal sampling effort or different evolutionary rates
between taxa (204).

The advantage of the Unifrac measure is that it can be used to compare multiple communities
simultaneously, to determine whether there is a significant difference between communities. The
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UniFrac measures, which utilize phylogenetic information, are more powerful than the other
distance measures by exploiting the degree of divergence between different sequences (61).
Also, the UniFrac measures are applicable for integrating sequencing data from multiple
communities or studies, which makes it suitable for large-scale comparisons between
environments. When the sample size is large, UniFrac measures can be robust to similar samples
(61). The unweighted UniFrac has been shown to have superior power compared with the
weighted UniFrac (206). A drawback is that the Unifrac measures can be computationally
expensive. Meanwhile, the UniFrac measures do not account for the evenness component, so
they cannot address how much of the observed community is attributable to the phylogenetic tree
(61, 207).

4.4 Association between Microbiome Diversity and Outcome

After assessing the microbiome community measures, such as α and β diversities, interest may
lie in evaluating the potential association between these measures and outcomes of interest.
Specifically, to assess the impact of a difference in the α diversity on the outcome, the α
diversity can simply be used as a covariate in a regression model, such as a linear or logistic
regression model (148).
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To assess the association between the β diversity and outcomes, the most commonly used
approach is the permutation-based nonparametric multivariate analysis of variance using distance
matrices (PERMANOVA) (208). PERMANOVA is a distribution-free test that measures the
overall difference for multiple responses based on permutation tests and partitions a symmetric
distance matrix based on linear models. The PERMANOVA approach cannot incorporate other
covariates in the test, and may be confounded by dispersion effects (148, 208).

4.4.1 Variable selection approach with sparse Dirichlet multinomial regression
One can also estimate the associated covariates for taxa counts using Chen & Li (2013) (209)
approach, which uses the variable selection approach with sparse Dirichlet multinomial
regression to estimate the association between the microbiome composition and environmental
covariates. This approach not only accounts for the overdispersion in taxa counts, but also
overcomes the limitation of losing power in multiple testing when the number of covariates is
large. The penalized likelihood approach imposes a sparse group 𝑙1 penalty to encourage both
group level and within group sparsity. Given that there are 𝑞 bacteria taxa with corresponding
counts 𝑌 = (𝑌1 , 𝑌2 , … , 𝑌𝑞 ) as random variables. Suppose the observed counts are 𝑦 =
(𝑦1 , 𝑦2 , … , 𝑦𝑞 ), and 𝑦+ = ∑𝑞𝑗=1 𝑦𝑗 . The underlying species proportions are 𝜙 = (𝜙1 , 𝜙2 , … , 𝜙𝑞 ).
𝑦+
𝑦
The probability function is given as 𝑓𝑀 (𝑦1 , 𝑦2 , … , 𝑦𝑞 ; 𝜙) = ( 𝑦 ) ∏𝑞𝑗=1 𝜙𝑗 𝑗 . The counts
marginally follow a Dirichlet-multinomial (DM) distribution as 𝑓𝐷𝑀 (𝑦1 , 𝑦2 , … , 𝑦𝑞 ; 𝛾) =
𝑦+ Γ (𝑦++1)Γ(𝛾+ ) 𝑞
Γ(𝑦𝑗 +𝛾𝑗 )
∏𝑗=1
( 𝑦 ) Γ(𝑦
, where 𝛾 = (𝛾1 , 𝛾2 , … , 𝛾𝑞 ) are positive parameters, and 𝛾+ =
+𝛾 )
Γ(𝛾 )Γ(𝑦 +1)
+

+

𝑗

𝑗
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∑𝑞𝑗=1 𝛾𝑗 . (209). To incorporate covariate effect vector 𝑋 = (𝑥1 , 𝑥2 , … , 𝑥𝑝 ), it is under the
assumption that the parameters 𝛾𝑗 in the DM model depend on covariates through a log-linear
model that 𝛾𝑗 (𝑋) = exp(𝛼𝑗 + ∑𝑝𝑘=1 𝛽𝑗𝑘 𝑥𝑘 ), where 𝛽𝑗𝑘 is the coefficient effect on the 𝑗th taxon of
the 𝑘th covariate. (45, 209) The penalty term of variable selection for sparse Dirichletmultinomial regression is 𝑝𝑙(𝛽; 𝑌, 𝑋, 𝜆1 , 𝜆2 ) = −𝑙(𝛽; 𝑌, 𝑋) + 𝜆1 ∑𝑝𝑘=1||𝛽𝑘 ||2 + 𝜆2 ∑𝑝𝑘=1||𝛽𝑘 ||1 ,
where 𝑙(𝛽; 𝑌, 𝑋) is log-likelihood function, 𝜆1 and 𝜆2 are tuning parameters and ||𝛽𝑘 ||1 =
2
∑𝑞𝑗=1 |𝛽𝑖𝑘 | is the 𝑙1 norm, ||𝛽𝑘 || = √∑𝑞𝑗=1 𝛽𝑖𝑘
is the group 𝑙1 norm of coefficient vector 𝛽𝑘 ,
2

respectively. (209)
This approach has limitation that it does not incorporate phylogenetic information. One potential
future research topic for extension of this approach is how to incorporate the phylogenetic tree
information into the DM regression model for more accurately estimation (45).

4.4.2 Microbiome Regression Based Kernel Association Test

Zhao et al. (2015) (210) proposed the microbiome regression-based kernel association test
(MiRKAT), which extend the association study that directly regresses the outcome on both
covariate information and semi-parametric kernel machine regression. (210). Compared to
PERMANOVA, MiRKAT is more computationally efficient and can adjust for other covariates
when assessing the association between outcomes of interest and microbiome profiles.
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The kernel in MiRKAT is capable of incorporating phylogenetic distance information, which
enables easy covariate adjustment and extension to alternative outcomes including survival
outcomes into MiRKAT modeling. This approach tests association through p-value by applying
a variance component score statistic. MiRKAT provides fast computation and also regresses
outcome on the whole microbiome pairwise similarity profiles. The framework of MiRKAT
approach is as the following. (210)

Suppose there are 𝑛 samples, and for the 𝑖 𝑡ℎ subject, 𝑦𝑖 is the corresponding outcome. The
′

abundances of all OTUs for individual 𝑖 is 𝒁𝑖 = (𝑍𝑖1 , 𝑍𝑖2 , … , 𝑍𝑖𝑝 ) , where 𝑝 is the total number
of OTUs. The covariate for individual 𝑖 is 𝑿𝑖 = (𝑋𝑖1 , 𝑋𝑖2 , … , 𝑋𝑖𝑚 )′. The goal is to test the
association between outcome and microbial similarity profiles by adjusting covariates 𝑿. For
continuous outcome variable, the linear kernel machine model is 𝑦𝑖 = 𝛽0 + 𝛽 ′ 𝑿𝑖 + 𝑓(𝒁𝑖 ) + 𝜀𝑖 ;
while for binary outcome variable, the logistic kernel machine model is logit( 𝑃(𝑦𝑖 = 1)) =
𝛽0 + 𝛽 ′ 𝑿𝑖 + 𝑓(𝒁𝑖 ), where 𝛽0 is the intercept and 𝜷 = [𝛽1 , 𝛽2 , … , 𝛽𝑚 ]′ is the coefficients of
covariates. 𝜀𝑖 is the error term with mean 0 and variance 𝜎 2 for continuous phenotypes. Under
the kernel machine regression assumption, 𝑓(𝒁𝑖 ) is from a reproducing kernel Hilbert space, 𝐻𝑘 ,
generated from a positive definite kernel function, 𝐾(. , . ), such that 𝑓(𝒁𝑖 ) = ∑𝑛𝑖′ =1 𝛼𝑖 ′ 𝐾(𝑍𝑖 , 𝑍𝑖 ′ ).
Specifically, the kernel matrix can be constructed to be the transformation metrics of
1

phylogenetic or taxonomic distance as 𝐊 = − 2 (𝐈 −

𝟏𝟏′
𝑛

)𝐃𝟐 (𝐈 −

𝟏𝟏′
𝑛

), where 𝑫 = [𝑑𝑖𝑗 ] is the

pairwise distance matrix such as Bray Curtis distance or weighted or unweighted UniFrac
dissimilarity, 𝐈 is the identity matrix, 𝟏 is the vector of ones. The estimation of coefficients 𝛽 and
1

𝑓(𝒁) is to maximize the penalized log-likelihood of 𝑝𝑙(𝑓, 𝛽) = ∑𝑛𝑖=1 log 𝐿(𝑓, 𝛽; 𝑦𝑖 , 𝑥𝑖 , 𝑧𝑖 ) − 2 𝜆 ∥
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1

𝑓 ∥𝐻𝑘 2 = ∑𝑛𝑖=1 log 𝐿(𝑓, 𝛽; 𝑦𝑖 , 𝑥𝑖 , 𝑧𝑖 ) − 2 𝜆𝛼 ′ 𝐾𝛼 . In order to test the association between outcome
and microbiome profiles, MiRKAT approach uses variance component score test. The score
1

′
̂)
̂),
statistic is 𝑄 = 2𝜙 (𝒚 − 𝒚
̂0 is the predicted mean of y under null
0 𝑲(𝒚 − 𝒚
0 where 𝑦

hypothesis that there is no association between microbiome profiles and outcome as 𝑓(𝒁) = 0. 𝜙
is the dispersion parameter, where 𝜙 = 𝜎
̂0 2 and 𝜎
̂0 2 is the estimated residual variance under null
hypothesis for linear kernel machine regression, and 𝜙 = 1 for logistic kernel machine
regression. (210)
An essential advantage of the score test is that it only requires fitting null model and allows for
fast, supervised, distance-based association testing under regression framework which permits
controls for potential confounding effect. Better kernels chosen improves statistical power. Even
if a poor kernel is chosen, the test is still statistically valid. Another advantage of MiRKAT
enables to simultaneously consider multiple distance and dissimilarity metrics. An alternative
approach for the MiRKAT is to implement a weighted combination of multiple kernels.
This approach can be implemented using the R package “MiRKAT.” (210)

4.5 Challenges in Analyzing Microbiome Data

This chapter covers relatively basic strategies for analyzing microbiome data, with the use of the
community-level summary measures (e.g., α and β diversities). However, analyzing microbiome
data can be challenging. First, there are challenges in data normalization and taxonomic
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abundance estimation (148). For a single sample with high-throughput sequencing reads, the big
data also present challenges for correct and full assembly and effective computing (69).
Moreover, there are challenges to analyzing microbiome data. In particular, the relative
abundances of species for one sample are usually quantified as a vector of the compositional
data, which is calculated by dividing the observed count in the taxa or OTUs by the total reads in
the sample, resulting in a vector of proportions residing in a nonnegative simplex. It is not
straightforward to model the joint distribution of such data. The Dirichlet class of distributions is
the most commonly used distribution to model such data (148, 211, 212). Alternatively, the
compositional data can be transformed before conducting the analysis, which may include using
square root transformation, additive log-ratio transformation or centered log-ratio transformation
(148, 213). Shi et al. (214) presented linear regression models for compositional microbiome
data analysis, using a set of linear constraints on the regression coefficients and estimating the
regression coefficients by using a penalized estimation procedure.

However, these methods might not be able to address the complexity of microbiome data,
especially the sparsity of the compositional data that involves a large number of zeros, because
most OTUs have extremely low abundance and a large proportion of OTUs occur only once
(possibly resulting from sequencing error) (148). Such a sparsity property increases the difficulty
in analyzing the composition of the microbiome. For example, the commonly used statistical
approaches, such as regression models and correlation measures, might not be directly applicable
to such data. Moreover, the compositional data of the microbiome are intrinsically high
dimensional, which further compounds the challenge for analyzing such data.
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This chapter does not cover the analysis of longitudinal microbiome data, which are commonly
observed in current studies of the human microbiome. Compared to cross-sectional analysis,
longitudinal data analysis allows the relative abundances for a single individual to vary over time
and utilizes dynamic modeling to understand the dependencies between species (214). Such
longitudinal data are important when assessing microbial changes throughout treatment (e.g.,
during chemotherapy) and the impact of such changes on long-term outcomes of interest (e.g.
overall survivorship). There are challenges and obstacles for such analyses (214): (i) the
correlation between the abundances of species does not imply that these species directly interact,
(ii) the constraint on the sum of relative abundance makes it difficult to perform parameter
inference in longitudinal models, and (iii) errors due to experimental uncertainty or biased
inferences of the interaction of species may occur for the longitudinal model. Fisher & Mehta
(214) proposed the approach of learning interactions from microbial time series (LIMITS) for
analyzing longitudinal microbiome data. The LIMITS approach uses a sparse linear regression
method with boostrap aggregation to infer the discrete time Lotka-Volterra model for microbial
dynamics, which allows this approach to overcome the three aforementioned obstacles (214).
Alternative methods for analyzing longitudinal microbiome data include using a Bayesian
network (215) and a two-part mixed effects model (216).

In the next section, we provide commands for processing the raw microbiome sequencing data
and extracting the OTUs, and demonstrate how to assess alpha diversities, beta diversities, and
evaluate the association between diversities and outcomes of interest using a regression model,
PERMANOVA and MiRKAT, based on the data from the foregut esophageal adenocarcinoma
study described previously.
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4.6. Processing Methods and Results

We provided commands in QIIME (163) for processing raw microbiome sequencing data and
generating an OTU table. We used the “phyloseq” package in the R program (171) to assess the
α and β diversities, the “vegan” package in R to conduct the PERMANOVA test, and
“MiRKAT” package in R to conduct the MiRKAT test (217).

4.6.1 Processes to Convert Raw Data into the OTU Table

4.6.1.1 Demultiplexing data

1. For data in fasta format

The command demultiplex_fasta.py can demultiplex sequences from one input fasta file by using
barcodes and/or data from the fasta labels provided in a metadata mapping file. Note that the
information for the barcode is necessary for the purpose of demultiplexing.
Input data files: (1) read.fasta file, (2) metadata mapping file
Output files: directory of output files, including seqs.fna, demultiplexed_sequences.log,
seqs.qual, and seqs_not_assigned.fna

demultiplex_fasta.py –f [read.fasta file] –m [metadata mapping file] –o [output directory
name]
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2. For data in fastq format

The function of split_libraries_fastq.py can demultiplex sequences from a data file in the fastq
format in which the barcodes and sequences are stored in two separate fastq files (163).

Input data files: (1) read.fastq file, (2) barcode fastq file
Output files: directory of output files, including seqs.fna, split_libraries_log.txt, histograms.txt

split_libraries_fastq.py –i [read.fastq file] –b [barcode fastq file] –o [output directory name]

4.6.1.2 Removing barcodes

1. The barcodes can be removed when demultiplexing is conducted. Specifically, for the files in
the fasta format, demultiplex_fasta.py removes the barcodes for the output sequences as a
default.
2. For data in the fastq format, the barcode extraction command can be used to remove barcodes.

Input files: read.fastq file
Output files: directory of output files

extract_barcodes.py –f [read.fastq file] –c [input type of barcode] –-bc1_len [barcode length]–o
[output directory name]
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4.6.1.3 Removing primers

1. The primers can be removed by using a Perl script if the primers are known. This can be used
for data in both fasta and fastq formats.

Input files: read file
Output files: new file with primer removed

use strict;
use warnings;
use Cwd;
my @fw_primers = ("AGAGTTTGATCCTGGCTCAG", "TACGGRAGGCAGCAG",
"GCCAGCAGCCGCGGTAA", "AGGATTAGATACCCT", "GAATTGACGGGGRCCC",
"GYAACGAGCGCAACCC");
my $dir = getcwd;
opendir(DIR, $dir) or die $!;
while (my $file = readdir(DIR)) {
next if ($file =~ m/^\_/);
next if ($file =~ m/^\./);
print $file;
open(IN, $file) or die $!;
my $outfile = "_dePrimer_".$file;
open(OUT,">$outfile");
while(my $line = <IN>){
foreach my $aprimer (@fw_primers){
$line =~s/$aprimer/\#/g;}
$line =~s/\#//g;
print OUT $line;
}
close(OUT);
close(IN);}
closedir(DIR);
exit 0;
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2. The barcode extraction command can be used twice to remove both the barcode and primer
(163).

Input files: read.fastq file, metadata file
Output files: directory of output files, including barcode file and read file(s)

extract_barcodes.py –f [read file] –m [metadata file] –o [output directory name]

4.6.1.4 Performing quality filtering

1. For data in fastq format

Quality filtering in QIIME is performed as part of split_libraries_fastq.py (see Note 1). The
following command can be executed to combine all the fastq files into one.

Input files: (1) directory of multiple fastq read files (2) parameter file
Output files: directory of output files, including seqs.fna file, which are used to select OTUs
multiple_split_libraries_fastq.py -i [input directory] -p [file path or name of parameter file] -o
[output directory]
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2. For data in fasta format

Quality filtering can be conducted by following the three steps described below.

Step 1: Clean the data to remove the incompatible lines and make the file compatible with
QIIME (Note 2).

Input files: fasta read file(s)
Output files: directory of output fasta files

clean_fasta.py –f [read file name] –o [output file directory]

Step 2: Use split_metadata.py and split_library.py to transform from the previous combined fasta
file format into another fasta format by parsing the sequences that meet user-defined quality
thresholds and then renaming each read with the appropriate sample ID (163, 218).

Step 3: Concatenate all the fasta files using cat in linux.

Input files: multiple fasta read files
Output files: fasta file (.fna format)

cat file1 file2 … file N > seq.fna
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4.6.1.5 Additional quality control procedures

As described above, additional quality control procedures may be conducted. For example, the
functions of split_libraries.py and denoise_wrapper.py can be used to de-noise the data (163).
Also, if chimeras are present in the sequencing read files, the function
parallel_identify_chimeric_seqs.py can be used to identify chimeric sequences and apply the
function of filter_fasta.py to filter the chimeras from the files (163).

4.6.1.6 Select OTUs

There are three approaches for picking OTU tables in QIIME. The first one is de novo OTU
picking, which clusters reads against one another based on the similarity between reads (e.g.,
default is 97%) without utilizing sequencing information from external references (163). A
drawback to the de novo approach is that there is no existing support for parallel computing in
QIIME, which may slow down the process (163).

Input files: fasta file (seqs.fna, which is a post-split_libraries fasta file)
Output files: directory of output files, including a phylogenetic tree file and a biom-formatted
OTU table
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pick_de_novo_otus.py –i [input read file] –o [output directory name]

The second approach for selecting the OTU is closed-reference OTU picking, where reads are
clustered against a reference. The reads that do not map to the reference are excluded from the
downstream analysis. The reference database used by default in QIIME is constructed by
clustering the full-length 16S rRNA sequences with 97% similarity in sequence fragments from
the Greengenes database (55, 219, 220). The drawback of this closed-reference approach is that,
by discarding reads that do not match the reference, the ability to detect novel diversity is lost
(163).

Input files: fasta file (seqs.fna, which is a post-split_libraries fasta file)
Output files: directory of output files, including a phylogenetic tree file and a biom-formatted
OTU table

pick_closed_reference_otus.py –i [input read file] –o [output directory name]

The third approach is the open-reference OTU picking approach. It combines the de novo and
closed-reference OTU picking approaches. The reads are first clustered against a reference, and
any reads that do not match the reference are clustered according to the de novo approach. All
reads in the sample are clustered by the open-reference approach (163). For illustration, we used
the open-reference OTU picking approach for the foregut esophageal adenocarcinoma dataset.

Input files: fasta file (seqs.fna, which is a post-split_libraries fasta file)
Output files: directory of output files, including a phylogenetic tree file and a biom-formatted
OTU table
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pick_open_reference_otus.py –i [input read file] –o [output directory name]

4.6.1.7 Summary of the OTU table

After selecting the OTU, we can summarize the generated OTU table in terms of the number of
samples, the number of observations and a summary of the total counts observed for each sample
(163). The OTU picking procedure may exclude some samples with low-quality scores in the
OTU table file.

Input files: the file generated in the previous OTU picking step, called
“otu_table_mc2_w_tax_no_pynast_failures.biom”
Output files: summary of OTU picking result
biom summarize-table -i otu_table_mc2_w_tax_no_pynast_failures.biom

4.6.2 Import OTUs into R for Downstream Analysis

There are multiple ways to import the OTUs generated by QIIME into R (221) for the
downstream analysis, as described below.

4.6.2.1 Read .biom file into R by using “compositional” library and QIIME

1. Convert .biom format to .txt file in QIIME (163).
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Input files: biom format file
Output files: file in the tab-delimited table format

biom convert -i otu_table_mc2_w_tax_no_pynast_failures.biom -o
table.from_biom_w_taxonomy_2.txt --to-tsv

2. Use R library to read the .txt file and convert to OTUs (222).

Input files: file in the tab-delimited table format from previous biom conversion step
Output files: OTU object of compositions in the framework of Aitchison Simplex by acomp( ) or
compositions as elements of simplex embedded in D-dimensional real space by rcomp( )

install.packages("compositions")
library(compositions)
sample<-read.table("table.from_biom_w_taxonomy_2.txt ")
counts_sample<-sample[,-1]
t_ct_sample<-t(counts_sample)
closure_t_sample<-clo(t_ct_sample)
comp_sample<-acomp(closure_t_sample)

or
real_sample<-rcomp(closure_t_sample)
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4.6.2.2 Read .biom file and phylogenetic tree information into R using the “phyloseq”
package (171)

1. Install “phyloseq” package
source("https://bioconductor.org/biocLite.R")
biocLite("phyloseq")

or
install.packages("devtools")
library("devtools")
install_github("phyloseq", "joey711")
library("phyloseq")

2. Import .biom file

Input files: (1) biom file (2) tree file
Output files: OTU object

biom_sample<-import_biom("otu_table_mc2_w_tax_no_pynast_failures.biom",
treefilename="rep_set.tre")
otu_sample<-otu_table(biom_sample)

3. Import phylogenetic tree file into R

Input files: tree file in
Output files: phylo class object

tree_sample<-read_tree("rep_set.tre")
117

4.6.3 Computations of the Diversities

For the calculations of the diversities, the input object “biom_sample”, which is necessary for all
scripts presented below, is obtained using the import_biom command in the “phyloseq” package
described previously.

4.6.3.1 Alpha Diversity
## summarize alpha diversity
> alpha_biom_sample<-estimate_richness(biom_sample,measures=c("Observed", "Chao1", "ACE",
"Shannon", "Simpson", "InvSimpson", "Fisher"))
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Table 15. Alpha diversity for foregut esophageal adenocarcinoma dataset

SRR1023240
SRR1023425
SRR1023460
…

Observed
richness

Chao1

ACE

Shannon

Simpson

InvSimpson

Fisher

818
904
1144

1167.20
989.52
1468.38

1300.73
1084.98
1615.59

5.05
3.73
3.59

0.98
0.94
0.89

50.09
16.51
8.87

250.41
190.43
244.86

119

Table 15 reports α diversities for microbiome samples from the foregut esophageal
adenocarcinoma study using various alpha diversity measures. In Table 15, we denote the
Shannon diversity index as Shannon, Simpson’s index as Simpson, inverse Simpson’s diversity
index as InvSimpson, Fisher’s 𝛼 diversity index as Fisher, Chao1 𝛼 diversity index as Chao1,
and the abundance-based coverage estimator as ACE. The observed richness measure, Chao1
measure, and the ACE measure are generally higher than the Shannon index, InvSimpson, and
Fisher’s alpha index. For example, the α diversity for sample SRR1023425 is 904 using the
observed richness, 989.52 using the Chao1 index, and 1084.98 in the ACE measure, respectively;
while the α diversities are respectively 3.73, 16.51, and 190.43 when using the Shannon,
InvSimpson, and Fisher diversity measures. The different 𝛼 diversity measures assess different
aspects of the community. For instance, a Shannon index implies higher uncertainty in correctly
predicting the identity of the next species chosen at random for the given sample (175) .
Simpson’s index emphasizes the evenness component in the sample (57). For example, for
sample SRR1023240, Simpson’s index is 0.98, which means that within the sample, the
probability that two randomly selected taxa belong to the same species is as high as 0.98. We
used the coefficient of variation to compare the different alpha diversity measures (see Note 3).

4.6.3.2 Plot Richness Graph
> ## plot alpha diversity
> plot_richness(biom_sample, measures=c("Observed", "Chao1", "ACE", "Shannon", "Simpson",
"InvSimpson", "Fisher"))
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Figure 5. Alpha diversity plots for the foregut esophageal adenocarcinoma dataset
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Figure 5 shows the richness of each sample using different alpha diversity measures, including
the observed richness, Chao1, ACE, Shannon, Simpson’s, inverse Simpson’s, and Fisher index.
The alpha diversity is relatively more evenly distributed when using the observed richness,
Chao1, and Shannon index compared to those obtained using inverse Simpson’s and Simpson’s
index.

4.6.3.2 Beta Diversity

4.6.3.2.1 Bray-Curtis Dissimilarity Index
> bray_dist <- distance(biom_sample, "bray")
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Table 16. Bray-Curtis dissimilarity index using the foregut esophageal adenocarcinoma
dataset

SRR1023582
SRR1023263
SRR1023425
SRR1023460
SRR1023343
…

SRR1023240
0.81
0.81
0.89
0.89
0.82

SRR1023582

SRR1023263

SRR1023425

SRR1023460

0.83
0.91
0.88
0.86

0.72
0.79
0.88

0.68
0.91

0.91
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Table 16 shows the Bray-Curtis dissimilarity index for the foregut esophageal adenocarcinoma
dataset. The larger the difference between two samples, the larger is the Bray-Curtis dissimilarity
index. From Table 16, we observe that the difference between samples is relatively high,
generally greater than 0.5. For example, the Bray-Curtis dissimilarity index between samples
SRR1023425 and SRR1023582 is 0.91. The Bray-Curtis dissimilarity index between samples
SRR1023425 and SRR1023263 is 0.72. Thus, sample SRR1023425 is more similar to sample
SRR1023263 compared with sample SRR1023582.

4.6.3.2.2 Cao Dissimilarity Index
> cao_dist <- distance(biom_sample, "cao")
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Table 17. Cao dissimilarity index using the foregut esophageal adenocarcinoma dataset

SRR1023582
SRR1023263
SRR1023425
SRR1023460
SRR1023343
…

SRR1023240
2.28
2.26
2.31
2.21
2.17

SRR1023582

SRR1023263

SRR1023425

SRR1023460

2.41
2.45
2.35
2.34

2.34
2.28
2.35

2.33
2.34

2.28
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Table 17 shows the Cao dissimilarity index for the foregut esophageal adenocarcinoma dataset.
A higher Cao dissimilarity index indicates more dissimilarity between samples. For example, the
index between samples SRR1023582 and SRR1023425 is 2.45, while the index between samples
SRR1023582 and SRR1023460 is 2.35, which implies that samples SRR1023460 and
SRR1023582 are more similar compared with samples SRR1023425 and SRR1023582.

4.6.3.2.3 UniFrac Measures

4.6.3.2.3.1 Unweighted UniFrac measure
> unweighted_unifrac<-distance(biom_sample,"uunifrac")

126

Table 18. Unweighted UniFrac measure for the foregut esophageal adenocarcinoma dataset

SRR1023582
SRR1023263
SRR1023425
SRR1023460
SRR1023343
…

SRR1023240
0.80
0.82
0.86
0.82
0.78

SRR1023582

SRR1023263

SRR1023425

SRR1023460

0.83
0.88
0.85
0.79

0.79
0.81
0.83

0.83
0.85

0.84
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Table 18 lists the results of the unweighted UniFrac measure for the foregut esophageal
adenocarcinoma dataset. A higher value of the UniFrac measure indicates more dissimilarity
between the samples. For example, the unweighted UniFrac dissimilarity between samples
SRR1023240 and SRR1023582 is 0.80. The dissimilarity between SRR1023460 and
SRR1023240 is 0.82, which implies that sample SRR1023240 is more similar to sample
SRR1023460 compared with sample SRR1023582.

4.6.3.2.3.2 Weighted UniFrac measure
> weighted_unifrac<-distance(biom_sample,"wunifrac")
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Table 19. Weighted UniFrac measure for the foregut esophageal adenocarcinoma dataset

SRR1023582
SRR1023263
SRR1023425
SRR1023460
SRR1023343
…

SRR1023240
0.37
0.41
0.54
0.50
0.41

SRR1023582

SRR1023263

SRR1023425

SRR1023460

0.44
0.58
0.51
0.35

0.43
0.47
0.38

0.41
0.42

0.42
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The dissimilarity values in Table 19 are lower overall than those in Table 18, which were
obtained using the unweighted UniFrac measure. Nonetheless, the patterns are similar. For
example, in Table 19, the weighted UniFrac dissimilarity between sample SRR1023240 and
sample SRR1023582 is 0.37, and the weighted UniFrac dissimilarity between sample
SRR1023263 and SRR1023240 is 0.41.

4.6.3.2.3.3 Normalized unweighted UniFrac measure
> unweighted_unif_norm<-UniFrac(biom_sample, weighted=FALSE, normalized=TRUE)
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Table 20. Normalized unweighted UniFrac measure for the foregut esophageal
adenocarcinoma dataset

SRR1023582
SRR1023263
SRR1023425
SRR1023460
SRR1023343
…

SRR1023240
0.80
0.82
0.86
0.82
0.78

SRR1023582

SRR1023263

SRR1023425

SRR1023460

0.83
0.88
0.85
0.79

0.79
0.81
0.83

0.83
0.85

0.84
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Table 20 shows the results for the normalized unweighted UniFrac dissimilarity, which is 0.82
between sample SRR1023460and sample SRR1023240, and 0.80 between sample SRR1023240
and sample SRR1023582.

4.6.3.2.3.4 Normalized weighted UniFrac measure
> weighted_unif_norm<-UniFrac(biom_sample, weighted=TRUE, normalized=TRUE)
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Table 21. Normalized weighted UniFrac measure for the foregut esophageal
adenocarcinoma dataset

SRR1023582
SRR1023263
SRR1023425
SRR1023460
SRR1023343
…

SRR1023240
0.34
0.36
0.42
0.40
0.34

SRR1023582

SRR1023263

SRR1023425

SRR1023460

0.38
0.44
0.41
0.29

0.31
0.36
0.30

0.27
0.29

0.30
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Table 21 provides the results of the normalized weighted UniFrac measure for the foregut
esophageal adenocarcinoma dataset. The distance between samples SRR1023263and
SRR1023240 is 0.36. The distance between samples SRR1023263 and SRR1023582 is 0.38,
which implies that sample SRR1023263 is more similar to sample SRR1023240 compared with
sample SRR1023582.

4.6.4 Association Tests

4.6.4.1 Regression Models for Alpha Diversity

>sample_data<-read.table("book_chapter_samples_2.txt")
>colnames(sample_data)<c("Run","disease_affected_status","Sex","BioSample","sample_name","SR
A_sample","dbGap_sample_id")
>sample_sex<-(sample_data$Sex == "male")**2
>disease_status<-(sample_data$disease_affected_status== "Yes")**2
>alpha_biom_sample<-estimate_richness(biom_sample,measures=c("Observed", "Chao1", "ACE",
"Shannon", "Simpson", "InvSimpson", "Fisher"))
>fit<-glm(disease_status~alpha_biom_sample$Chao1,family="binomial")
>summary(fit)

To study the association between outcomes and α diversity, we applied logistic regression for
each of the α diversity measures using the foregut esophageal adenocarcinoma dataset. We used
the esophageal adenocarcinoma status as the outcome variable. The input information is
available in the file book_chapter_samples_2.txt. The association results show that the P-value is
0.18 for the observed richness approach, 0.33 for the Chao1 index, 0.33 for the ACE approach,
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0.36 for the Shannon index, 0.98 for Simpson’s index, 0.97 for the inverse Simpson’s index, and
0.52 for the Fisher index approach. Therefore, at the nominal significance level of 0.05, there is
no association between esophageal adenocarcinoma status and α diversity.

4.6.4.2 Permutation-based Nonparametric MANOVA (PERMANOVA)

The PERMANOVA test can be applied by using R package “vegan” (223)as described here.
Similar to the association test for alpha diversity, we used the esophageal adenocarcinoma status
as the outcome variable. We used the Bray-Curtis measure as the dissimilarity metric for the
illustration below. Other beta diversity measures can also be used by modifying the argument in
the “distance” function.

>sample_data<-read.table("book_chapter_samples_2.txt")
>colnames(sample_data)<c("Run","disease_affected_status","Sex","BioSample","sample_name","SRA_sample","dbGap_sample_
id")
>sample_sex<-(sample_data$Sex == "male")**2
>disease_status<-(sample_data$disease_affected_status== "Yes")**2
>bray_dist <- distance(biom_sample, "bray")
>adonis(bray_dist~disease_status )

Given 20 oral samples from healthy subjects and 20 oral samples from the patients with
esophageal adenocarcinoma, the PERMANOVA test gives a P-value of 0.15 for the association
between esophageal adenocarcinoma status and the Bray-Curtis dissimilarity measure. The Pvalues for the other beta diversity measures were 0.07 for Cao beta diversity, and 0.17 and 0.04
for the unweighted and weighted UniFrac measures, respectively.
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4.6.4.3 Microbiome Regression-based Kernel Association Test (MiRKAT)

The R packages of “MiRKAT” (217), “phyloseq” (171), and “ape” (224)are needed to perform
the MiRKAT test. In addition to the information about OTUs
(otu_table_mc2_w_tax_no_pynast_failures.biom), to conduct this test, information is needed on
the phylogenetic tree (rep_set.tre file) and phenotypes (book_chapter_samples_2.txt file). Given
all these files, the MiRKAT test, using the UniFrac measure in the kernel matrix, can be
conducted by running the following script:

>##import biom file into phyloseq library
>biom_sample<-import_biom("otu_table_mc2_w_tax_no_pynast_failures.biom",
treefilename="rep_set.tre")
>otu_sample<-otu_table(biom_sample)
>### read tree file
>tree_sample<-read_tree("rep_set.tre")
>##Prepare the data
>sample_data<-read.table("book_chapter_samples_2.txt")
>colnames(sample_data)<c("Run","disease_affected_status","Sex","BioSample","sample_name","SR
A_sample","dbGap_sample_id")
>sample_sex<-(sample_data$Sex == "male")**2
>disease_status<-(sample_data$disease_affected_status== "Yes")**2
>#transpose otu sample
>trans_otu_sample<-t(otu_sample)
>#root the tree
>tr <- root(tree_sample,1,resolve.root=TRUE)
>#Create the UniFrac Distances
>otu.tab.rff <- Rarefy(trans_otu_sample)$otu.tab.rff
>unifracs <- GUniFrac(otu.tab.rff, tr, alpha=c(0, 0.5, 1))$unifracs
>D.weighted = unifracs[,,"d_1"]
>D.BC= as.matrix(vegdist(otu.tab.rff , method="bray"))
># Convert Distances to kernel matrices
>K.weighted = D2K(D.weighted)
>K.BC = D2K(D.BC)
># Testing using a single kernel
>MiRKAT(y = disease_status, Ks = K.weighted, X = sample_sex,out_type = "D",method =
"permutation", nperm=10000)
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Given 20 oral samples from healthy subjects and 20 samples from the patients with esophageal
adenocarcinoma, the MiRKAT test gives a P-value of 0.04. The MiRKAT test accounts for the
covariates, which may have confounding effects, and incorporates the phylogenetic tree
information; therefore, the MiRKAT approach can be robust compared to the PERMANOVA
approach.

4.7. Notes

1. Details on the quality filtering strategy in QIIME, including motivation for the default
parameter settings, are provided by Bokulich et al. (225). We note that the threshold parameter
may require modification for quality scores, if necessary, by the creation of a parameter file. For
example, the threshold parameter can be defined as given below in the parameter file.

split_libraries_fastq:phred_offset
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2. It needs to install the PrimerProspector, a pipeline of programs for designing and analyzing
PCR primers (226), to make the file compatible with QIIME.

3. To compare the different alpha diversity measures, we calculated the coefficient of variation,
which is the ratio of the standard deviation to the mean, for each of the measures using the
foregut esophageal adenocarcinoma dataset. The coefficient of variation shows the variability of
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each measure over all the samples. The results show that the variability is 0.43 for the observed
approach, 0.43 for the Chao1 index, 0.43 for the ACE approach, 0.2 for the Shannon index, 0.1
for Simpson’s index, 0.82 for inverse Simpson’s index, and 0.41 for the Fisher index approach.
Among all the approaches, the inverse Simpson’s index has the highest variability, while the
Shannon index and Simpson’s index have relatively lower variability. Based on the coefficient of
variation, the Shannon index and Simpson’s index have less variability than the other measures.
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Chapter 5
Conclusions and Future Directions

This chapter summarizes the thesis, discusses its findings and contributions, points out
limitations of the current work, and also outlines directions for future research. Depending on the
genomic data for the human and microbiome, the aim of this thesis is to explore the statistical
applications of frequentist methods to the sequencing data. However, many extensions of this
research deserve further consideration under the Bayesian statistical point of view. The chapter is
divided into two sections. Section 5.1 summarizes the thesis and provides conclusions. Section
5.2 discusses future work.
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5.1 Conclusions

In this dissertation, we investigated and developed novel statistical approaches for assessing
human and microbiome genetic data. First, we introduced the definition of sequencing data and
summarized the well-known sequencing techniques and approaches, e.g., Sanger sequencing,
next-generation sequencing, DNA sequencing, and RNA sequencing approaches. Detailed
discussions were provided as the background of our proposed methods. We also gave a brief
introduction to the definitions of 16S rRNA and provided background information for the human
microbiome, which may be associated with human disease.
In Chapter 2, we introduced the sequencing error rates in next-generation sequencing short read
data and reviewed the traditional error rate estimation approaches, including the shadow
regression estimation method. When estimating sequencing error rates, the shadow regression
estimation approach is widely used, but operates under the linearity assumption that the number
of shadow counts increases linearly with the number of error-free read counts, which may not be
appropriate for all types of sequencing data. To obtain a unified model, we developed the
empirical error rate estimation approach by using a nonlinear statistical model of cubic
smoothing splines or robust smoothing splines to estimate the shadow counts in next-generation
sequencing data. Our proposed empirical error rate estimation approach is applicable for multiple
datasets, including DNA sequencing data and mRNA sequencing data. Under all the simulation
scenarios tested, our proposed empirical error rate estimation approach is less biased than
shadow regression estimation. We also reproduced the results of the Wang et al. simulation study
(4). We note that the data generated using the simulation approach of Wang et al. may not reflect
the real sequencing data structure, especially the nonlinear relationship. Therefore, the
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frequency-based simulation approach was proposed in this thesis, aiming to mimic the real
sequencing data structure and increase computational efficiency. To make our method
expandable to specific sequencing reads, we made some effort to re-define the sequencing perbased error rate that enables the expansion of the error rate estimation to specific sequencing
reads instead of a fixed value for all the sequences in the sample. The adjusted per-base error rate
definition provides more information according to the sequencing read compared with the
original per-base error rate definition in the shadow regression approach.

In Chapter 3, we expanded the error rate estimation to more diverse definitions of shadow. The
shadow error rate investigated in Chapter 2 focused on error rates with substitution, which are
the error rates studied in the majority of the literature that discusses sequencing errors.
Specifically, the shadows studied in Chapter 2 are sequences with up to two base differences
from error-free sequences, which were recommended in a previous study (4). In Chapter 3, we
varied the definition of shadows to be sequences that are different from error-free sequencing
reads by only one base, only two bases, and up to two bases, respectively. We also extended the
estimation to deletion and insertion error rates, where the difference is only one base, only two
bases, and up to two bases from those of the error-free sequences. In addition, we confirmed
with the comments from a previous study (4) that using shadows that differ from the error-free
sequences by up to two bases are good enough without excessive additional computational cost.

In Chapter 4, we studied the association of the human microbiome with complex diseases and
reviewed multiple approaches for processing and analyzing human microbiome data. We
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provided detailed programming scripts about processing raw microbiome data into downstream
analysis OTU format, calculating various alpha and beta diversities to estimate within-sample
and between-sample distances, and analyzing the statistical association between the distance
metrics of the microbiome and outcomes of interest. We performed real data analysis using data
from the foregut microbiome in esophageal adenocarcinoma to illustrate the statistical
approaches.
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5.2 Future Directions
The human microbiome interacts with the environment dynamically and lives on surfaces with
which we interact daily (42). The composition of the microbiome in the human body varies over
time according to a person’s health, diet, lifestyle, social interactions, early antibiotic therapy,
genotype, and environmental chemicals (45, 48). A cross-sectional study, in which only a single
response is available, ignores the unstable and changeable characteristic of the human
microbiome and does not sufficiently reflect the overall performance of the composition of the
human microbiome over time. In contrast to cross-sectional data, longitudinal data comprise
repeated observation measures over time (227).
Heuristically, a longitudinal study enables each microbiome sample to act as its own control,
which allows for a reduction of the ever-present heterogeneity (227). Longitudinal analysis of
time-series data helps to capture the outcome changes and progression of the microbiome over
time (79). Traditional longitudinal analysis, such as a simple regression of a dependent variable
on a time measure, a general linear model with a fixed effect, or analyzing a single summary
subject-level number that indexes changes for each subject, has limitations in detecting important
signals and effects, and loses information on bacterial connections as the individual taxon is
treated as a separate outcome, even in well-designed and conducted studies (79, 80). The
analytical model for longitudinal data should take into account the correlation on repeated
observations in order to obtain valid statistical inference on coefficient estimates. Ignoring
bacterial correlations may lead to inefficient parameter estimates and inconsistent estimates of
precision. (227)
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A Bayesian network is a graphical model of joint multivariate probability that describes the
statistical dependence and conditional independence between variables according to the data
(228). It has the ability to capture complicated stochastic processes and has been shown to be a
clear methodology for learning from noisy observations (228). In addition, a Bayesian network
has the capability of describing interaction relationships between random variables. The
established networks, working as a framework of relationships, can describe the dependence
structure between multiple interacting quantities (228). Another widely-known advantage of a
Bayesian network is the capacity to indicate causal influence. A Bayesian network has strictly
mathematically defined probabilities and conditional independence statements, which implies the
direct causal influence based on the network (228). Even though several assumptions may not be
necessary in gene expression or taxa count data, the connections for some causality may be
indicative based using the network to learn from the observational data (228).
The Bayesian network consists of two components that describe the joint probability distribution
of random variables. The first component is a directed or undirected acyclic graph for which the
vertices represent random variables. The second component includes the probabilities that
describe the conditional distribution of each variable given its parents in the graph. Under the
Markov assumption, each variable is independent of its descendants given the corresponding
parents in the graph (228). There are two commonly used approaches to describe the conditional
distributions, depending on the data types of the variables. If the variables are discrete, the
general representation involves constructing a table with the probability of each joint assignment
to the corresponding parents specified. Specifying the conditional distribution of discrete
variables is flexible and can describe any discrete conditional distribution in all possible
densities, at the cost of an exponential increase in the number of free parameters. (228) If the
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variables are continuous, the conditional independence relationship usually will be described
with a linear Gaussian conditional density, where the variable is normally distributed with a
mean linearly associated with the values of its parents, and the variance is independent of its
parents. A joint multivariate Gaussian distribution will be attained under the assumption that all
variables have linear Gaussian distribution in the network (228). In addition, the general
approach to learn a Bayesian network is to use a scoring function that estimates the possible
networks based on the training data and then to select the one with the optimal score (228).
Multivariate Gaussian graphical models (GGMs) are widely used and considered as the standard
approach to model the conditional independence relationship in multivariate Gaussian data (229).
Multivariate GGMs have been successfully implemented in various areas, including health
sciences, genomics, and economics. However, traditional multivariate GGMs may have
limitations due to the lack of efficiency and accuracy, and loss of statistical power in handling
high-dimensional data (229). Ni et al. developed the novel matrix-variate directed acyclic graph
approach and extended it to model both directed and undirected graphs and paired it with an
efficient Markov chain Monte Carlo (MCMC) algorithm (229). This matrix-variate graph can be
a mixture of directed and undirected graphs (hybrid mGGM), i.e., when the prior ordering
information is known, it may be represented as a directed graph; whereas when the prior ordering
information is missing, it may be represented as a undirected graph. The hybrid mGGM
approach enables accounting for the uncertainty of the graphical structure and providing
regularized and sparse estimators under a Bayesian framework. The uncertainty consideration is
essential when handling high-dimensional complicated datasets, as there may be several graphs
that equally explain the observed data and which are well under the limited number of samples.
(229) Based on previous simulation studies, the hybrid mGGM approach performs better than the
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traditional alternative naïve directed acyclic graph approach, as well as the state-of-the-art
Bayesian approach (230) and the matrix-variate Gaussian non-Bayesian graphical model
approach in terms of the true positive rate, false discovery rate, and Mathews correlation
coefficient (229, 231).
In future studies, we will expand the cross-sectional analysis of the microbiome to an analysis of
longitudinal microbiome data to study the specific relationships and general trend in microbiome
taxa with time series information. The hybrid mGGM approach can be used to study the
longitudinal microbiome data. If the prior ordering information is not clear, an undirected graph
can be used to specify the microbiome taxa, while a directed graph can be used to specify the
time. This approach will overcome the limitations in previous longitudinal studies of the
microbiome, which ignored the interaction association between taxa, and will be able to predict
future changes in the composition of the microbiome over time. A Bayesian network has been
successfully utilized to study time-series data in other areas, including clinical research and
ecological prediction. So far, there is little in the literature that proposes using a Bayesian
network to analyze longitudinal microbiomic data. The byproducts of using a Bayesian network
are the estimated relationships of how one taxon influences another taxon over time (232).
Before fitting the hybrid mGGM approach to a longitudinal dataset of the microbiome, there is a
need to preprocess the high-dimensional raw microbiome data into an appropriate format. There
are mainly two challenges involving the microbiome data before constructing a Bayesian
network. The first challenge involves high percentage of zero counts in the OTU table. One
essential problem in microbiomic data analysis is that there are many zeros in taxa counts, which
will not allow for the direct use of standard statistical models. One approach to solve this issue is
to combine the OTUs into the genera level that is a higher taxonomic level in the microbiome,
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and then remove the genera with zero taxa counts in more than 90% of the sample. After the
zero-checking stage, the remaining zero counts may be replaced by a pseudo value to better
facilitate the estimation (usually 0.05 or 0.5). This replacement will not affect the estimation,
which was confirmed by a previous study, especially when the replaced number is very small
and the number of read counts is large enough (>>0.05 or o.5). These read counts will be
converted into compositions, and a log-ratio transformation will then be applied to these
compositional data (213, 214, 233, 234). Then the hybrid mGGM approach can be applied to the
log-transformed compositional data to study the specific relationship structure and general trends
in the microbiome genera over time.

A simulation analysis may be applied to further study the performance of the hybrid mGGM
approach on longitudinal microbiome data. One possible approach was introduced by using Chen
and Li’s approach (235). This simulation approach uses a Dirichlet multinomial distribution to
model the OTU counts, which takes the overdispersion of the OTU table into account. The
maximum likelihood method is used to estimate the mean proportions and overdispersion
parameters in the Dirichlet distribution of the OTU table. The taxa counts will then be generated
using a multinomial distribution. The outcome of interest will be generated using a normal
distribution if it is continuous; otherwise, if the outcome is binary, it will be generated using a
Bernoulli distribution with the mean following a pre-specified distribution. (235)
One of the major goals when using the hybrid mGGM approach to construct the Bayesian
network is to integrate the taxa count data in the microbiome and capture the common structure
of the genera-level taxa over time to find how the microbiome genera interacted with each other,
which may be associated with the outcome. Another goal is to utilize the Bayesian network in a
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clinical study, which may help to make predictions for future therapeutic strategies or disease
prevention. For example, if the outcome of interest is a fatal or disease event with some
microbiome genera available in high proportions, it would be feasible to inhibit both these
genera and the associated genera in order to cure or prevent the disease. Previous simulation
studies showed that the hybrid mGGM approach demonstrated superior performance compared
to that of the conventional Bayesian network approaches in terms of increased computational
efficiency, estimation accuracy, and statistical power (229). A Bayesian network also accounts
for microbiome taxa interaction and is capable of predicting future changes in the microbiome’s
composition over time.

148

References
[1] Goldstein, D. B. (2009) Common genetic variation and human traits, N Engl J Med 360,
1696-1698.
[2] Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J.,
McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., Cho, J. H., Guttmacher,
A. E., Kong, A., Kruglyak, L., Mardis, E., Rotimi, C. N., Slatkin, M., Valle, D.,
Whittemore, A. S., Boehnke, M., Clark, A. G., Eichler, E. E., Gibson, G., Haines, J. L.,
Mackay, T. F. C., McCarroll, S. A., and Visscher, P. M. (2009) Finding the missing
heritability of complex diseases, Nature 461, 747-753.
[3] Conesa, A., Madrigal, P., Tarazona, S., Gomez-Cabrero, D., Cervera, A., McPherson, A.,
Szczesniak, M. W., Gaffney, D. J., Elo, L. L., Zhang, X. G., and Mortazavi, A. (2016) A
survey of best practices for RNA-seq data analysis (vol 17, 13, 2016), Genome Biol 17.
[4] Wang, X. V., Blades, N., Ding, J., Sultana, R., and Parmigiani, G. (2012) Estimation of
sequencing error rates in short reads, Bmc Bioinformatics 13.
[5] Shendure, J., and Ji, H. (2008) Next-generation DNA sequencing, Nat Biotechnol 26, 11351145.
[6] Ross, J. S., and Cronin, M. (2011) Whole Cancer Genome Sequencing by Next-Generation
Methods, Am J Clin Pathol 136, 527-539.
[7] Kobayashi, S., Boggon, T. J., Dayaram, T., Janne, P. A., Kocher, O., Meyerson, M., Johnson,
B. E., Eck, M. J., Tenen, D. G., and Halmos, B. (2005) EGFR mutation and resistance of
non-small-cell lung cancer to gefitinib, N Engl J Med 352, 786-792.
[8] Shearer, A. E., DeLuca, A. P., Hildebrand, M. S., Taylor, K. R., Gurrola, J., Scherer, S.,
Scheetz, T. E., and Smith, R. J. H. (2010) Comprehensive genetic testing for hereditary
149

hearing loss using massively parallel sequencing, P Natl Acad Sci USA 107, 2110421109.
[9] Sanger, F., Nicklen, S., and Coulson, A. R. (1977) DNA sequencing with chain-terminating
inhibitors, Proc Natl Acad Sci U S A 74, 5463-5467.
[10] Olena Morozova, M. H., Marco A. Marra. (2009) Applications of New Sequencing
Technologies for Transcriptome Analysis, Annu. Rev. Genomics Hum. Genet.
[11] Altimari, A., de Biase, D., De Maglio, G., Gruppioni, E., Capizzi, E., Degiovanni, A.,
D'Errico, A., Pession, A., Pizzolitto, S., Fiorentino, M., and Tallini, G. (2013) 454 next
generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and
pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffinembedded samples, Onco Targets Ther 6, 1057-1064.
[12] Ladouceur, M., Dastani, Z., Aulchenko, Y. S., Greenwood, C. M., and Richards, J. B.
(2012) The empirical power of rare variant association methods: results from sanger
sequencing in 1,998 individuals, PLoS Genet 8, e1002496.
[13] Rizzo, J. M., and Buck, M. J. (2012) Key principles and clinical applications of "nextgeneration" DNA sequencing, Cancer Prev Res (Phila) 5, 887-900.
[14] Craig DW, P. J., Szelinger S, Sekar A, Redman M, Corneveaux JJ, Pawlowski TL, Laub T,
Nunn G, Stephan DA, Homer N, Huentelman MJ. (2008) Identification of genetic
variants using bar-coded multiplexed sequencing, Nat Methods.
[15] Park, P. J. (2009) ChIP-Seq: advantages and challenges of a maturing technology, Nat Rev
Genet.
[16] Alkan C, K. J., Marques-Bonet T, Aksay G, Antonacci F, Hormozdiari F, Kitzman JO,
Baker C, Malig M, Mutlu O, Sahinalp SC, Gibbs RA, Eichler EE. (2009) Personalized

150

copy number and segmental duplication maps using next-generation sequencing, Nat
Genet.
[17] Joshua S Bloom, Z. K., Leonid Kruglyak, Mona Singh, Amy A Caudy. (2009) Measuring
differential gene expression by short read sequencing: quantitative comparison to 2channel gene expression microarrays, BMC Genomics.
[18] Mardis, E. R. (2008) Next-generation DNA sequencing methods, Annu Rev Genomics Hum
Genet 9, 387-402.
[19] Sultan M, S. M., Richard H, Magen A, Klingenhoff A, Scherf M, Seifert M, Borodina T,
Soldatov A, Parkhomchuk D, Schmidt D, O'Keeffe S, Haas S, Vingron M, Lehrach H,
Yaspo ML. (2008 ) A global view of gene activity and alternative splicing by deep
sequencing of the human transcriptome, Science.
[20] Paul L. Auer, R. W. D. (2010 ) Statistical Design and Analysis of RNA Sequencing Data,
GENETICS.
[21] Noonan, J. P., Hofreiter, M., Smith, D., Priest, J. R., Rohland, N., Rabeder, G., Krause, J.,
Detter, J. C., Paabo, S., and Rubin, E. M. (2005) Genomic sequencing of Pleistocene cave
bears, Science 309, 597-599.
[22] Poinar, H. N., Schwarz, C., Qi, J., Shapiro, B., Macphee, R. D., Buigues, B., Tikhonov, A.,
Huson, D. H., Tomsho, L. P., Auch, A., Rampp, M., Miller, W., and Schuster, S. C.
(2006) Metagenomics to paleogenomics: large-scale sequencing of mammoth DNA,
Science 311, 392-394.
[23] Green, R. E., Krause, J., Ptak, S. E., Briggs, A. W., Ronan, M. T., Simons, J. F., Du, L.,
Egholm, M., Rothberg, J. M., Paunovic, M., and Paabo, S. (2006) Analysis of one million
base pairs of Neanderthal DNA, Nature 444, 330-336.

151

[24] Noonan, J. P., Coop, G., Kudaravalli, S., Smith, D., Krause, J., Alessi, J., Chen, F., Platt, D.,
Paabo, S., Pritchard, J. K., and Rubin, E. M. (2006) Sequencing and analysis of
Neanderthal genomic DNA, Science 314, 1113-1118.
[25] Mark A DePristo, E. B., Ryan Poplin,Kiran V Garimella,Jared R Maguire, Christopher
Hartl,Anthony A Philippakis,Guillermo del Angel,Manuel A Rivas,Matt Hanna,Aaron
McKenna,Tim J Fennell,Andrew M Kernytsky,Andrey Y Sivachenko, Kristian
Cibulskis,Stacey B Gabriel,David Altshuler, Mark J Daly. (2011) A framework for
variation discovery and genotyping using next-generation DNA sequencing data, Nature
Genetics.
[26] Mortazavi, A., Williams, Brian A., McCue, Kenneth, Schaeffer, Lorian, Wold, Barbara.
(2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq, Nature
Methods.
[27] Wang, Z., Gerstein, M., and Snyder, M. (2009) RNA-Seq: a revolutionary tool for
transcriptomics, Nat Rev Genet 10, 57-63.
[28] Goldman, D., and Domschke, K. (2014) Making sense of deep sequencing, Int J
Neuropsychopharmacol 17, 1717-1725.
[29] Marioni, J. C., Mason, C. E., Mane, S. M., Stephens, M., and Gilad, Y. (2008) RNA-seq: An
assessment of technical reproducibility and comparison with gene expression arrays,
Genome Res 18, 1509-1517.
[30] Cloonan, N., Forrest, A. R. R., Kolle, G., Gardiner, B. B. A., Faulkner, G. J., Brown, M. K.,
Taylor, D. F., Steptoe, A. L., Wani, S., Bethel, G., Robertson, A. J., Perkins, A. C.,
Bruce, S. J., Lee, C. C., Ranade, S. S., Peckham, H. E., Manning, J. M., McKernan, K. J.,

152

and Grimmond, S. M. (2008) Stem cell transcriptome profiling via massive-scale mRNA
sequencing, Nature Methods 5, 613-619.
[31] Morin, R. D., Bainbridge, M., Fejes, A., Hirst, M., Krzywinski, M., Pugh, T. J., McDonald,
H., Varhol, R., Jones, S. J. M., and Marra, M. A. (2008) Profiling the HeLa S3
transcriptome using randomly primed cDNA and massively parallel short-read
sequencing, Biotechniques 45, 81-+.
[32] Ugrappa Nagalakshmi, Z. W., Karl Waern, Chong Shou, Debasish Raha, Mark Gerstein,
Michael Snyder. (2008) The Transcriptional Landscape of the Yeast Genome Defined by
RNA Sequencing, Science.
[33] Andrea L. Eveland, D. R. M., Karen E. Koch. (2008) Transcript Profiling by 3#Untranslated Region Sequencing Resolves Expression of Gene Families, Plant
Physiology.
[34] Nagalakshmi, U., Wang, Z., Waern, K., Shou, C., Raha, D., Gerstein, M., and Snyder, M.
(2008) The transcriptional landscape of the yeast genome defined by RNA sequencing,
Science 320, 1344-1349.
[35] Wilhelm, B. T., Marguerat, S., Watt, S., Schubert, F., Wood, V., Goodhead, I., Penkett, C.
J., Rogers, J., and Bahler, J. (2008) Dynamic repertoire of a eukaryotic transcriptome
surveyed at single-nucleotide resolution, Nature 453, 1239-U1239.
[36] Mortazavi, A., Williams, B. A., Mccue, K., Schaeffer, L., and Wold, B. (2008) Mapping and
quantifying mammalian transcriptomes by RNA-Seq, Nature Methods 5, 621-628.
[37] Lister, R., O'Malley, R. C., Tonti-Filippini, J., Gregory, B. D., Berry, C. C., Millar, A. H.,
and Ecker, J. R. (2008) Highly integrated single-base resolution maps of the epigenome
in Arabidopsis, Cell 133, 523-536.

153

[38] Nicole Cloonan, Q. X. G. J. F. D. F. T. D. T. P. T. G. K. S. M. G. (2009) RNA-MATE: a
recursive mapping strategy for high-throughput RNA-sequencing data Bioinformatics.
[39] Eloe-Fadrosh, E. A., and Rasko, D. A. (2013) The human microbiome: from symbiosis to
pathogenesis, Annu Rev Med 64, 145-163.
[40] Bromberg, J. S., Fricke, W. F., Brinkman, C. C., Simon, T., and Mongodin, E. F. (2015)
Microbiota-implications for immunity and transplantation, Nat Rev Nephrol 11, 342-353.
[41] Johnson, C. L., and Versalovic, J. (2012) The human microbiome and its potential
importance to pediatrics, Pediatrics 129, 950-960.
[42] Luke K Ursell, J. L. M., Laura Wegener Parfrey, and Rob Knight. (2012) Defining the
Human Microbiome, Nutr Rev.
[43] Hooper, L. V., and Gordon, J. I. (2001) Commensal host-bacterial relationships in the gut,
Science 292, 1115-1118.
[44] Maslowski, K. M., and Mackay, C. R. (2011) Diet, gut microbiota and immune responses,
Nat Immunol 12, 5-9.
[45] Li, H. (2015) Microbiome, Metagenomics, and High-Dimensional Compositional Data
Analysis, Annual Review of Statistics and Its Application.
[46] Backhed F, L. R., Sonnenburg JL, Peterson DA, Gordon JI. (2005) Host-bacterial
mutualism in the human intestine., Science.
[47] http://hmpdacc.org/micro_analysis/microbiome_analyses.phpProject, N. H. M. About HMP
Metagenomic Sequencing & Analysis.
[48] Sandrine P Claus, H. G., Sandrine Ellero-Simatos. (2016) The gut microbiota: a major
player in the toxicity of environmental pollutants?, npj Biofilms and Microbiomes.

154

[49] http://www.illumina.com/areas-of-interest/microbiology/human-microbiomeanalysis.htmlIntroduction to Human Microbiome Analysis.
[50] Clarridge, J. E. (2004) Impact of 16S rRNA gene sequence analysis for identification of
bacteria on clinical microbiology and infectious diseases, Clin Microbiol Rev 17, 840862.
[51] Hartstra, A. V., Bouter, K. E. C., Backhed, F., and Nieuwdorp, M. (2015) Insights Into the
Role of the Microbiome in Obesity and Type 2 Diabetes, Diabetes Care 38, 159-165.
[52] Janda, J. M., and Abbott, S. L. (2007) 16S rRNA gene sequencing for bacterial
identification in the diagnostic laboratory: pluses, perils, and pitfalls, J Clin Microbiol 45,
2761-2764.
[53] Cole, J. R., Wang, Q., Fish, J. A., Chai, B., McGarrell, D. M., Sun, Y., Brown, C. T.,
Porras-Alfaro, A., Kuske, C. R., and Tiedje, J. M. (2014) Ribosomal Database Project:
data and tools for high throughput rRNA analysis, Nucleic Acids Res 42, D633-642.
[54] Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., and
Glockner, F. O. (2013) The SILVA ribosomal RNA gene database project: improved data
processing and web-based tools, Nucleic Acids Res 41, D590-596.
[55] DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T.,
Dalevi, D., Hu, P., and Andersen, G. L. (2006) Greengenes, a chimera-checked 16S
rRNA gene database and workbench compatible with ARB, Appl Environ Microb 72,
5069-5072.
[56] Li, K., Bihan, M., Yooseph, S., and Methe, B. A. (2012) Analyses of the Microbial
Diversity across the Human Microbiome, Plos One 7.

155

[57] Nagendra, H. (2002) Opposite trends in response for the Shannon and Simpson indices of
landscape diversity, Appl Geogr 22, 175-186.
[58] Basualdo, C. V. (2011) Choosing the best non-parametric richness estimator for benthic
macroinvertebrates databases, Rev. Soc. Entomol. Argent 70(1-2), 27-38.
[59] Anderson, M. J., Ellingsen, K. E., and McArdle, B. H. (2006) Multivariate dispersion as a
measure of beta diversity, Ecol Lett 9, 683-693.
[60] Cao, Y., Williams, W. P., and Bark, A. W. (1997) Similarity measure bias in river benthic
Aufwuchs community analysis, Water Environ Res 69, 95-106.
[61] Lozupone, C., and Knight, R. (2005) UniFrac: a new phylogenetic method for comparing
microbial communities, Appl Environ Microb 71, 8228-8235.
[62] Shah, N., Tang, H., Doak, T. G., and Ye, Y. (2011) Comparing bacterial communities
inferred from 16S rRNA gene sequencing and shotgun metagenomics, Pac Symp
Biocomput, 165-176.
[63] Ranjan, R., Rani, A., Metwally, A., McGee, H. S., and Perkins, D. L. (2016) Analysis of the
microbiome: Advantages of whole genome shotgun versus 16S amplicon sequencing,
Biochem Biophys Res Commun 469, 967-977.
[64] Sharpton, T. J. (2014) An introduction to the analysis of shotgun metagenomic data, Front
Plant Sci 5, 209.
[65] Jovel, J., Patterson, J., Wang, W., Hotte, N., O'Keefe, S., Mitchel, T., Perry, T., Kao, D.,
Mason, A. L., Madsen, K. L., and Wong, G. K. S. (2016) Characterization of the Gut
Microbiome Using 16S or Shotgun Metagenomics, Front Microbiol 7.

156

[66] Franzosa, E. A., Hsu, T., Sirota-Madi, A., Shafquat, A., Abu-Ali, G., Morgan, X. C., and
Huttenhower, C. (2015) Sequencing and beyond: integrating molecular 'omics' for
microbial community profiling, Nat Rev Microbiol 13, 360-372.
[67] Norman, J. M., Handley, S. A., and Virgin, H. W. (2014) Kingdom-agnostic metagenomics
and the importance of complete characterization of enteric microbial communities,
Gastroenterology 146, 1459-1469.
[68] Poretsky, R., Rodriguez, R. L., Luo, C., Tsementzi, D., and Konstantinidis, K. T. (2014)
Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal
microbial community dynamics, Plos One 9, e93827.
[69] Zhu, X., Wang, J., Peng, B., and Shete, S. (2016) Empirical estimation of sequencing error
rates using smoothing splines, Bmc Bioinformatics 17.
[70] van Dijk, E. L., Auger, H., Jaszczyszyn, Y., and Thermes, C. (2014) Ten years of nextgeneration sequencing technology, Trends Genet 30, 418-426.
[71] Schlotterer, C., Tobler, R., Kofler, R., and Nolte, V. (2014) Sequencing pools of
individuals-mining genome-wide polymorphism data without big funding, Nature
Reviews Genetics 15, 749-763.
[72] Mardis, E. R. (2013) Next-Generation Sequencing Platforms, Annu Rev Anal Chem 6, 287303.
[73] Yang, Y., Xie, B., and Yan, J. (2014) Application of next-generation sequencing technology
in forensic science, Genomics Proteomics Bioinformatics 12, 190-197.
[74] Metzker, M. L. (2010) Sequencing technologies - the next generation, Nat Rev Genet 11,
31-46.

157

[75] Jeck, W. R., Reinhardt, J. A., Baltrus, D. A., Hickenbotham, M. T., Magrini, V., Mardis, E.
R., Dangl, J. L., and Jones, C. D. (2007) Extending assembly of short DNA sequences to
handle error, Bioinformatics 23, 2942-2944.
[76] Hoffmann, S., Otto, C., Kurtz, S., Sharma, C. M., Khaitovich, P., Vogel, J., Stadler, P. F.,
and Hackermuller, J. (2009) Fast Mapping of Short Sequences with Mismatches,
Insertions and Deletions Using Index Structures, Plos Comput Biol 5.
[77] Simpson, J. T. (2014) Exploring genome characteristics and sequence quality without a
reference, Bioinformatics 30, 1228-1235.
[78] Trivedil, U. H., Cezard, T., Bridgett, S., Montazam, A., Nichols, J., Blaxter, M., and Gharbi,
K. (2014) Quality control of next-generation sequencing data without a reference, Front
Genet 5.
[79] Michael J. McGeachie, J. E. S., Travis Gibson, George M. Weinstock, Yang-Yu Liu, Diane
R. Gold, Scott T. Weiss, Augusto Litonjua. (2016) Longitudinal Prediction of the Infant
Gut Microbiome with Dynamic Bayesian Networks, Nature Scientific Reports.
[80] Joseph J. Locascio, Alireza A. (2011) An Overview of Longitudinal Data Analysis Methods
for Neurological Research, Dement Geriatr Cogn Disord Extra
[81] Schlotterer, C., Tobler, R., Kofler, R., and Nolte, V. (2014) Sequencing pools of individuals
- mining genome-wide polymorphism data without big funding, Nature reviews. Genetics
15, 749-763.
[82] Mardis, E. R. (2013) Next-generation sequencing platforms, Annual review of analytical
chemistry 6, 287-303.
[83] Wang, X. V., Blades, N., Ding, J., Sultana, R., and Parmigiani, G. (2012) Estimation of
sequencing error rates in short reads, BMC Bioinformatics 13, 185.

158

[84] Magurran, A. E. (2004) Measuring Biological Diversity, Blackwell Publishing, Oxford, UK.
[85] Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E.,
Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., Egholm, M., Henrissat, B., Heath,
A. C., Knight, R., and Gordon, J. I. (2009) A core gut microbiome in obese and lean
twins, Nature 457, 480-484.
[86] Jeck, W. R., Reinhardt, J. A., Baltrus, D. A., Hickenbotham, M. T., Magrini, V., Mardis, E.
R., Dangl, J. L., and Jones, C. D. (2007) Extending assembly of short DNA sequences to
handle error, Bioinformatics.
[87] Sundquist, A. e. a. (2007) Whole-genome sequencing and assembly with high-throuput,
short-read technologies, PLoS One.
[88] Hert, D. G., Fredlake, C. P., and Barron, A. E. (2008) Advantages and limitations of nextgeneration sequencing technologies: a comparison of electrophoresis and nonelectrophoresis methods, Electrophoresis 29, 4618-4626.
[89] Brown, T., Howe, A., Zhang, Q., Pyrkosz, A. B., and Brom, T. H. (2012) A Reference-Free
Algorithm for Computational Normalization of Shotgun Sequencing Data, Cornell
University Library.
[90] Hoffmann, S., Otto, C., Kurtz, S., Sharma, C. M., Khaitovich, P., Vogel, J., Stadler, P. F.,
and Hackermuller, J. (2009) Fast Mapping of Short Sequences with Mismatches,
Insertions and Deletions Using Index Structures, PLoS One.
[91] Trivedi, U. H., Cezard, T., Bridgett, S., Montazam, A., Nichols, J., Blaxter, M., and Gharbi,
K. (2014) Quality control of next-generation sequencing data without a reference,
Frontiers in genetics 5, 111.

159

[92] http://www.bioinformatics.babraham.ac.uk/projects/fastqc/Andrews, S. FastQC a quality
control tool for high throughput sequence data.
[93] Bullard, J. H., Purdom, E., Hansen, K. D., and Dudoit, S. (2010) Evaluation of statistical
methods for normalization and differential expression in mRNA-Seq experiments, BMC
Bioinformatics 11, 94.
[94] Butler, J., MacCallum, I., Kleber, M., Shlyakhter, I. A., Belmonte, M. K., Lander, E. S.,
Nusbaum, C., and Jaffe, D. B. (2008) ALLPATHS: de novo assembly of whole-genome
shotgun microreads, Genome Res 18, 810-820.
[95] Schroder, J., Schroder, H., Puglisi, S. J., Sinha, R., and Schmidt, B. (2009) SHREC: a shortread error correction method, Bioinformatics 25, 2157-2163.
[96] Kelley, D. R., Schatz, M. C., and Salzberg, S. L. (2010) Quake: quality-aware detection and
correction of sequencing errors, Genome Biol 11, R116.
[97] Salmela, L. (2010) Correction of sequencing errors in a mixed set of reads, Bioinformatics
26, 1284-1290.
[98] Schroder, J., Bailey, J., Conway, T., and Zobel, J. (2010) Reference-free validation of short
read data, PLoS One 5, e12681.
[99] Li, R., Zhu, H., Ruan, J., Qian, W., Fang, X., Shi, Z., Li, Y., Li, S., Shan, G., Kristiansen,
K., Li, S., Yang, H., Wang, J., and Wang, J. (2010) De novo assembly of human genomes
with massively parallel short read sequencing, Genome Res 20, 265-272.
[100] Keele, L. J. (2008) Semiparametric Regression for the Social Sciences, John Wiley & Sons
Ltd. , Chichester, England.
[101] Schroder, J., Bailey, J., Conway, T., and Zobel, J. (2010) Reference Free Validation of
Short Read Data, PLoS One.

160

[102] Gunewardena, S. S. (2013) Optimum-time, Optimum-space, Algorithms for k-mer
Analysis of Whole Genome Sequences, Bioinformatics and Comparative Genomes.
[103] Melsted, P., and Pritchard, J. K. (2011) Efficient counting of k-mers in DNA sequences
using a bloom filter, BMC Bioinformatics.
[104] Heo, Y., Wu, X. L., Chen, D., Ma, J., and Hwu, W. M. (2014) BLESS: bloom filter-based
error correction solution for high-throughput sequencing reads, Bioinformatics 30, 13541362.
[105] Shi, L., and Reid, L. H., and Jones, W. D., and Shippy, R., and Warrington, J. A., and
Baker, S. C., and Collins, P. J., and de Longueville, F., and Kawasaki, E. S., and Lee, K.
Y., and Luo, Y., and Sun, Y. A., and Willey, J. C., and Setterquist, R. A., and Fischer, G.
M., and Tong, W., and Dragan, Y. P., and Dix, D. J., and Frueh, F. W., and Goodsaid, F.
M., and Herman, D., and Jensen, R. V., and Johnson, C. D., and Lobenhofer, E. K., and
Puri, R. K., and Schrf, U., and Thierry-Mieg, J., and Wang, C., and Wilson, M., and
Wolber, P. K., and Zhang, L., and Amur, S., and Bao, W., and Barbacioru, C. C., and
Lucas, A. B., and Bertholet, V., and Boysen, C., and Bromley, B., and Brown, D., and
Brunner, A., and Canales, R., and Cao, X. M., and Cebula, T. A., and Chen, J. J., and
Cheng, J., and Chu, T. M., and Chudin, E., and Corson, J., and Corton, J. C., and Croner,
L. J., and Davies, C., and Davison, T. S., and Delenstarr, G., and Deng, X., and Dorris,
D., and Eklund, A. C., and Fan, X. H., and Fang, H., and Fulmer-Smentek, S., and
Fuscoe, J. C., and Gallagher, K., and Ge, W., and Guo, L., and Guo, X., and Hager, J.,
and Haje, P. K., and Han, J., and Han, T., and Harbottle, H. C., and Harris, S. C., and
Hatchwell, E., and Hauser, C. A., and Hester, S., and Hong, H., and Hurban, P., and
Jackson, S. A., and Ji, H., and Knight, C. R., and Kuo, W. P., and LeClerc, J. E., and

161

Levy, S., and Li, Q. Z., and Liu, C., and Liu, Y., and Lombardi, M. J., and Ma, Y., and
Magnuson, S. R., and Maqsodi, B., and McDaniel, T., and Mei, N., and Myklebost, O.,
and Ning, B., and Novoradovskaya, N., and Orr, M. S., and Osborn, T. W., and Papallo,
A., and Patterson, T. A., and Perkins, R. G., and Peters, E. H., and Peterson, R., and
Philips, K. L., and Pine, P. S., and Pusztai, L., and Qian, F., and Ren, H., and Rosen, M.,
and Rosenzweig, B. A., and Samaha, R. R., and Schena, M., and Schroth, G. P., and
Shchegrova, S., and Smith, D. D., and Staedtler, F., and Su, Z., and Sun, H., and Szallasi,
Z., and Tezak, Z., and Thierry-Mieg, D., and Thompson, K. L., and Tikhonova, I., and
Turpaz, Y., and Vallanat, B., and Van, C., and Walker, S. J., and Wang, S. J., and Wang,
Y., and Wolfinger, R., and Wong, A., and Wu, J., and Xiao, C., and Xie, Q., and Xu, J.,
and Yang, W., and Zhang, L., and Zhong, S., and Zong, Y., and Slikker, W., Jr. (2006)
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform
reproducibility of gene expression measurements, Nature biotechnology 24, 1151-1161.
[106] Hu, H., Wrogemann, K., Kalscheuer, V., Tzschach, A., Richard, H., Haas, S. A., Menzel,
C., Bienek, M., Froyen, G., Raynaud, M., Van Bokhoven, H., Chelly, J., Ropers, H., and
Chen, W. (2009) Mutation screening in 86 known X-linked mental retardation genes by
droplet-based multiplex PCR and massive parallel sequencing, Hugo J 3, 41-49.
[107] Birney, E., and Stamatoyannopoulos, J. A., and Dutta, A., and Guigo, R., and Gingeras, T.
R., and Margulies, E. H., and Weng, Z., and Snyder, M., and Dermitzakis, E. T., and
Thurman, R. E., and Kuehn, M. S., and Taylor, C. M., and Neph, S., and Koch, C. M.,
and Asthana, S., and Malhotra, A., and Adzhubei, I., and Greenbaum, J. A., and
Andrews, R. M., and Flicek, P., and Boyle, P. J., and Cao, H., and Carter, N. P., and
Clelland, G. K., and Davis, S., and Day, N., and Dhami, P., and Dillon, S. C., and

162

Dorschner, M. O., and Fiegler, H., and Giresi, P. G., and Goldy, J., and Hawrylycz, M.,
and Haydock, A., and Humbert, R., and James, K. D., and Johnson, B. E., and Johnson,
E. M., and Frum, T. T., and Rosenzweig, E. R., and Karnani, N., and Lee, K., and
Lefebvre, G. C., and Navas, P. A., and Neri, F., and Parker, S. C., and Sabo, P. J., and
Sandstrom, R., and Shafer, A., and Vetrie, D., and Weaver, M., and Wilcox, S., and Yu,
M., and Collins, F. S., and Dekker, J., and Lieb, J. D., and Tullius, T. D., and Crawford,
G. E., and Sunyaev, S., and Noble, W. S., and Dunham, I., and Denoeud, F., and
Reymond, A., and Kapranov, P., and Rozowsky, J., and Zheng, D., and Castelo, R., and
Frankish, A., and Harrow, J., and Ghosh, S., and Sandelin, A., and Hofacker, I. L., and
Baertsch, R., and Keefe, D., and Dike, S., and Cheng, J., and Hirsch, H. A., and Sekinger,
E. A., and Lagarde, J., and Abril, J. F., and Shahab, A., and Flamm, C., and Fried, C., and
Hackermuller, J., and Hertel, J., and Lindemeyer, M., and Missal, K., and Tanzer, A., and
Washietl, S., and Korbel, J., and Emanuelsson, O., and Pedersen, J. S., and Holroyd, N.,
and Taylor, R., and Swarbreck, D., and Matthews, N., and Dickson, M. C., and Thomas,
D. J., and Weirauch, M. T., and Gilbert, J., and Drenkow, J., and Bell, I., and Zhao, X.,
and Srinivasan, K. G., and Sung, W. K., and Ooi, H. S., and Chiu, K. P., and Foissac, S.,
and Alioto, T., and Brent, M., and Pachter, L., and Tress, M. L., and Valencia, A., and
Choo, S. W., and Choo, C. Y., and Ucla, C., and Manzano, C., and Wyss, C., and
Cheung, E., and Clark, T. G., and Brown, J. B., and Ganesh, M., and Patel, S., and
Tammana, H., and Chrast, J., and Henrichsen, C. N., and Kai, C., and Kawai, J., and
Nagalakshmi, U., and Wu, J., and Lian, Z., and Lian, J., and Newburger, P., and Zhang,
X., and Bickel, P., and Mattick, J. S., and Carninci, P., and Hayashizaki, Y., and
Weissman, S., and Hubbard, T., and Myers, R. M., and Rogers, J., and Stadler, P. F., and

163

Lowe, T. M., and Wei, C. L., and Ruan, Y., and Struhl, K., and Gerstein, M., and
Antonarakis, S. E., and Fu, Y., and Green, E. D., and Karaoz, U., and Siepel, A., and
Taylor, J., and Liefer, L. A., and Wetterstrand, K. A., and Good, P. J., and Feingold, E.
A., and Guyer, M. S., and Cooper, G. M., and Asimenos, G., and Dewey, C. N., and Hou,
M., and Nikolaev, S., and Montoya-Burgos, J. I., and Loytynoja, A., and Whelan, S., and
Pardi, F., and Massingham, T., and Huang, H., and Zhang, N. R., and Holmes, I., and
Mullikin, J. C., and Ureta-Vidal, A., and Paten, B., and Seringhaus, M., and Church, D.,
and Rosenbloom, K., and Kent, W. J., and Stone, E. A., and Program, N. C. S., and
Baylor College of Medicine Human Genome Sequencing, C., and Washington University
Genome Sequencing, C., and Broad, I., and Children's Hospital Oakland Research, I., and
Batzoglou, S., and Goldman, N., and Hardison, R. C., and Haussler, D., and Miller, W.,
and Sidow, A., and Trinklein, N. D., and Zhang, Z. D., and Barrera, L., and Stuart, R.,
and King, D. C., and Ameur, A., and Enroth, S., and Bieda, M. C., and Kim, J., and
Bhinge, A. A., and Jiang, N., and Liu, J., and Yao, F., and Vega, V. B., and Lee, C. W.,
and Ng, P., and Shahab, A., and Yang, A., and Moqtaderi, Z., and Zhu, Z., and Xu, X.,
and Squazzo, S., and Oberley, M. J., and Inman, D., and Singer, M. A., and Richmond, T.
A., and Munn, K. J., and Rada-Iglesias, A., and Wallerman, O., and Komorowski, J., and
Fowler, J. C., and Couttet, P., and Bruce, A. W., and Dovey, O. M., and Ellis, P. D., and
Langford, C. F., and Nix, D. A., and Euskirchen, G., and Hartman, S., and Urban, A. E.,
and Kraus, P., and Van Calcar, S., and Heintzman, N., and Kim, T. H., and Wang, K.,
and Qu, C., and Hon, G., and Luna, R., and Glass, C. K., and Rosenfeld, M. G., and
Aldred, S. F., and Cooper, S. J., and Halees, A., and Lin, J. M., and Shulha, H. P., and
Zhang, X., and Xu, M., and Haidar, J. N., and Yu, Y., and Ruan, Y., and Iyer, V. R., and

164

Green, R. D., and Wadelius, C., and Farnham, P. J., and Ren, B., and Harte, R. A., and
Hinrichs, A. S., and Trumbower, H., and Clawson, H., and Hillman-Jackson, J., and
Zweig, A. S., and Smith, K., and Thakkapallayil, A., and Barber, G., and Kuhn, R. M.,
and Karolchik, D., and Armengol, L., and Bird, C. P., and de Bakker, P. I., and Kern, A.
D., and Lopez-Bigas, N., and Martin, J. D., and Stranger, B. E., and Woodroffe, A., and
Davydov, E., and Dimas, A., and Eyras, E., and Hallgrimsdottir, I. B., and Huppert, J.,
and Zody, M. C., and Abecasis, G. R., and Estivill, X., and Bouffard, G. G., and Guan,
X., and Hansen, N. F., and Idol, J. R., and Maduro, V. V., and Maskeri, B., and
McDowell, J. C., and Park, M., and Thomas, P. J., and Young, A. C., and Blakesley, R.
W., and Muzny, D. M., and Sodergren, E., and Wheeler, D. A., and Worley, K. C., and
Jiang, H., and Weinstock, G. M., and Gibbs, R. A., and Graves, T., and Fulton, R., and
Mardis, E. R., and Wilson, R. K., and Clamp, M., and Cuff, J., and Gnerre, S., and Jaffe,
D. B., and Chang, J. L., and Lindblad-Toh, K., and Lander, E. S., and Koriabine, M., and
Nefedov, M., and Osoegawa, K., and Yoshinaga, Y., and Zhu, B., and de Jong, P. J.
(2007) Identification and analysis of functional elements in 1% of the human genome by
the ENCODE pilot project, Nature 447, 799-816.
[108] Fox, J. (2000) Nonparametric Simple Regression : Smoothing Scatterplots, In Quantitative
Applications in the Social Sciences.Thousand Oaks, Calif : Sage
[109] Pollock, D. S. G., and Green, R. C. (1999) Handbook of Time Series Analysis, Signal
Processing, and Dynamics (Signal Processing and its Applications), Academic Press.
[110] Reinsch, C. H. (1967) Smoothing by Spline Functions, Numerische Mathematik.
[111] Pollock, D. S. G. (1999) A Handbook of Time-series Analysis, Signal Processing and
Dynamics, Academic, San Diego, CA.

165

[112] Bengtsson, H. (2004) aroma - An R Object-oriented Microarray Analysis environment,
Centre for Mathematical Sciences, Lund University.
[113] Bengtsson, H., and Hossjer, O. (2006) Methodological study of affine transformations of
gene expression data with proposed robust non-parametric multi-dimensional
normalization method, BMC Bioinformatics 7, 100.
[114] Leinonen, R., Sugawara, H., Shumway, M., and International Nucleotide Sequence
Database, C. (2011) The sequence read archive, Nucleic acids research 39, D19-21.
[115] McKenna, R., Xia, D., Willingmann, P., Ilag, L. L., Krishnaswamy, S., Rossmann, M. G.,
Olson, N. H., Baker, T. S., and Incardona, N. L. (2014) Atomic structure of singlestranded DNA bacteriophage ΦX174 and its functional implications, Nature.
[116] Sanger, F., Air, G., Barrell, B., Brown, N., Coulson, A., Fiddes, C., Hutchison, C.,
Slocombe, P., and Smith, M. (1977) Nucleotide sequence of bacteriophage phi X174
DNA, Nature.
[117] Shaw, D., Walker, J., Northrop, F., Barrell, B., Godson, G., and Fiddes, J. (1978) Gene K,
a new overlapping gene in bacteriophage G4, Nature.
[118] Dixon, W. J. (1950) Analysis of extreme values, The Annals of Mathematical Statistics.
[119] Dixon, W. J. (1951) Ratios involving extreme values, The Annals of Mathematical
Statistics.
[120] Grubbs, F. E. (1950) Sample criteria for testing outlying observations, The Annals of
Mathematical Statistics.
[121] Wei, Y., Pere, A., Koenker, R., and He, X. (2006) Quantile regression methods for
reference growth charts, Statistics In Medicine.

166

[122] Akima, H. (1970) A new method of interpolation and smooth curve fitting based on local
procedures, Journal of the Association for Computing Machinery.
[123] Knott, G. D. (2000) Interpolating Cubic Splines, Springer-Science+Business Media, LLC,
New York.
[124] Chen JQ, W. Y., Yang H, Bergelson J, Kreitman M, Tian D. (2009) Variation in the ratio
of nucleotide substitution and indel rates across genomes in mammals and bacteria, Mol
Biol Evol.
[125] Denver DR, M. K., Lynch M, Thomas WK. (2004) High mutation rate and predominance
of insertions in the Caenorhabditis elegans nuclear genome, Nature.
[126] Britten RJ, R. L., Williams J, Cameron RA. (2003) Majority of divergence between closely
related DNA samples is due to indels, Proc Natl Acad Sci USA.
[127] Sun X, Z. Y., Yang S, Chen JQ, Hohn B, Tian D. (2008) Insertion DNA promotes ectopic
recombination during meiosis in Arabidopsis, Mol Biol Evol.
[128] AM, N. (2001) Complex patterns of plastid 16S rRNA gene evolution in
nonphotosynthetic green algae, Mol Evol.
[129] Zhang Z, G. M. (2003) Patterns of nucleotide substitution, insertion and deletion in the
human genome inferred from pseudogenes, Nucleic Acids Res.
[130] Petrov DA, S. T., Johnston JS, Hartl DL, Shaw KL. (2000) Evidence for DNA loss as a
determinant of genome size. Science, Science
[131] TR, G. (2004) Insertion-deletion biases and the evolution of genome size, Gene.
[132] Zoghbi HY, O. H. (2000) Glutamine repeats and neurodegeneration, Annu Rev Neurosci.
[133] Kondrashov AS, R. I. (2004) Context of deletions and insertions in human coding
sequences, Hum Mutat.

167

[134] Ferro P, d. E. R., Pfeffer U. (2001) Are there CAG repeat expansion-related disorders
outside the central nervous system?, Brain Res Bull.
[135] Burch CL, D. R., Stein DC. (1997) Antigenic variation in Neisseria gonorrhoeae:
production of multiple lipooligosaccharides, J Bacteriol.
[136] Rocha EP, B. A. (2002) Genomic repeats, genome plasticity and the dynamics of
Mycoplasma evolution, Nucleic Acids Res.
[137] Yang H, Z. Y., Peng C, Chen JQ, Tian D. (2010) Important role of indels in somatic
mutations of human cancer genes, BMC Med Genet.
[138] Lee, H., Doak, T. G., Popodi, E., Foster, P. L., and Tang, H. (2016) Insertion sequencecaused large-scale rearrangements in the genome of Escherichia coli, Nucleic Acids Res
44, 7109-7119.
[139] https://ghr.nlm.nih.gov/primer/mutationsanddisorders/structuralchangesReference, G. H.
Can changes in the structure of chromosomes affect health and development?, U.S.
National Library of Medicine.
[140] Korbel, J. O., Urban, A. E., Affourtit, J. P., Godwin, B., Grubert, F., Simons, J. F., Kim, P.
M., Palejev, D., Carriero, N. J., Du, L., Taillon, B. E., Chen, Z. T., Tanzer, A., Saunders,
A. C. E., Chi, J. X., Yang, F. T., Carter, N. P., Hurles, M. E., Weissman, S. M., Harkins,
T. T., Gerstein, M. B., Egholm, M., and Snyder, M. (2007) Paired-end mapping reveals
extensive structural variation in the human genome, Science 318, 420-426.
[141] Chen, J., Kim, Y. C., Jung, Y. C., Xuan, Z. Y., Dworkin, G., Zhang, Y. M., Zhang, M. Q.,
and Wang, S. M. (2008) Scanning the human genome at kilobase resolution, Genome Res
18, 751-762.

168

[142] Kidd, J. M., Cooper, G. M., Donahue, W. F., Hayden, H. S., Sampas, N., Graves, T.,
Hansen, N., Teague, B., Alkan, C., Antonacci, F., Haugen, E., Zerr, T., Yamada, N. A.,
Tsang, P., Newman, T. L., Tuzun, E., Cheng, Z., Ebling, H. M., Tusneem, N., David, R.,
Gillett, W., Phelps, K. A., Weaver, M., Saranga, D., Brand, A., Tao, W., Gustafson, E.,
McKernan, K., Chen, L., Malig, M., Smith, J. D., Korn, J. M., McCarroll, S. A.,
Altshuler, D. A., Peiffer, D. A., Dorschner, M., Stamatoyannopoulos, J., Schwartz, D.,
Nickerson, D. A., Mullikin, J. C., Wilson, R. K., Bruhn, L., Olson, M. V., Kaul, R.,
Smith, D. R., and Eichler, E. E. (2008) Mapping and sequencing of structural variation
from eight human genomes, Nature 453, 56-64.
[143] Korbel, J. O., Abyzov, A., Mu, X. J., Carriero, N., Cayting, P., Zhang, Z. D., Snyder, M.,
and Gerstein, M. B. (2009) PEMer: a computational framework with simulation-based
error models for inferring genomic structural variants from massive paired-end
sequencing data, Genome Biol 10.
[144] Robert McKenna, D. X., Peter Willingmann, Leodevico L. Ilag, S. Krishnaswamy,
Michael G. Rossmann, Norman H. Olson, Timothy S. Baker, Nino L. Incardona. (1992)
Atomic structure of single-stranded DNA bacteriophage ΦX174 and its functional
implications, Nature.
[145] Xuan Zhu, J. W., Bo Peng, Sanjay Shete. (2016) Empirical estimation of sequencing error
rates using smoothing splines, BMC Bioinformatics.
[146] Nakamura, K., Oshima, T., Morimoto, T., Ikeda, S., Yoshikawa, H., Shiwa, Y., Ishikawa,
S., Linak, M. C., Hirai, A., Takahashi, H., Altaf-Ul-Amin, M., Ogasawara, N., and
Kanaya, S. (2011) Sequence-specific error profile of Illumina sequencers, Nucleic Acids
Res 39, e90.

169

[147] Ursell, L. K., Metcalf, J. L., Parfrey, L. W., and Knight, R. (2012) Defining the human
microbiome, Nutr Rev 70 Suppl 1, S38-44.
[148] Li, H. (2015) Microbiome, Metagenomics, and High-Dimensional Compositional Data
Analysis, Annual Review of Statistics and Its Application 2, 73-94.
[149] Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., and Gordon, J. I. (2005) Hostbacterial mutualism in the human intestine, Science 307, 1915-1920.
[150] http://hmpdacc.org/micro_analysis/microbiome_analyses.phpAbout HMP Metagenomic
Sequencing & Analysis
[151] Sandrine P Claus, H. G., Sandrine Ellero-Simatos. (2016) The gut microbiota: a major
player in the toxicity of environmental pollutants?, npj Biofilms and Microbiomes 2.
[152] https://www.nih.gov/news-events/news-releases/nih-human-microbiome-project-definesnormal-bacterial-makeup-body(2012) NIH Human Microbiome Project defines normal
bacterial makeup of the body
[153] Tang, W. H. W., and Hazen, S. L. (2014) The contributory role of gut microbiota in
cardiovascular disease, J Clin Invest 124, 4204-4211.
[154] Dulal, S., and Keku, T. O. (2014) Gut Microbiome and Colorectal Adenomas, Cancer J
20, 225-231.
[155] Woo, P. C. Y., Lau, S. K. P., Teng, J. L. L., Tse, H., and Yuen, K. Y. (2008) Then and
now: use of 16S rDNA gene sequencing for bacterial identification and discovery of
novel bacteria in clinical microbiology laboratories, Clin Microbiol Infec 14, 908-934.
[156] Hamady, M., and Knight, R. (2009) Microbial community profiling for human microbiome
projects: Tools, techniques, and challenges, Genome Res 19, 1141-1152.

170

[157] Fiona Stewart, E. Y. (2014) Addressing Challenges in Microbiome DNA Analysis, NEB
UK Expressions.
[158] Brooks, J. P. (2016) Challenges for case-control studies with microbiome data, Ann
Epidemiol 26, 336-341 e331.
[159] Yang, L., Chaudhary, N., Baghdadi, J., and Pei, Z. (2014) Microbiome in reflux disorders
and esophageal adenocarcinoma, Cancer J 20, 207-210.
[160] Gilles, A., Meglecz, E., Pech, N., Ferreira, S., Malausa, T., and Martin, J. F. (2011)
Accuracy and quality assessment of 454 GS-FLX Titanium pyrosequencing, BMC
Genomics 12, 245.
[161] Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N.,
Owens, S. M., Betley, J., Fraser, L., Bauer, M., Gormley, N., Gilbert, J. A., Smith, G.,
and Knight, R. (2012) Ultra-high-throughput microbial community analysis on the
Illumina HiSeq and MiSeq platforms, ISME J 6, 1621-1624.
[162] Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B.,
Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., Sahl, J. W., Stres, B.,
Thallinger, G. G., Van Horn, D. J., and Weber, C. F. (2009) Introducing mothur: opensource, platform-independent, community-supported software for describing and
comparing microbial communities, Appl Environ Microbiol 75, 7537-7541.
[163] Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E.
K., Fierer, N., Pena, A. G., Goodrich, J. K., Gordon, J. I., Huttley, G. A., Kelley, S. T.,
Knights, D., Koenig, J. E., Ley, R. E., Lozupone, C. A., McDonald, D., Muegge, B. D.,
Pirrung, M., Reeder, J., Sevinsky, J. R., Turnbaugh, P. J., Walters, W. A., Widmann, J.,

171

Yatsunenko, T., Zaneveld, J., and Knight, R. (2010) QIIME allows analysis of highthroughput community sequencing data, Nat Methods 7, 335-336.
[164] Erica Plummer, J. T., Dieter M. Bulach, Suzanne M. Garland, Sepehr N Tabrizi. (2015) A
Comparison of Three Bioinformatics Pipelines for the Analysis of Preterm Gut
Microbiota using 16S rRNA Gene Sequencing Data, Journal of Proteomics &
Bioinformatics 8, 283-291.
[165] Navas-Molina, J. A., Peralta-Sanchez, J. M., Gonzalez, A., McMurdie, P. J., VazquezBaeza, Y., Xu, Z. J., Ursell, L. K., Lauber, C., Zhou, H. W., Song, S. J., Huntley, J.,
Ackermann, G. L., Berg-Lyons, D., Holmes, S., Caporaso, J. G., and Knight, R. (2013)
Advancing Our Understanding of the Human Microbiome Using QIIME, Method
Enzymol 531, 371-444.
[166] Mir, K., Neuhaus, K., Bossert, M., and Schober, S. (2013) Short Barcodes for Next
Generation Sequencing, Plos One 8.
[167] Edgar, R. C. (2013) UPARSE: highly accurate OTU sequences from microbial amplicon
reads, Nature Methods 10, 996–998.
[168] http://www.nature.com/scitable/definition/primer-305(2014) Scitable by nature education.
[169] De Beuf, K., De Schrijver, J., Thas, O., Van Criekinge, W., Irizarry, R. A., and Clement,
L. (2012) Improved base-calling and quality scores for 454 sequencing based on a Hurdle
Poisson model, Bmc Bioinformatics 13.
[170] Si, X. F., Baselga, A., Leprieur, F., Song, X., and Ding, P. (2016) Selective extinction
drives taxonomic and functional alpha and beta diversities in island bird assemblages, J
Anim Ecol 85, 409-418.

172

[171] McMurdie, P. J., and Holmes, S. (2013) phyloseq: An R Package for Reproducible
Interactive Analysis and Graphics of Microbiome Census Data, Plos One 8.
[172] Hill, M. O. (1973) Diversity and Evenness: A Unifying Notation and Its Consequences,
Ecology 54, 427-432.
[173] Lande, R. (1996) Statistics and partitioning of species diversity, and similarity among
multiple communities, Oikos 76, 5-13.
[174] Sandra D. Williamson, K. B. (2013) Species richness and diversity of a terrestrial insular
environment: serpentine of the Barberton Greenstone Belt, South Africa, International
Journal of Biodiversity and Conservation 5(5), 296-310.
[175] Morris, E. K., Caruso, T., Buscot, F., Fischer, M., Hancock, C., Maier, T. S., Meiners, T.,
Muller, C., Obermaier, E., Prati, D., Socher, S. A., Sonnemann, I., Waschke, N., Wubet,
T., Wurst, S., and Rillig, M. C. (2014) Choosing and using diversity indices: insights for
ecological applications from the German Biodiversity Exploratories, Ecol Evol 4, 35143524.
[176] Saucedo-Garcia, A., Anaya, A. L., Espinosa-Garcia, F. J., and Gonzalez, M. C. (2014)
Diversity and Communities of Foliar Endophytic Fungi from Different Agroecosystems
of Coffea arabica L. in Two Regions of Veracruz, Mexico, Plos One 9.
[177] Williams, V. L., Witkowski, E. T. F., and Balkwill, K. (2005) Application of diversity
indices to appraise plant availability in the traditional medicinal markets of Johannesburg,
South Africa, Biodivers Conserv 14, 2971-3001.
[178] Colwell, R. K. (2009) Biodiversity: concepts, patterns, and measurement, In The Princeton
Guide to Ecology (Levin, S. A., Ed.), pp 257-263, Princeton Univ. Press, Princeton, NJ.

173

[179] Fisher, R. A., Corbet, A. S., and Williams, C. B. (1943) The relation between the number
of species and the number of individuals in a random sample of an animal population, J
Anim Ecol 12, 42-58.
[180] Hughes, J. B., Hellmann, J. J., Ricketts, T. H., and Bohannan, B. J. (2001) Counting the
uncountable: statistical approaches to estimating microbial diversity, Appl Environ
Microbiol 67, 4399-4406.
[181] Chao, A., Ma, M. C., and Yang, M. C. K. (1993) Stopping Rules and Estimation for
Recapture Debugging with Unequal Failure Rates, Biometrika 80, 193-201.
[182] Gotelli, N. J. a. R. K. C. (2010) Estimating species richness, In Frontiers in measuring
biodiversity (Anne E. Magurran, B. J. M., Ed.), pp 39-54, Oxford University New York.
[183] Chao, A., Chazdon, R. L., Colwell, R. K., and Shen, T. J. (2005) A new statistical
approach for assessing similarity of species composition with incidence and abundance
data, Ecol Lett 8, 148-159.
[184] Soininen, J. (2010) Species Turnover along Abiotic and Biotic Gradients: Patterns in Space
Equal Patterns in Time?, Bioscience 60, 433-439.
[185] Koleff, P., Gaston, K. J., and Lennon, J. J. (2003) Measuring beta diversity for presenceabsence data, J Anim Ecol 72, 367-382.
[186] http://biology-forums.com/definitions/index.php/Species_turnoverIn Biology-forums.com.
[187] Shirkhorshidi, A. S., Aghabozorgi, S., and Wah, T. Y. (2015) A Comparison Study on
Similarity and Dissimilarity Measures in Clustering Continuous Data, Plos One 10,
e0144059.
[188] Emran, S. M., and Ye, N. (2002) Robustness of Chi-square and Canberra distance metrics
for computer intrusion detection, Qual Reliab Eng Int 18, 19-28.

174

[189] Giuseppe Jurman, S. R., Roberto Visintainer, Cesare Furlanello. (2009) Canberra distance
on ranked lists, Advances in Ranking–NIPS 09 Workshop, 22-27.
[190] Hennig, C., and Hausdorf, B. (2006) Design of dissimilarity measures: A new dissimilarity
between species distribution areas, In Stud Class Data Anal (Batagelj, V., Bock, H.-H.,
Ferligoj, A., and Žiberna, A., Eds.), pp 29-37, Springer Berlin Heidelberg, Berlin,
Heidelberg.
[191] Anderson, M. J., and Millar, R. B. (2004) Spatial variation and effects of habitat on
temperate reef fish assemblages in northeastern New Zealand, J Exp Mar Biol Ecol 305,
191-221.
[192] Horn, H. S. (1966) Measurement of Overlap in Comparative Ecological Studies, Am Nat
100, 419-&.
[193] Ali Seyed Shirkhorshidi, S. A., Teh Ying Wah. (2015) A Comparison Study on Similarity
and Dissimilarity Measures in Clustering Continuous Data, PLOS ONE.
[194] Syed Masum Emran, N. Y. (2002) Robustness of Chi-Square and Canberrra distance
metreics for computer intrusion detection, Quality and Reliability Engineering
International.
[195] Giuseppe Jurman, S. R., Roberto Visintainer, Cesare Furlanello. (2009) Canberra distance
on ranked lists, Advances in Ranking–NIPS 09 Workshop.
[196] Christian Hennig, B. H. (2006) Design of Dissimilarity Measures: A New Dissimilarity
Between Species Distribution Areas In Data Science and Classification (Prof. Dr.
Vladimir Batagelj, P. D. H.-H. B., Prof. Dr. Anuška Ferligoj, Aleš Žiberna, Ed.), pp 57203, Springer Berlin Heidelberg.

175

[197] Tulloss, R. E. (1997) Assessment of Similarity Indices for Undesirable Properties and a
new Tripartite Similarity Index Based on Cost Functions, Mycology in Sustainable
Development: Expanding Concepts, Vanishing Borders.
[198] Anderson, M. J. a. M., R.B. . (2004) Spatial variation and effects of habitat on temperate
reef fish assemblages in northeastern New Zealand. , Journal of Experimental Marine
Biology and Ecology 191–221.
[199] Clark, P. J. (1952) An Extension of the Coefficient of Divergence for Use with Multiple
Characters, American Society of Ichthyologists and Herpetologists (ASIH) 2, 61-64.
[200] Horn, H. S. (1966) Measurement of "Overlap" in comparative ecological studies. , The
American Naturalist, 419-424.
[201] Horn, H. S. (1966) Measurement of "Overlap" in Comparative Ecological Studies, The
American Naturalist 100.
[202] V. Arora a, S. K., S.S. Ghantoji, H.L. DuPont, K.W. Garey. (2011) High Horn’s index
score predicts poor outcomes in patients with Clostridium difficile infection, Journal of
Hospital Infection 79.
[203] Clarke, K. R., Somerfield, P. J., and Chapman, M. G. (2006) On resemblance measures for
ecological studies, including taxonomic dissimilarities and a zero-adjusted Bray-Curtis
coefficient for denuded assemblages, J Exp Mar Biol Ecol 330, 55-80.
[204] Fukuyama, J., McMurdie, P. J., Dethlefsen, L., Relman, D. A., and Holmes, S. (2012)
Comparisons of distance methods for combining covariates and abundances in
microbiome studies, Pac Symp Biocomput, 213-224.
[205] Lozupone, C. A., and Knight, R. (2007) Global patterns in bacterial diversity, P Natl Acad
Sci USA 104, 11436-11440.

176

[206] Schloss, P. D. (2008) Evaluating different approaches that test whether microbial
communities have the same structure, Isme Journal 2, 265-275.
[207] Ives, A. R., and Helmus, M. R. (2010) Phylogenetic metrics of community similarity, Am
Nat 176, E128-142.
[208] McArdle, B. H., and Anderson, M. J. (2001) Fitting multivariate models to community
data: A comment on distance-based redundancy analysis, Ecology 82, 290-297.
[209] Jun Chen, H. L. (2013) Variable selection for sparse Dirichlet-multinomial regression with
an application to microbiome data analysis, Ann. Appl. Stat.
[210] Ni Zhao, J. C., Ian M. Carroll, Tamar Ringel-Kulka, Michael P. Epstein, Hua Zhou, Jin J.
Zhou, Yehuda Ringel, Hongzhe Li, Michael C. Wu. (2015) Testing in MicrobiomeProfiling Studies with MiRKAT, the Microbiome Regression-Based Kernel Association
Test, The American Society of Human Genetics.
[211] Scealy, J. L., and Welsh, A. H. (2011) Regression for compositional data by using
distributions defined on the hypersphere, J R Stat Soc B 73, 351-375.
[212] Kent, J. T. (1982) The Fisher-Bingham Distribution on the Sphere, J Roy Stat Soc B Met
44, 71-80.
[213] Aitchison, J. (1982) The Statistical-Analysis of Compositional Data, J Roy Stat Soc B Met
44, 139-177.
[214] Shi, P. X., Zhang, A. R., and Li, H. Z. (2016) Regression Analysis for Microbiome
Compositional Data, Ann Appl Stat 10, 1019-1040.
[215] Fisher, C. K., and Mehta, P. (2014) Identifying Keystone Species in the Human Gut
Microbiome from Metagenomic Timeseries Using Sparse Linear Regression, Plos One 9.

177

[216] Chen, E. Z., and Li, H. Z. (2016) A two-part mixed-effects model for analyzing
longitudinal microbiome compositional data, Bioinformatics 32, 2611-2617.
[217] Zhao, N., Chen, J., Carroll, I. M., Ringel-Kulka, T., Epstein, M. P., Zhou, H., Zhou, J. J.,
Ringel, Y., Li, H. Z., and Wu, M. C. (2015) Testing in Microbiome-Profiling Studies
with MiRKAT, the Microbiome Regression-Based Kernel Association Test, Am J Hum
Genet 96, 797-807.
[218] Gevers, D., Knight, R., Petrosino, J. F., Huang, K., McGuire, A. L., Birren, B. W., Nelson,
K. E., White, O., Methe, B. A., and Huttenhower, C. (2012) The Human Microbiome
Project: A Community Resource for the Healthy Human Microbiome, Plos Biol 10.
[219] http://dx.doi.org/10.1101/088666Edgar, R. C. (2016) Filtering of high-frequency crosstalk in 16S amplicon reads.
[220] McDonald, D., Price, M. N., Goodrich, J., Nawrocki, E. P., DeSantis, T. Z., Probst, A.,
Andersen, G. L., Knight, R., and Hugenholtz, P. (2012) An improved Greengenes
taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and
archaea, Isme Journal 6, 610-618.
[221] https://www.R-project.org/Team, R. C. (2015) R: A language and environment for
statistical computing, In R Foundation for Statistical Computing, Vienna, Austria.
[222] K. Gerald van den Boogaart, R. T., Matevz Bren. (2014) compositions: Compositional
Data Analysis, In R package version 1.40-1.
[223] Jari Oksanen, F. G. B., Michael Friendly, Roeland Kindt, Pierre Legendre, Dan McGlinn,
Peter R. Minchin, R. B. O'Hara, Gavin L. Simpson, Peter Solymos, M. Henry H.
Stevens. (2016) vegan: Community Ecology Package, (Wagner, E. S. a. H., Ed.).

178

[224] Paradis, E., Claude, J., and Strimmer, K. (2004) APE: Analyses of Phylogenetics and
Evolution in R language, Bioinformatics 20, 289-290.
[225] Bokulich, N. A., Subramanian, S., Faith, J. J., Gevers, D., Gordon, J. I., Knight, R., Mills,
D. A., and Caporaso, J. G. (2013) Quality-filtering vastly improves diversity estimates
from Illumina amplicon sequencing, Nature Methods 10, 57-U11.
[226] Walters, W. A., Caporaso, J. G., Lauber, C. L., Berg-Lyons, D., Fierer, N., and Knight, R.
(2011) PrimerProspector: de novo design and taxonomic analysis of barcoded polymerase
chain reaction primers, Bioinformatics 27, 1159-1161.
[227] Scott L. Zeger, K. Y. L. (1992) An overview of methods for the analysis of longitudinal
data, Statistics in Medicine.
[228] Friedman, N., Linial, M., Nachman, I., and Pe'er, D. (2000) Using Bayesian networks to
analyze expression data, J Comput Biol 7, 601-620.
[229] Yang Ni, F. C. S. V. B. (2016) Sparse Multi-dimensional Graphical Models: A Unified
Bayesian Framework, Journal of the American Statistical Association.
[230] Dobra, A., Lenkoski, A., and Rodriguez, A. (2011) Bayesian Inference for General
Gaussian Graphical Models With Application to Multivariate Lattice Data, J Am Stat
Assoc 106, 1418-1433.
[231] Leng, C. L., and Tang, C. Y. (2012) Sparse Matrix Graphical Models, Journal of the
American Statistical Association 107, 1187-1200.
[232] McGeachie, M. J., Sordillo, J. E., Gibson, T., Weinstock, G. M., Liu, Y. Y., Gold, D. R.,
Weiss, S. T., and Litonjua, A. (2016) Longitudinal Prediction of the Infant Gut
Microbiome with Dynamic Bayesian Networks, Sci Rep-Uk 6.

179

[233] Xia, F., Chen, J., Fung, W. K., and Li, H. Z. (2013) A Logistic Normal Multinomial
Regression Model for Microbiome Compositional Data Analysis, Biometrics 69, 10531063.
[234] Kurtz, Z. D., Muller, C. L., Miraldi, E. R., Littman, D. R., Blaser, M. J., and Bonneau, R.
A. (2015) Sparse and Compositionally Robust Inference of Microbial Ecological
Networks, Plos Comput Biol 11.
[235] Chen, J., and Li, H. Z. (2013) Kernel Methods for Regression Analysis of Microbiome
Compositional Data, Springer P Math Stat 55, 191-201.

180

VITA

Xuan Zhu was born in March 1989 in China. She graduated from The Ohio State University,
Columbus, with a major in actuarial science and a minor in statistics. In January 2013, she
officially started her Ph.D. training in the Biostatistics, Bioinformatics and Systems Biology
Program at The University of Texas MD Anderson Cancer Center UT Health Graduate School of
Biomedical Sciences. She conducted her thesis research under the supervision of Dr. Sanjay S.
Shete, a professor in the Department of Biostatistics at The University of Texas MD Anderson
Cancer Center. She expects to finish her Ph.D. in May 2017.

181

